id	sid	tid	token	lemma	pos
cord-018907-c84t1bo5	1	1	key	key	JJ
cord-018907-c84t1bo5	1	2	:	:	:
cord-018907-c84t1bo5	1	3	cord-018907-c84t1bo5	cord-018907-c84t1bo5	NN
cord-018907-c84t1bo5	1	4	authors	author	NNS
cord-018907-c84t1bo5	1	5	:	:	:
cord-018907-c84t1bo5	1	6	Bin	Bin	NNP
cord-018907-c84t1bo5	1	7	-	-	HYPH
cord-018907-c84t1bo5	1	8	Hussain	Hussain	NNP
cord-018907-c84t1bo5	1	9	,	,	,
cord-018907-c84t1bo5	1	10	Ibrahim	Ibrahim	NNP
cord-018907-c84t1bo5	1	11	title	title	NN
cord-018907-c84t1bo5	1	12	:	:	:
cord-018907-c84t1bo5	1	13	Infections	infection	NNS
cord-018907-c84t1bo5	1	14	in	in	IN
cord-018907-c84t1bo5	1	15	the	the	DT
cord-018907-c84t1bo5	1	16	Immunocompromised	Immunocompromised	NNP
cord-018907-c84t1bo5	1	17	Host	Host	NNP
cord-018907-c84t1bo5	1	18	date	date	NN
cord-018907-c84t1bo5	1	19	:	:	:
cord-018907-c84t1bo5	1	20	2012	2012	CD
cord-018907-c84t1bo5	1	21	journal	journal	NNP
cord-018907-c84t1bo5	1	22	:	:	:
cord-018907-c84t1bo5	2	1	Textbook	textbook	NN
cord-018907-c84t1bo5	2	2	of	of	IN
cord-018907-c84t1bo5	2	3	Clinical	Clinical	NNP
cord-018907-c84t1bo5	2	4	Pediatrics	Pediatrics	NNP
cord-018907-c84t1bo5	2	5	DOI	DOI	NNP
cord-018907-c84t1bo5	2	6	:	:	:
cord-018907-c84t1bo5	3	1	10.1007/978	10.1007/978	LS
cord-018907-c84t1bo5	3	2	-	-	SYM
cord-018907-c84t1bo5	3	3	3	3	CD
cord-018907-c84t1bo5	3	4	-	-	HYPH
cord-018907-c84t1bo5	3	5	642	642	CD
cord-018907-c84t1bo5	3	6	-	-	HYPH
cord-018907-c84t1bo5	3	7	02202	02202	CD
cord-018907-c84t1bo5	3	8	-	-	HYPH
cord-018907-c84t1bo5	3	9	9_68	9_68	CD
cord-018907-c84t1bo5	3	10	sha	sha	NNP
cord-018907-c84t1bo5	3	11	:	:	:
cord-018907-c84t1bo5	3	12	d862b4875d483afd2789ea3f5df303c3bdbd76d4	d862b4875d483afd2789ea3f5df303c3bdbd76d4	NNP
cord-018907-c84t1bo5	3	13	doc_id	doc_id	NNPS
cord-018907-c84t1bo5	3	14	:	:	:
cord-018907-c84t1bo5	3	15	18907	18907	CD
cord-018907-c84t1bo5	3	16	cord_uid	cord_uid	NNS
cord-018907-c84t1bo5	3	17	:	:	:
cord-018907-c84t1bo5	4	1	c84t1bo5	c84t1bo5	NNP
cord-018907-c84t1bo5	4	2	nan	nan	NNP
cord-018907-c84t1bo5	4	3	Infections	Infections	NNP
cord-018907-c84t1bo5	4	4	are	be	VBP
cord-018907-c84t1bo5	4	5	considered	consider	VBN
cord-018907-c84t1bo5	4	6	a	a	DT
cord-018907-c84t1bo5	4	7	major	major	JJ
cord-018907-c84t1bo5	4	8	cause	cause	NN
cord-018907-c84t1bo5	4	9	of	of	IN
cord-018907-c84t1bo5	4	10	morbidity	morbidity	NN
cord-018907-c84t1bo5	4	11	and	and	CC
cord-018907-c84t1bo5	4	12	mortality	mortality	NN
cord-018907-c84t1bo5	4	13	in	in	IN
cord-018907-c84t1bo5	4	14	immunocompromised	immunocompromised	JJ
cord-018907-c84t1bo5	4	15	children	child	NNS
cord-018907-c84t1bo5	4	16	.	.	.
cord-018907-c84t1bo5	5	1	The	the	DT
cord-018907-c84t1bo5	5	2	survival	survival	NN
cord-018907-c84t1bo5	5	3	rate	rate	NN
cord-018907-c84t1bo5	5	4	in	in	IN
cord-018907-c84t1bo5	5	5	this	this	DT
cord-018907-c84t1bo5	5	6	particular	particular	JJ
cord-018907-c84t1bo5	5	7	population	population	NN
cord-018907-c84t1bo5	5	8	has	have	VBZ
cord-018907-c84t1bo5	5	9	increased	increase	VBN
cord-018907-c84t1bo5	5	10	over	over	IN
cord-018907-c84t1bo5	5	11	the	the	DT
cord-018907-c84t1bo5	5	12	last	last	JJ
cord-018907-c84t1bo5	5	13	3	3	CD
cord-018907-c84t1bo5	5	14	decades	decade	NNS
cord-018907-c84t1bo5	5	15	.	.	.
cord-018907-c84t1bo5	6	1	This	this	DT
cord-018907-c84t1bo5	6	2	is	be	VBZ
cord-018907-c84t1bo5	6	3	mainly	mainly	RB
cord-018907-c84t1bo5	6	4	due	due	JJ
cord-018907-c84t1bo5	6	5	to	to	IN
cord-018907-c84t1bo5	6	6	the	the	DT
cord-018907-c84t1bo5	6	7	advancement	advancement	NN
cord-018907-c84t1bo5	6	8	in	in	IN
cord-018907-c84t1bo5	6	9	medical	medical	JJ
cord-018907-c84t1bo5	6	10	technology	technology	NN
cord-018907-c84t1bo5	6	11	leading	lead	VBG
cord-018907-c84t1bo5	6	12	to	to	IN
cord-018907-c84t1bo5	6	13	improvement	improvement	NN
cord-018907-c84t1bo5	6	14	in	in	IN
cord-018907-c84t1bo5	6	15	diagnosis	diagnosis	NN
cord-018907-c84t1bo5	6	16	capabilities	capability	NNS
cord-018907-c84t1bo5	6	17	as	as	RB
cord-018907-c84t1bo5	6	18	well	well	RB
cord-018907-c84t1bo5	6	19	as	as	IN
cord-018907-c84t1bo5	6	20	supportive	supportive	JJ
cord-018907-c84t1bo5	6	21	care	care	NN
cord-018907-c84t1bo5	6	22	including	include	VBG
cord-018907-c84t1bo5	6	23	antimicrobial	antimicrobial	JJ
cord-018907-c84t1bo5	6	24	therapy	therapy	NN
cord-018907-c84t1bo5	6	25	.	.	.
cord-018907-c84t1bo5	7	1	Immunodeficiency	immunodeficiency	NN
cord-018907-c84t1bo5	7	2	can	can	MD
cord-018907-c84t1bo5	7	3	be	be	VB
cord-018907-c84t1bo5	7	4	divided	divide	VBN
cord-018907-c84t1bo5	7	5	into	into	IN
cord-018907-c84t1bo5	7	6	primary	primary	JJ
cord-018907-c84t1bo5	7	7	and	and	CC
cord-018907-c84t1bo5	7	8	secondary	secondary	JJ
cord-018907-c84t1bo5	7	9	immunodeficiency	immunodeficiency	NN
cord-018907-c84t1bo5	7	10	disorders	disorder	NNS
cord-018907-c84t1bo5	7	11	.	.	.
cord-018907-c84t1bo5	8	1	Primary	primary	JJ
cord-018907-c84t1bo5	8	2	immunodeficiency	immunodeficiency	NN
cord-018907-c84t1bo5	8	3	disorders	disorder	NNS
cord-018907-c84t1bo5	8	4	including	include	VBG
cord-018907-c84t1bo5	8	5	combined	combine	VBN
cord-018907-c84t1bo5	8	6	T	t	NN
cord-018907-c84t1bo5	8	7	-	-	HYPH
cord-018907-c84t1bo5	8	8	cell	cell	NN
cord-018907-c84t1bo5	8	9	and	and	CC
cord-018907-c84t1bo5	8	10	B	b	NN
cord-018907-c84t1bo5	8	11	-	-	HYPH
cord-018907-c84t1bo5	8	12	cell	cell	NN
cord-018907-c84t1bo5	8	13	immunodeficiencies	immunodeficiency	NNS
cord-018907-c84t1bo5	8	14	,	,	,
cord-018907-c84t1bo5	8	15	antibody	antibody	NN
cord-018907-c84t1bo5	8	16	deficiency	deficiency	NN
cord-018907-c84t1bo5	8	17	,	,	,
cord-018907-c84t1bo5	8	18	disease	disease	NN
cord-018907-c84t1bo5	8	19	of	of	IN
cord-018907-c84t1bo5	8	20	immune	immune	JJ
cord-018907-c84t1bo5	8	21	dysregulation	dysregulation	NN
cord-018907-c84t1bo5	8	22	,	,	,
cord-018907-c84t1bo5	8	23	congenital	congenital	JJ
cord-018907-c84t1bo5	8	24	defects	defect	NNS
cord-018907-c84t1bo5	8	25	of	of	IN
cord-018907-c84t1bo5	8	26	Phagocyte	Phagocyte	NNP
cord-018907-c84t1bo5	8	27	number	number	NN
cord-018907-c84t1bo5	8	28	or	or	CC
cord-018907-c84t1bo5	8	29	function	function	NN
cord-018907-c84t1bo5	8	30	or	or	CC
cord-018907-c84t1bo5	8	31	both	both	DT
cord-018907-c84t1bo5	8	32	,	,	,
cord-018907-c84t1bo5	8	33	defects	defect	NNS
cord-018907-c84t1bo5	8	34	in	in	IN
cord-018907-c84t1bo5	8	35	innate	innate	JJ
cord-018907-c84t1bo5	8	36	immunity	immunity	NN
cord-018907-c84t1bo5	8	37	,	,	,
cord-018907-c84t1bo5	8	38	autoimmunity	autoimmunity	NN
cord-018907-c84t1bo5	8	39	disorders	disorder	NNS
cord-018907-c84t1bo5	8	40	,	,	,
cord-018907-c84t1bo5	8	41	complement	complement	NN
cord-018907-c84t1bo5	8	42	deficiencies	deficiency	NNS
cord-018907-c84t1bo5	8	43	,	,	,
cord-018907-c84t1bo5	8	44	and	and	CC
cord-018907-c84t1bo5	8	45	cytokine	cytokine	NN
cord-018907-c84t1bo5	8	46	defects	defect	NNS
cord-018907-c84t1bo5	8	47	.	.	.
cord-018907-c84t1bo5	9	1	Secondary	secondary	JJ
cord-018907-c84t1bo5	9	2	immunodeficiency	immunodeficiency	NN
cord-018907-c84t1bo5	9	3	disorders	disorder	NNS
cord-018907-c84t1bo5	9	4	include	include	VBP
cord-018907-c84t1bo5	9	5	human	human	JJ
cord-018907-c84t1bo5	9	6	immunodeficiency	immunodeficiency	NN
cord-018907-c84t1bo5	9	7	virus	virus	NN
cord-018907-c84t1bo5	9	8	(	(	-LRB-
cord-018907-c84t1bo5	9	9	HIV	HIV	NNP
cord-018907-c84t1bo5	9	10	)	)	-RRB-
cord-018907-c84t1bo5	9	11	and	and	CC
cord-018907-c84t1bo5	9	12	acquired	acquire	VBD
cord-018907-c84t1bo5	9	13	immune	immune	JJ
cord-018907-c84t1bo5	9	14	deficiency	deficiency	NN
cord-018907-c84t1bo5	9	15	syndrome	syndrome	NN
cord-018907-c84t1bo5	9	16	(	(	-LRB-
cord-018907-c84t1bo5	9	17	AIDS	AIDS	NNP
cord-018907-c84t1bo5	9	18	)	)	-RRB-
cord-018907-c84t1bo5	9	19	-both	-both	.
cord-018907-c84t1bo5	10	1	of	of	IN
cord-018907-c84t1bo5	10	2	which	which	WDT
cord-018907-c84t1bo5	10	3	lead	lead	NN
cord-018907-c84t1bo5	10	4	to	to	IN
cord-018907-c84t1bo5	10	5	altered	alter	VBN
cord-018907-c84t1bo5	10	6	cellular	cellular	JJ
cord-018907-c84t1bo5	10	7	immunity	immunity	NN
cord-018907-c84t1bo5	10	8	-dysgammaglobulinemia	-dysgammaglobulinemia	NN
cord-018907-c84t1bo5	10	9	,	,	,
cord-018907-c84t1bo5	10	10	defective	defective	JJ
cord-018907-c84t1bo5	10	11	phagocytic	phagocytic	JJ
cord-018907-c84t1bo5	10	12	function	function	NN
cord-018907-c84t1bo5	10	13	or	or	CC
cord-018907-c84t1bo5	10	14	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	10	15	.	.	.
cord-018907-c84t1bo5	11	1	Cancer	cancer	NN
cord-018907-c84t1bo5	11	2	leading	lead	VBG
cord-018907-c84t1bo5	11	3	to	to	IN
cord-018907-c84t1bo5	11	4	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	11	5	,	,	,
cord-018907-c84t1bo5	11	6	lymphopenia	lymphopenia	NNP
cord-018907-c84t1bo5	11	7	,	,	,
cord-018907-c84t1bo5	11	8	humoral	humoral	JJ
cord-018907-c84t1bo5	11	9	deficiencies	deficiency	NNS
cord-018907-c84t1bo5	11	10	and	and	CC
cord-018907-c84t1bo5	11	11	altered	alter	VBN
cord-018907-c84t1bo5	11	12	physical	physical	JJ
cord-018907-c84t1bo5	11	13	integrity	integrity	NN
cord-018907-c84t1bo5	11	14	especially	especially	RB
cord-018907-c84t1bo5	11	15	with	with	IN
cord-018907-c84t1bo5	11	16	the	the	DT
cord-018907-c84t1bo5	11	17	use	use	NN
cord-018907-c84t1bo5	11	18	of	of	IN
cord-018907-c84t1bo5	11	19	chemotherapeutic	chemotherapeutic	JJ
cord-018907-c84t1bo5	11	20	agents	agent	NNS
cord-018907-c84t1bo5	11	21	leading	lead	VBG
cord-018907-c84t1bo5	11	22	to	to	IN
cord-018907-c84t1bo5	11	23	disruption	disruption	NN
cord-018907-c84t1bo5	11	24	barrier	barrier	NN
cord-018907-c84t1bo5	11	25	integrity	integrity	NN
cord-018907-c84t1bo5	11	26	with	with	IN
cord-018907-c84t1bo5	11	27	mucositis	mucositis	NNP
cord-018907-c84t1bo5	11	28	leading	lead	VBG
cord-018907-c84t1bo5	11	29	to	to	IN
cord-018907-c84t1bo5	11	30	easy	easy	JJ
cord-018907-c84t1bo5	11	31	access	access	NN
cord-018907-c84t1bo5	11	32	of	of	IN
cord-018907-c84t1bo5	11	33	microorganisms	microorganism	NNS
cord-018907-c84t1bo5	11	34	,	,	,
cord-018907-c84t1bo5	11	35	solid	solid	JJ
cord-018907-c84t1bo5	11	36	organ	organ	NN
cord-018907-c84t1bo5	11	37	transplant	transplant	NN
cord-018907-c84t1bo5	11	38	leading	lead	VBG
cord-018907-c84t1bo5	11	39	to	to	IN
cord-018907-c84t1bo5	11	40	deficiencies	deficiency	NNS
cord-018907-c84t1bo5	11	41	in	in	IN
cord-018907-c84t1bo5	11	42	cellular	cellular	JJ
cord-018907-c84t1bo5	11	43	and	and	CC
cord-018907-c84t1bo5	11	44	phagocytic	phagocytic	JJ
cord-018907-c84t1bo5	11	45	immunity	immunity	NN
cord-018907-c84t1bo5	11	46	,	,	,
cord-018907-c84t1bo5	11	47	malnutrition	malnutrition	NN
cord-018907-c84t1bo5	11	48	which	which	WDT
cord-018907-c84t1bo5	11	49	leads	lead	VBZ
cord-018907-c84t1bo5	11	50	to	to	IN
cord-018907-c84t1bo5	11	51	impaired	impaired	JJ
cord-018907-c84t1bo5	11	52	immunity	immunity	NN
cord-018907-c84t1bo5	11	53	,	,	,
cord-018907-c84t1bo5	11	54	and	and	CC
cord-018907-c84t1bo5	11	55	complement	complement	JJ
cord-018907-c84t1bo5	11	56	activity	activity	NN
cord-018907-c84t1bo5	11	57	.	.	.
cord-018907-c84t1bo5	12	1	Fever	fever	NN
cord-018907-c84t1bo5	12	2	is	be	VBZ
cord-018907-c84t1bo5	12	3	the	the	DT
cord-018907-c84t1bo5	12	4	main	main	JJ
cord-018907-c84t1bo5	12	5	manifestation	manifestation	NN
cord-018907-c84t1bo5	12	6	and	and	CC
cord-018907-c84t1bo5	12	7	occasionally	occasionally	RB
cord-018907-c84t1bo5	12	8	the	the	DT
cord-018907-c84t1bo5	12	9	only	only	JJ
cord-018907-c84t1bo5	12	10	sign	sign	NN
cord-018907-c84t1bo5	12	11	of	of	IN
cord-018907-c84t1bo5	12	12	infection	infection	NN
cord-018907-c84t1bo5	12	13	in	in	IN
cord-018907-c84t1bo5	12	14	immunocompromised	immunocompromised	JJ
cord-018907-c84t1bo5	12	15	children	child	NNS
cord-018907-c84t1bo5	12	16	.	.	.
cord-018907-c84t1bo5	13	1	When	when	WRB
cord-018907-c84t1bo5	13	2	approaching	approach	VBG
cord-018907-c84t1bo5	13	3	a	a	DT
cord-018907-c84t1bo5	13	4	patient	patient	NN
cord-018907-c84t1bo5	13	5	with	with	IN
cord-018907-c84t1bo5	13	6	immunodeficiency	immunodeficiency	NN
cord-018907-c84t1bo5	13	7	in	in	IN
cord-018907-c84t1bo5	13	8	the	the	DT
cord-018907-c84t1bo5	13	9	context	context	NN
cord-018907-c84t1bo5	13	10	of	of	IN
cord-018907-c84t1bo5	13	11	infection	infection	NN
cord-018907-c84t1bo5	13	12	,	,	,
cord-018907-c84t1bo5	13	13	one	one	PRP
cord-018907-c84t1bo5	13	14	needs	need	VBZ
cord-018907-c84t1bo5	13	15	to	to	TO
cord-018907-c84t1bo5	13	16	look	look	VB
cord-018907-c84t1bo5	13	17	at	at	IN
cord-018907-c84t1bo5	13	18	the	the	DT
cord-018907-c84t1bo5	13	19	net	net	JJ
cord-018907-c84t1bo5	13	20	state	state	NN
cord-018907-c84t1bo5	13	21	of	of	IN
cord-018907-c84t1bo5	13	22	immunosuppression	immunosuppression	NN
cord-018907-c84t1bo5	13	23	.	.	.
cord-018907-c84t1bo5	14	1	The	the	DT
cord-018907-c84t1bo5	14	2	net	net	JJ
cord-018907-c84t1bo5	14	3	state	state	NN
cord-018907-c84t1bo5	14	4	of	of	IN
cord-018907-c84t1bo5	14	5	immunosuppression	immunosuppression	NN
cord-018907-c84t1bo5	14	6	can	can	MD
cord-018907-c84t1bo5	14	7	be	be	VB
cord-018907-c84t1bo5	14	8	evaluated	evaluate	VBN
cord-018907-c84t1bo5	14	9	by	by	IN
cord-018907-c84t1bo5	14	10	the	the	DT
cord-018907-c84t1bo5	14	11	host	host	NN
cord-018907-c84t1bo5	14	12	defense	defense	NN
cord-018907-c84t1bo5	14	13	defects	defect	NNS
cord-018907-c84t1bo5	14	14	caused	cause	VBN
cord-018907-c84t1bo5	14	15	by	by	IN
cord-018907-c84t1bo5	14	16	the	the	DT
cord-018907-c84t1bo5	14	17	primary	primary	JJ
cord-018907-c84t1bo5	14	18	disease	disease	NN
cord-018907-c84t1bo5	14	19	,	,	,
cord-018907-c84t1bo5	14	20	dose	dose	NN
cord-018907-c84t1bo5	14	21	and	and	CC
cord-018907-c84t1bo5	14	22	duration	duration	NN
cord-018907-c84t1bo5	14	23	of	of	IN
cord-018907-c84t1bo5	14	24	the	the	DT
cord-018907-c84t1bo5	14	25	immunosuppressive	immunosuppressive	JJ
cord-018907-c84t1bo5	14	26	therapy	therapy	NN
cord-018907-c84t1bo5	14	27	(	(	-LRB-
cord-018907-c84t1bo5	14	28	the	the	DT
cord-018907-c84t1bo5	14	29	longer	long	JJR
cord-018907-c84t1bo5	14	30	duration	duration	NN
cord-018907-c84t1bo5	14	31	of	of	IN
cord-018907-c84t1bo5	14	32	immunosuppressive	immunosuppressive	JJ
cord-018907-c84t1bo5	14	33	therapy	therapy	NN
cord-018907-c84t1bo5	14	34	,	,	,
cord-018907-c84t1bo5	14	35	the	the	DT
cord-018907-c84t1bo5	14	36	higher	high	JJR
cord-018907-c84t1bo5	14	37	risk	risk	NN
cord-018907-c84t1bo5	14	38	of	of	IN
cord-018907-c84t1bo5	14	39	infection	infection	NN
cord-018907-c84t1bo5	14	40	)	)	-RRB-
cord-018907-c84t1bo5	14	41	,	,	,
cord-018907-c84t1bo5	14	42	presence	presence	NN
cord-018907-c84t1bo5	14	43	of	of	IN
cord-018907-c84t1bo5	14	44	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	14	45	,	,	,
cord-018907-c84t1bo5	14	46	and	and	CC
cord-018907-c84t1bo5	14	47	anatomical	anatomical	JJ
cord-018907-c84t1bo5	14	48	and	and	CC
cord-018907-c84t1bo5	14	49	functional	functional	JJ
cord-018907-c84t1bo5	14	50	integrity	integrity	NN
cord-018907-c84t1bo5	14	51	because	because	IN
cord-018907-c84t1bo5	14	52	defect	defect	NN
cord-018907-c84t1bo5	14	53	in	in	IN
cord-018907-c84t1bo5	14	54	the	the	DT
cord-018907-c84t1bo5	14	55	skin	skin	NN
cord-018907-c84t1bo5	14	56	or	or	CC
cord-018907-c84t1bo5	14	57	mucosa	mucosa	NN
cord-018907-c84t1bo5	14	58	can	can	MD
cord-018907-c84t1bo5	14	59	lead	lead	VB
cord-018907-c84t1bo5	14	60	to	to	IN
cord-018907-c84t1bo5	14	61	easy	easy	JJ
cord-018907-c84t1bo5	14	62	access	access	NN
cord-018907-c84t1bo5	14	63	for	for	IN
cord-018907-c84t1bo5	14	64	the	the	DT
cord-018907-c84t1bo5	14	65	microorganisms	microorganism	NNS
cord-018907-c84t1bo5	14	66	,	,	,
cord-018907-c84t1bo5	14	67	metabolic	metabolic	JJ
cord-018907-c84t1bo5	14	68	factors	factor	NNS
cord-018907-c84t1bo5	14	69	,	,	,
cord-018907-c84t1bo5	14	70	and	and	CC
cord-018907-c84t1bo5	14	71	infection	infection	NN
cord-018907-c84t1bo5	14	72	with	with	IN
cord-018907-c84t1bo5	14	73	immunomodulating	immunomodulate	VBG
cord-018907-c84t1bo5	14	74	viruses	virus	NNS
cord-018907-c84t1bo5	14	75	(	(	-LRB-
cord-018907-c84t1bo5	14	76	HIV	HIV	NNP
cord-018907-c84t1bo5	14	77	,	,	,
cord-018907-c84t1bo5	14	78	HBV	HBV	NNP
cord-018907-c84t1bo5	14	79	,	,	,
cord-018907-c84t1bo5	14	80	HCV	HCV	NNP
cord-018907-c84t1bo5	14	81	,	,	,
cord-018907-c84t1bo5	14	82	CMV	CMV	NNP
cord-018907-c84t1bo5	14	83	,	,	,
cord-018907-c84t1bo5	14	84	EBV	EBV	NNP
cord-018907-c84t1bo5	14	85	,	,	,
cord-018907-c84t1bo5	14	86	and	and	CC
cord-018907-c84t1bo5	14	87	HHV-6	HHV-6	NNP
cord-018907-c84t1bo5	14	88	)	)	-RRB-
cord-018907-c84t1bo5	14	89	.	.	.
cord-018907-c84t1bo5	15	1	Risk	risk	NN
cord-018907-c84t1bo5	15	2	of	of	IN
cord-018907-c84t1bo5	15	3	infections	infection	NNS
cord-018907-c84t1bo5	15	4	can	can	MD
cord-018907-c84t1bo5	15	5	be	be	VB
cord-018907-c84t1bo5	15	6	classified	classify	VBN
cord-018907-c84t1bo5	15	7	as	as	IN
cord-018907-c84t1bo5	15	8	high	high	JJ
cord-018907-c84t1bo5	15	9	,	,	,
cord-018907-c84t1bo5	15	10	intermediate	intermediate	JJ
cord-018907-c84t1bo5	15	11	,	,	,
cord-018907-c84t1bo5	15	12	and	and	CC
cord-018907-c84t1bo5	15	13	low	low	JJ
cord-018907-c84t1bo5	15	14	.	.	.
cord-018907-c84t1bo5	16	1	High	high	JJ
cord-018907-c84t1bo5	16	2	risk	risk	NN
cord-018907-c84t1bo5	16	3	includes	include	VBZ
cord-018907-c84t1bo5	16	4	hematologic	hematologic	JJ
cord-018907-c84t1bo5	16	5	malignancies	malignancy	NNS
cord-018907-c84t1bo5	16	6	,	,	,
cord-018907-c84t1bo5	16	7	AIDS	AIDS	NNP
cord-018907-c84t1bo5	16	8	,	,	,
cord-018907-c84t1bo5	16	9	HSCT	HSCT	NNP
cord-018907-c84t1bo5	16	10	,	,	,
cord-018907-c84t1bo5	16	11	splenectomized	splenectomized	JJ
cord-018907-c84t1bo5	16	12	patient	patient	NN
cord-018907-c84t1bo5	16	13	,	,	,
cord-018907-c84t1bo5	16	14	and	and	CC
cord-018907-c84t1bo5	16	15	congenital	congenital	JJ
cord-018907-c84t1bo5	16	16	immunodeficiency	immunodeficiency	NN
cord-018907-c84t1bo5	16	17	especially	especially	RB
cord-018907-c84t1bo5	16	18	severe	severe	JJ
cord-018907-c84t1bo5	16	19	combined	combine	VBN
cord-018907-c84t1bo5	16	20	immune	immune	JJ
cord-018907-c84t1bo5	16	21	deficiency	deficiency	NN
cord-018907-c84t1bo5	16	22	(	(	-LRB-
cord-018907-c84t1bo5	16	23	SCID	SCID	NNP
cord-018907-c84t1bo5	16	24	)	)	-RRB-
cord-018907-c84t1bo5	16	25	.	.	.
cord-018907-c84t1bo5	17	1	Intermediate	intermediate	JJ
cord-018907-c84t1bo5	17	2	risk	risk	NN
cord-018907-c84t1bo5	17	3	includes	include	VBZ
cord-018907-c84t1bo5	17	4	solid	solid	JJ
cord-018907-c84t1bo5	17	5	tumors	tumor	NNS
cord-018907-c84t1bo5	17	6	,	,	,
cord-018907-c84t1bo5	17	7	HIV	HIV	NNP
cord-018907-c84t1bo5	17	8	/	/	SYM
cord-018907-c84t1bo5	17	9	AIDS	AIDS	NNP
cord-018907-c84t1bo5	17	10	,	,	,
cord-018907-c84t1bo5	17	11	and	and	CC
cord-018907-c84t1bo5	17	12	solid	solid	JJ
cord-018907-c84t1bo5	17	13	organ	organ	NN
cord-018907-c84t1bo5	17	14	transplantation	transplantation	NN
cord-018907-c84t1bo5	17	15	.	.	.
cord-018907-c84t1bo5	18	1	Low	low	JJ
cord-018907-c84t1bo5	18	2	-	-	HYPH
cord-018907-c84t1bo5	18	3	risk	risk	NN
cord-018907-c84t1bo5	18	4	patients	patient	NNS
cord-018907-c84t1bo5	18	5	include	include	VBP
cord-018907-c84t1bo5	18	6	patients	patient	NNS
cord-018907-c84t1bo5	18	7	with	with	IN
cord-018907-c84t1bo5	18	8	corticosteroid	corticosteroid	NN
cord-018907-c84t1bo5	18	9	therapy	therapy	NN
cord-018907-c84t1bo5	18	10	,	,	,
cord-018907-c84t1bo5	18	11	local	local	JJ
cord-018907-c84t1bo5	18	12	defects	defect	NNS
cord-018907-c84t1bo5	18	13	,	,	,
cord-018907-c84t1bo5	18	14	and	and	CC
cord-018907-c84t1bo5	18	15	diabetes	diabetes	NN
cord-018907-c84t1bo5	18	16	.	.	.
cord-018907-c84t1bo5	19	1	The	the	DT
cord-018907-c84t1bo5	19	2	pathogens	pathogen	NNS
cord-018907-c84t1bo5	19	3	in	in	IN
cord-018907-c84t1bo5	19	4	immunocompromised	immunocompromised	JJ
cord-018907-c84t1bo5	19	5	patients	patient	NNS
cord-018907-c84t1bo5	19	6	can	can	MD
cord-018907-c84t1bo5	19	7	be	be	VB
cord-018907-c84t1bo5	19	8	predicted	predict	VBN
cord-018907-c84t1bo5	19	9	based	base	VBN
cord-018907-c84t1bo5	19	10	on	on	IN
cord-018907-c84t1bo5	19	11	the	the	DT
cord-018907-c84t1bo5	19	12	immune	immune	JJ
cord-018907-c84t1bo5	19	13	defect	defect	NN
cord-018907-c84t1bo5	19	14	.	.	.
cord-018907-c84t1bo5	20	1	For	for	IN
cord-018907-c84t1bo5	20	2	example	example	NN
cord-018907-c84t1bo5	20	3	,	,	,
cord-018907-c84t1bo5	20	4	if	if	IN
cord-018907-c84t1bo5	20	5	there	there	EX
cord-018907-c84t1bo5	20	6	is	be	VBZ
cord-018907-c84t1bo5	20	7	an	an	DT
cord-018907-c84t1bo5	20	8	anatomical	anatomical	JJ
cord-018907-c84t1bo5	20	9	disruption	disruption	NN
cord-018907-c84t1bo5	20	10	in	in	IN
cord-018907-c84t1bo5	20	11	the	the	DT
cord-018907-c84t1bo5	20	12	oral	oral	JJ
cord-018907-c84t1bo5	20	13	cavity	cavity	NN
cord-018907-c84t1bo5	20	14	it	-PRON-	PRP
cord-018907-c84t1bo5	20	15	lead	lead	VBP
cord-018907-c84t1bo5	20	16	to	to	IN
cord-018907-c84t1bo5	20	17	infections	infection	NNS
cord-018907-c84t1bo5	20	18	caused	cause	VBN
cord-018907-c84t1bo5	20	19	by	by	IN
cord-018907-c84t1bo5	20	20	alpha	alpha	NN
cord-018907-c84t1bo5	20	21	hemolytic	hemolytic	JJ
cord-018907-c84t1bo5	20	22	streptococci	streptococcus	NNS
cord-018907-c84t1bo5	20	23	,	,	,
cord-018907-c84t1bo5	20	24	anaerobes	anaerobe	NNS
cord-018907-c84t1bo5	20	25	,	,	,
cord-018907-c84t1bo5	20	26	Candida	candida	NN
cord-018907-c84t1bo5	20	27	species	specie	NNS
cord-018907-c84t1bo5	20	28	,	,	,
cord-018907-c84t1bo5	20	29	and	and	CC
cord-018907-c84t1bo5	20	30	herpes	herpes	NN
cord-018907-c84t1bo5	20	31	simplex	simplex	NNP
cord-018907-c84t1bo5	20	32	virus	virus	NN
cord-018907-c84t1bo5	20	33	(	(	-LRB-
cord-018907-c84t1bo5	20	34	HSV	HSV	NNP
cord-018907-c84t1bo5	20	35	)	)	-RRB-
cord-018907-c84t1bo5	20	36	.	.	.
cord-018907-c84t1bo5	21	1	Patients	patient	NNS
cord-018907-c84t1bo5	21	2	with	with	IN
cord-018907-c84t1bo5	21	3	urinary	urinary	JJ
cord-018907-c84t1bo5	21	4	catheters	catheter	NNS
cord-018907-c84t1bo5	21	5	will	will	MD
cord-018907-c84t1bo5	21	6	be	be	VB
cord-018907-c84t1bo5	21	7	at	at	IN
cord-018907-c84t1bo5	21	8	risk	risk	NN
cord-018907-c84t1bo5	21	9	for	for	IN
cord-018907-c84t1bo5	21	10	infection	infection	NN
cord-018907-c84t1bo5	21	11	caused	cause	VBN
cord-018907-c84t1bo5	21	12	by	by	IN
cord-018907-c84t1bo5	21	13	gram	gram	NN
cord-018907-c84t1bo5	21	14	negative	negative	JJ
cord-018907-c84t1bo5	21	15	bacteria	bacteria	NNS
cord-018907-c84t1bo5	21	16	including	include	VBG
cord-018907-c84t1bo5	21	17	Pseudomonas	Pseudomonas	NNP
cord-018907-c84t1bo5	21	18	spp	spp	NNS
cord-018907-c84t1bo5	21	19	.	.	.
cord-018907-c84t1bo5	22	1	,	,	,
cord-018907-c84t1bo5	22	2	enterococci	enterococci	NNP
cord-018907-c84t1bo5	22	3	,	,	,
cord-018907-c84t1bo5	22	4	and	and	CC
cord-018907-c84t1bo5	22	5	possibly	possibly	RB
cord-018907-c84t1bo5	22	6	candida	candida	NNP
cord-018907-c84t1bo5	22	7	.	.	.
cord-018907-c84t1bo5	23	1	If	if	IN
cord-018907-c84t1bo5	23	2	there	there	EX
cord-018907-c84t1bo5	23	3	is	be	VBZ
cord-018907-c84t1bo5	23	4	a	a	DT
cord-018907-c84t1bo5	23	5	skin	skin	NN
cord-018907-c84t1bo5	23	6	defect	defect	NN
cord-018907-c84t1bo5	23	7	including	include	VBG
cord-018907-c84t1bo5	23	8	central	central	JJ
cord-018907-c84t1bo5	23	9	venous	venous	JJ
cord-018907-c84t1bo5	23	10	catheter	catheter	NN
cord-018907-c84t1bo5	23	11	(	(	-LRB-
cord-018907-c84t1bo5	23	12	CVC	CVC	NNP
cord-018907-c84t1bo5	23	13	)	)	-RRB-
cord-018907-c84t1bo5	23	14	,	,	,
cord-018907-c84t1bo5	23	15	the	the	DT
cord-018907-c84t1bo5	23	16	patient	patient	NN
cord-018907-c84t1bo5	23	17	will	will	MD
cord-018907-c84t1bo5	23	18	be	be	VB
cord-018907-c84t1bo5	23	19	at	at	IN
cord-018907-c84t1bo5	23	20	risk	risk	NN
cord-018907-c84t1bo5	23	21	of	of	IN
cord-018907-c84t1bo5	23	22	Staphylococcus	Staphylococcus	NNP
cord-018907-c84t1bo5	23	23	species	specie	NNS
cord-018907-c84t1bo5	23	24	(	(	-LRB-
cord-018907-c84t1bo5	23	25	both	both	DT
cord-018907-c84t1bo5	23	26	coagulase	coagulase	NN
cord-018907-c84t1bo5	23	27	-	-	HYPH
cord-018907-c84t1bo5	23	28	negative	negative	JJ
cord-018907-c84t1bo5	23	29	staphylococci	staphylococcus	NNS
cord-018907-c84t1bo5	23	30	and	and	CC
cord-018907-c84t1bo5	23	31	Staphylococcus	Staphylococcus	NNP
cord-018907-c84t1bo5	23	32	aureus	aureus	NN
cord-018907-c84t1bo5	23	33	,	,	,
cord-018907-c84t1bo5	23	34	Bacillus	bacillus	NN
cord-018907-c84t1bo5	23	35	species	specie	NNS
cord-018907-c84t1bo5	23	36	,	,	,
cord-018907-c84t1bo5	23	37	atypical	atypical	JJ
cord-018907-c84t1bo5	23	38	Mycobacterium	Mycobacterium	NNP
cord-018907-c84t1bo5	23	39	,	,	,
cord-018907-c84t1bo5	23	40	and	and	CC
cord-018907-c84t1bo5	23	41	Gram	gram	NN
cord-018907-c84t1bo5	23	42	-	-	HYPH
cord-018907-c84t1bo5	23	43	negative	negative	JJ
cord-018907-c84t1bo5	23	44	organism	organism	NN
cord-018907-c84t1bo5	23	45	.	.	.
cord-018907-c84t1bo5	24	1	If	if	IN
cord-018907-c84t1bo5	24	2	a	a	DT
cord-018907-c84t1bo5	24	3	defect	defect	NN
cord-018907-c84t1bo5	24	4	in	in	IN
cord-018907-c84t1bo5	24	5	the	the	DT
cord-018907-c84t1bo5	24	6	phagocytic	phagocytic	JJ
cord-018907-c84t1bo5	24	7	function	function	NN
cord-018907-c84t1bo5	24	8	,	,	,
cord-018907-c84t1bo5	24	9	either	either	CC
cord-018907-c84t1bo5	24	10	quantitative	quantitative	JJ
cord-018907-c84t1bo5	24	11	or	or	CC
cord-018907-c84t1bo5	24	12	qualitative	qualitative	JJ
cord-018907-c84t1bo5	24	13	,	,	,
cord-018907-c84t1bo5	24	14	predispose	predispose	VB
cord-018907-c84t1bo5	24	15	what	what	WP
cord-018907-c84t1bo5	24	16	to	to	IN
cord-018907-c84t1bo5	24	17	invasive	invasive	JJ
cord-018907-c84t1bo5	24	18	diseases	disease	NNS
cord-018907-c84t1bo5	24	19	like	like	IN
cord-018907-c84t1bo5	24	20	invasive	invasive	JJ
cord-018907-c84t1bo5	24	21	pneumonia	pneumonia	NN
cord-018907-c84t1bo5	24	22	caused	cause	VBN
cord-018907-c84t1bo5	24	23	by	by	IN
cord-018907-c84t1bo5	24	24	bacterial	bacterial	JJ
cord-018907-c84t1bo5	24	25	pathogens	pathogen	NNS
cord-018907-c84t1bo5	24	26	:	:	:
cord-018907-c84t1bo5	24	27	Gram	gram	NN
cord-018907-c84t1bo5	24	28	-	-	HYPH
cord-018907-c84t1bo5	24	29	positive	positive	JJ
cord-018907-c84t1bo5	24	30	(	(	-LRB-
cord-018907-c84t1bo5	24	31	staphylococci	staphylococcus	NNS
cord-018907-c84t1bo5	24	32	,	,	,
cord-018907-c84t1bo5	24	33	streptococci	streptococcus	NNS
cord-018907-c84t1bo5	24	34	,	,	,
cord-018907-c84t1bo5	24	35	and	and	CC
cord-018907-c84t1bo5	24	36	Nocardia	Nocardia	NNP
cord-018907-c84t1bo5	24	37	species	specie	NNS
cord-018907-c84t1bo5	24	38	)	)	-RRB-
cord-018907-c84t1bo5	24	39	and	and	CC
cord-018907-c84t1bo5	24	40	Gram	gram	NN
cord-018907-c84t1bo5	24	41	-	-	HYPH
cord-018907-c84t1bo5	24	42	negative	negative	JJ
cord-018907-c84t1bo5	24	43	bacilli	bacilli	NN
cord-018907-c84t1bo5	24	44	(	(	-LRB-
cord-018907-c84t1bo5	24	45	Escherichia	escherichia	NN
cord-018907-c84t1bo5	24	46	coli	coli	NNS
cord-018907-c84t1bo5	24	47	,	,	,
cord-018907-c84t1bo5	24	48	Klebsiella	Klebsiella	NNP
cord-018907-c84t1bo5	24	49	pneumoniae	pneumoniae	NN
cord-018907-c84t1bo5	24	50	,	,	,
cord-018907-c84t1bo5	24	51	P.	P.	NNP
cord-018907-c84t1bo5	24	52	aeruginosa	aeruginosa	NNP
cord-018907-c84t1bo5	24	53	)	)	-RRB-
cord-018907-c84t1bo5	24	54	,	,	,
cord-018907-c84t1bo5	24	55	other	other	JJ
cord-018907-c84t1bo5	24	56	enterobacteriaceae	enterobacteriaceae	NNS
cord-018907-c84t1bo5	24	57	,	,	,
cord-018907-c84t1bo5	24	58	and	and	CC
cord-018907-c84t1bo5	24	59	fungal	fungal	JJ
cord-018907-c84t1bo5	24	60	pathogens	pathogen	NNS
cord-018907-c84t1bo5	24	61	like	like	IN
cord-018907-c84t1bo5	24	62	Candida	Candida	NNP
cord-018907-c84t1bo5	24	63	species	specie	NNS
cord-018907-c84t1bo5	24	64	and	and	CC
cord-018907-c84t1bo5	24	65	Aspergillus	aspergillus	NN
cord-018907-c84t1bo5	24	66	species	specie	NNS
cord-018907-c84t1bo5	24	67	.	.	.
cord-018907-c84t1bo5	25	1	Patients	patient	NNS
cord-018907-c84t1bo5	25	2	with	with	IN
cord-018907-c84t1bo5	25	3	defective	defective	JJ
cord-018907-c84t1bo5	25	4	cell	cell	NN
cord-018907-c84t1bo5	25	5	-	-	HYPH
cord-018907-c84t1bo5	25	6	mediated	mediate	VBN
cord-018907-c84t1bo5	25	7	immunity	immunity	NN
cord-018907-c84t1bo5	25	8	are	be	VBP
cord-018907-c84t1bo5	25	9	at	at	IN
cord-018907-c84t1bo5	25	10	risk	risk	NN
cord-018907-c84t1bo5	25	11	of	of	IN
cord-018907-c84t1bo5	25	12	infections	infection	NNS
cord-018907-c84t1bo5	25	13	caused	cause	VBN
cord-018907-c84t1bo5	25	14	by	by	IN
cord-018907-c84t1bo5	25	15	intracellular	intracellular	JJ
cord-018907-c84t1bo5	25	16	pathogens	pathogen	NNS
cord-018907-c84t1bo5	25	17	(	(	-LRB-
cord-018907-c84t1bo5	25	18	i.e.	i.e.	FW
cord-018907-c84t1bo5	25	19	,	,	,
cord-018907-c84t1bo5	25	20	viral	viral	JJ
cord-018907-c84t1bo5	25	21	,	,	,
cord-018907-c84t1bo5	25	22	fungi	fungus	NNS
cord-018907-c84t1bo5	25	23	,	,	,
cord-018907-c84t1bo5	25	24	mycobacterial	mycobacterial	NNP
cord-018907-c84t1bo5	25	25	,	,	,
cord-018907-c84t1bo5	25	26	and	and	CC
cord-018907-c84t1bo5	25	27	intracellular	intracellular	JJ
cord-018907-c84t1bo5	25	28	bacteria	bacteria	NNS
cord-018907-c84t1bo5	25	29	)	)	-RRB-
cord-018907-c84t1bo5	25	30	.	.	.
cord-018907-c84t1bo5	26	1	Intracellular	Intracellular	NNP
cord-018907-c84t1bo5	26	2	pathogens	pathogen	NNS
cord-018907-c84t1bo5	26	3	include	include	VBP
cord-018907-c84t1bo5	26	4	Legionella	Legionella	NNP
cord-018907-c84t1bo5	26	5	species	specie	NNS
cord-018907-c84t1bo5	26	6	,	,	,
cord-018907-c84t1bo5	26	7	Salmonella	salmonella	NN
cord-018907-c84t1bo5	26	8	species	specie	NNS
cord-018907-c84t1bo5	26	9	,	,	,
cord-018907-c84t1bo5	26	10	Mycobacteria	Mycobacteria	NNP
cord-018907-c84t1bo5	26	11	,	,	,
cord-018907-c84t1bo5	26	12	and	and	CC
cord-018907-c84t1bo5	26	13	Listeria	Listeria	NNP
cord-018907-c84t1bo5	26	14	species	specie	NNS
cord-018907-c84t1bo5	26	15	,	,	,
cord-018907-c84t1bo5	26	16	Histoplasma	Histoplasma	NNP
cord-018907-c84t1bo5	26	17	capsulatum	capsulatum	NN
cord-018907-c84t1bo5	26	18	,	,	,
cord-018907-c84t1bo5	26	19	Coccidioides	Coccidioides	NNP
cord-018907-c84t1bo5	26	20	immitis	immitis	NNP
cord-018907-c84t1bo5	26	21	,	,	,
cord-018907-c84t1bo5	26	22	Cryptococcus	Cryptococcus	NNP
cord-018907-c84t1bo5	26	23	neoformens	neoformen	NNS
cord-018907-c84t1bo5	26	24	,	,	,
cord-018907-c84t1bo5	26	25	Candida	Candida	NNP
cord-018907-c84t1bo5	26	26	species	specie	NNS
cord-018907-c84t1bo5	26	27	,	,	,
cord-018907-c84t1bo5	26	28	Pneumocystis	Pneumocystis	NNP
cord-018907-c84t1bo5	26	29	jiroveci	jiroveci	NNS
cord-018907-c84t1bo5	26	30	,	,	,
cord-018907-c84t1bo5	26	31	cytomegalovirus	cytomegalovirus	NN
cord-018907-c84t1bo5	26	32	,	,	,
cord-018907-c84t1bo5	26	33	Varicella	varicella	NN
cord-018907-c84t1bo5	26	34	-	-	HYPH
cord-018907-c84t1bo5	26	35	zoster	zoster	NN
cord-018907-c84t1bo5	26	36	virus	virus	NN
cord-018907-c84t1bo5	26	37	,	,	,
cord-018907-c84t1bo5	26	38	Epstein	Epstein	NNP
cord-018907-c84t1bo5	26	39	-	-	HYPH
cord-018907-c84t1bo5	26	40	Barr	Barr	NNP
cord-018907-c84t1bo5	26	41	virus	virus	NN
cord-018907-c84t1bo5	26	42	,	,	,
cord-018907-c84t1bo5	26	43	live	live	VBP
cord-018907-c84t1bo5	26	44	viral	viral	JJ
cord-018907-c84t1bo5	26	45	vaccines	vaccine	NNS
cord-018907-c84t1bo5	26	46	(	(	-LRB-
cord-018907-c84t1bo5	26	47	measles	measle	NNS
cord-018907-c84t1bo5	26	48	,	,	,
cord-018907-c84t1bo5	26	49	mumps	mumps	NN
cord-018907-c84t1bo5	26	50	,	,	,
cord-018907-c84t1bo5	26	51	rubella	rubella	NN
cord-018907-c84t1bo5	26	52	,	,	,
cord-018907-c84t1bo5	26	53	and	and	CC
cord-018907-c84t1bo5	26	54	polio	polio	NN
cord-018907-c84t1bo5	26	55	)	)	-RRB-
cord-018907-c84t1bo5	26	56	and	and	CC
cord-018907-c84t1bo5	26	57	protozoal	protozoal	NNP
cord-018907-c84t1bo5	26	58	,	,	,
cord-018907-c84t1bo5	26	59	Toxoplasma	toxoplasma	NN
cord-018907-c84t1bo5	26	60	gondii	gondii	NN
cord-018907-c84t1bo5	26	61	,	,	,
cord-018907-c84t1bo5	26	62	Strongyloides	Strongyloides	NNP
cord-018907-c84t1bo5	26	63	stercoralis	stercoralis	NNP
cord-018907-c84t1bo5	26	64	,	,	,
cord-018907-c84t1bo5	26	65	Cryptosporidia	Cryptosporidia	NNP
cord-018907-c84t1bo5	26	66	,	,	,
cord-018907-c84t1bo5	26	67	Microsporidia	Microsporidia	NNP
cord-018907-c84t1bo5	26	68	,	,	,
cord-018907-c84t1bo5	26	69	and	and	CC
cord-018907-c84t1bo5	26	70	Isospora	Isospora	NNP
cord-018907-c84t1bo5	26	71	species	specie	NNS
cord-018907-c84t1bo5	26	72	.	.	.
cord-018907-c84t1bo5	27	1	Patients	patient	NNS
cord-018907-c84t1bo5	27	2	with	with	IN
cord-018907-c84t1bo5	27	3	immunoglobulin	immunoglobulin	NN
cord-018907-c84t1bo5	27	4	deficiencyo	deficiencyo	NN
cord-018907-c84t1bo5	27	5	are	be	VBP
cord-018907-c84t1bo5	27	6	at	at	IN
cord-018907-c84t1bo5	27	7	risk	risk	NN
cord-018907-c84t1bo5	27	8	of	of	IN
cord-018907-c84t1bo5	27	9	sinupulmonary	sinupulmonary	JJ
cord-018907-c84t1bo5	27	10	infection	infection	NN
cord-018907-c84t1bo5	27	11	caused	cause	VBN
cord-018907-c84t1bo5	27	12	by	by	IN
cord-018907-c84t1bo5	27	13	S.	S.	NNP
cord-018907-c84t1bo5	27	14	pneumoniae	pneumoniae	NN
cord-018907-c84t1bo5	27	15	,	,	,
cord-018907-c84t1bo5	27	16	Haemophilus	haemophilus	JJ
cord-018907-c84t1bo5	27	17	influenzae	influenzae	NN
cord-018907-c84t1bo5	27	18	,	,	,
cord-018907-c84t1bo5	27	19	and	and	CC
cord-018907-c84t1bo5	27	20	CNS	cns	JJ
cord-018907-c84t1bo5	27	21	infection	infection	NN
cord-018907-c84t1bo5	27	22	from	from	IN
cord-018907-c84t1bo5	27	23	viral	viral	JJ
cord-018907-c84t1bo5	27	24	infections	infection	NNS
cord-018907-c84t1bo5	27	25	,	,	,
cord-018907-c84t1bo5	27	26	especially	especially	RB
cord-018907-c84t1bo5	27	27	enterovirus	enterovirus	NN
cord-018907-c84t1bo5	27	28	,	,	,
cord-018907-c84t1bo5	27	29	leading	lead	VBG
cord-018907-c84t1bo5	27	30	to	to	IN
cord-018907-c84t1bo5	27	31	chronic	chronic	JJ
cord-018907-c84t1bo5	27	32	meningoencephalitis	meningoencephalitis	NNP
cord-018907-c84t1bo5	27	33	as	as	RB
cord-018907-c84t1bo5	27	34	well	well	RB
cord-018907-c84t1bo5	27	35	as	as	IN
cord-018907-c84t1bo5	27	36	gastrointestinal	gastrointestinal	JJ
cord-018907-c84t1bo5	27	37	infection	infection	NN
cord-018907-c84t1bo5	27	38	due	due	IN
cord-018907-c84t1bo5	27	39	to	to	IN
cord-018907-c84t1bo5	27	40	giardiasis	giardiasis	NN
cord-018907-c84t1bo5	27	41	.	.	.
cord-018907-c84t1bo5	28	1	Patients	patient	NNS
cord-018907-c84t1bo5	28	2	with	with	IN
cord-018907-c84t1bo5	28	3	complement	complement	JJ
cord-018907-c84t1bo5	28	4	deficiency	deficiency	NN
cord-018907-c84t1bo5	28	5	are	be	VBP
cord-018907-c84t1bo5	28	6	at	at	IN
cord-018907-c84t1bo5	28	7	risk	risk	NN
cord-018907-c84t1bo5	28	8	of	of	IN
cord-018907-c84t1bo5	28	9	diseases	disease	NNS
cord-018907-c84t1bo5	28	10	caused	cause	VBN
cord-018907-c84t1bo5	28	11	by	by	IN
cord-018907-c84t1bo5	28	12	S.	S.	NNP
cord-018907-c84t1bo5	28	13	pneumoniae	pneumoniae	NN
cord-018907-c84t1bo5	28	14	,	,	,
cord-018907-c84t1bo5	28	15	H.	H.	NNP
cord-018907-c84t1bo5	28	16	influenzae	influenzae	NN
cord-018907-c84t1bo5	28	17	,	,	,
cord-018907-c84t1bo5	28	18	and	and	CC
cord-018907-c84t1bo5	28	19	Neisseria	Neisseria	NNP
cord-018907-c84t1bo5	28	20	species	specie	NNS
cord-018907-c84t1bo5	28	21	.	.	.
cord-018907-c84t1bo5	29	1	Splenectomized	splenectomized	JJ
cord-018907-c84t1bo5	29	2	patients	patient	NNS
cord-018907-c84t1bo5	29	3	are	be	VBP
cord-018907-c84t1bo5	29	4	at	at	IN
cord-018907-c84t1bo5	29	5	risk	risk	NN
cord-018907-c84t1bo5	29	6	of	of	IN
cord-018907-c84t1bo5	29	7	invasive	invasive	JJ
cord-018907-c84t1bo5	29	8	diseases	disease	NNS
cord-018907-c84t1bo5	29	9	(	(	-LRB-
cord-018907-c84t1bo5	29	10	e.g.	e.g.	RB
cord-018907-c84t1bo5	29	11	,	,	,
cord-018907-c84t1bo5	29	12	sepsis	sepsis	NN
cord-018907-c84t1bo5	29	13	,	,	,
cord-018907-c84t1bo5	29	14	meningitis	meningitis	NN
cord-018907-c84t1bo5	29	15	)	)	-RRB-
cord-018907-c84t1bo5	29	16	caused	cause	VBN
cord-018907-c84t1bo5	29	17	by	by	IN
cord-018907-c84t1bo5	29	18	encapsulated	encapsulate	VBN
cord-018907-c84t1bo5	29	19	organism	organism	NN
cord-018907-c84t1bo5	29	20	including	include	VBG
cord-018907-c84t1bo5	29	21	S.	S.	NNP
cord-018907-c84t1bo5	29	22	pneumoniae	pneumoniae	NN
cord-018907-c84t1bo5	29	23	,	,	,
cord-018907-c84t1bo5	29	24	H.	H.	NNP
cord-018907-c84t1bo5	29	25	influenzae	influenzae	NN
cord-018907-c84t1bo5	29	26	,	,	,
cord-018907-c84t1bo5	29	27	and	and	CC
cord-018907-c84t1bo5	29	28	Neisseria	Neisseria	NNP
cord-018907-c84t1bo5	29	29	meningitidis	meningitidis	NNP
cord-018907-c84t1bo5	29	30	.	.	.
cord-018907-c84t1bo5	30	1	In	in	IN
cord-018907-c84t1bo5	30	2	evaluating	evaluate	VBG
cord-018907-c84t1bo5	30	3	patients	patient	NNS
cord-018907-c84t1bo5	30	4	with	with	IN
cord-018907-c84t1bo5	30	5	immunodeficiency	immunodeficiency	NN
cord-018907-c84t1bo5	30	6	,	,	,
cord-018907-c84t1bo5	30	7	one	one	PRP
cord-018907-c84t1bo5	30	8	can	can	MD
cord-018907-c84t1bo5	30	9	predict	predict	VB
cord-018907-c84t1bo5	30	10	the	the	DT
cord-018907-c84t1bo5	30	11	pathogen	pathogen	NN
cord-018907-c84t1bo5	30	12	based	base	VBN
cord-018907-c84t1bo5	30	13	on	on	IN
cord-018907-c84t1bo5	30	14	the	the	DT
cord-018907-c84t1bo5	30	15	primary	primary	JJ
cord-018907-c84t1bo5	30	16	immune	immune	JJ
cord-018907-c84t1bo5	30	17	defects	defect	NNS
cord-018907-c84t1bo5	30	18	,	,	,
cord-018907-c84t1bo5	30	19	the	the	DT
cord-018907-c84t1bo5	30	20	organs	organ	NNS
cord-018907-c84t1bo5	30	21	involved	involve	VBN
cord-018907-c84t1bo5	30	22	,	,	,
cord-018907-c84t1bo5	30	23	and	and	CC
cord-018907-c84t1bo5	30	24	the	the	DT
cord-018907-c84t1bo5	30	25	clinical	clinical	JJ
cord-018907-c84t1bo5	30	26	presentation	presentation	NN
cord-018907-c84t1bo5	30	27	of	of	IN
cord-018907-c84t1bo5	30	28	the	the	DT
cord-018907-c84t1bo5	30	29	patient	patient	NN
cord-018907-c84t1bo5	30	30	.	.	.
cord-018907-c84t1bo5	31	1	For	for	IN
cord-018907-c84t1bo5	31	2	instance	instance	NN
cord-018907-c84t1bo5	31	3	,	,	,
cord-018907-c84t1bo5	31	4	Staphylococcus	Staphylococcus	NNP
cord-018907-c84t1bo5	31	5	aureus	aureus	NN
cord-018907-c84t1bo5	31	6	,	,	,
cord-018907-c84t1bo5	31	7	Burkholderia	Burkholderia	NNP
cord-018907-c84t1bo5	31	8	cepacia	cepacia	NNP
cord-018907-c84t1bo5	31	9	,	,	,
cord-018907-c84t1bo5	31	10	Serratia	Serratia	NNP
cord-018907-c84t1bo5	31	11	marcescens	marcescen	NNS
cord-018907-c84t1bo5	31	12	,	,	,
cord-018907-c84t1bo5	31	13	Pseudomonas	Pseudomonas	NNP
cord-018907-c84t1bo5	31	14	and	and	CC
cord-018907-c84t1bo5	31	15	aspergillous	aspergillous	JJ
cord-018907-c84t1bo5	31	16	infection	infection	NN
cord-018907-c84t1bo5	31	17	should	should	MD
cord-018907-c84t1bo5	31	18	be	be	VB
cord-018907-c84t1bo5	31	19	considered	consider	VBN
cord-018907-c84t1bo5	31	20	for	for	IN
cord-018907-c84t1bo5	31	21	a	a	DT
cord-018907-c84t1bo5	31	22	chronic	chronic	JJ
cord-018907-c84t1bo5	31	23	granulomatous	granulomatous	JJ
cord-018907-c84t1bo5	31	24	diseased	disease	VBN
cord-018907-c84t1bo5	31	25	(	(	-LRB-
cord-018907-c84t1bo5	31	26	CGD	CGD	NNP
cord-018907-c84t1bo5	31	27	)	)	-RRB-
cord-018907-c84t1bo5	31	28	patient	patient	JJ
cord-018907-c84t1bo5	31	29	with	with	IN
cord-018907-c84t1bo5	31	30	soft	soft	JJ
cord-018907-c84t1bo5	31	31	tissue	tissue	NN
cord-018907-c84t1bo5	31	32	infection	infection	NN
cord-018907-c84t1bo5	31	33	,	,	,
cord-018907-c84t1bo5	31	34	lymphadenitis	lymphadenitis	NNP
cord-018907-c84t1bo5	31	35	,	,	,
cord-018907-c84t1bo5	31	36	liver	liver	NN
cord-018907-c84t1bo5	31	37	abscess	abscess	NN
cord-018907-c84t1bo5	31	38	,	,	,
cord-018907-c84t1bo5	31	39	osteomyelitis	osteomyelitis	NN
cord-018907-c84t1bo5	31	40	,	,	,
cord-018907-c84t1bo5	31	41	pneumonia	pneumonia	NN
cord-018907-c84t1bo5	31	42	,	,	,
cord-018907-c84t1bo5	31	43	and	and	CC
cord-018907-c84t1bo5	31	44	sepsis	sepsis	NN
cord-018907-c84t1bo5	31	45	.	.	.
cord-018907-c84t1bo5	32	1	In	in	IN
cord-018907-c84t1bo5	32	2	centers	center	NNS
cord-018907-c84t1bo5	32	3	dealing	deal	VBG
cord-018907-c84t1bo5	32	4	with	with	IN
cord-018907-c84t1bo5	32	5	immunocompromised	immunocompromised	JJ
cord-018907-c84t1bo5	32	6	patients	patient	NNS
cord-018907-c84t1bo5	32	7	,	,	,
cord-018907-c84t1bo5	32	8	the	the	DT
cord-018907-c84t1bo5	32	9	microbiology	microbiology	NN
cord-018907-c84t1bo5	32	10	laboratory	laboratory	NN
cord-018907-c84t1bo5	32	11	as	as	RB
cord-018907-c84t1bo5	32	12	well	well	RB
cord-018907-c84t1bo5	32	13	as	as	IN
cord-018907-c84t1bo5	32	14	the	the	DT
cord-018907-c84t1bo5	32	15	radiology	radiology	NN
cord-018907-c84t1bo5	32	16	service	service	NN
cord-018907-c84t1bo5	32	17	need	need	VBP
cord-018907-c84t1bo5	32	18	to	to	TO
cord-018907-c84t1bo5	32	19	be	be	VB
cord-018907-c84t1bo5	32	20	well	well	RB
cord-018907-c84t1bo5	32	21	equipped	equipped	JJ
cord-018907-c84t1bo5	32	22	and	and	CC
cord-018907-c84t1bo5	32	23	trained	train	VBN
cord-018907-c84t1bo5	32	24	in	in	IN
cord-018907-c84t1bo5	32	25	diagnosing	diagnose	VBG
cord-018907-c84t1bo5	32	26	these	these	DT
cord-018907-c84t1bo5	32	27	patients	patient	NNS
cord-018907-c84t1bo5	32	28	.	.	.
cord-018907-c84t1bo5	33	1	Patients	patient	NNS
cord-018907-c84t1bo5	33	2	with	with	IN
cord-018907-c84t1bo5	33	3	fever	fever	NN
cord-018907-c84t1bo5	33	4	should	should	MD
cord-018907-c84t1bo5	33	5	be	be	VB
cord-018907-c84t1bo5	33	6	worked	work	VBN
cord-018907-c84t1bo5	33	7	up	up	RP
cord-018907-c84t1bo5	33	8	with	with	IN
cord-018907-c84t1bo5	33	9	complete	complete	JJ
cord-018907-c84t1bo5	33	10	blood	blood	NN
cord-018907-c84t1bo5	33	11	count	count	NN
cord-018907-c84t1bo5	33	12	with	with	IN
cord-018907-c84t1bo5	33	13	differential	differential	JJ
cord-018907-c84t1bo5	33	14	,	,	,
cord-018907-c84t1bo5	33	15	renal	renal	JJ
cord-018907-c84t1bo5	33	16	,	,	,
cord-018907-c84t1bo5	33	17	and	and	CC
cord-018907-c84t1bo5	33	18	hepatic	hepatic	JJ
cord-018907-c84t1bo5	33	19	profile	profile	NN
cord-018907-c84t1bo5	33	20	,	,	,
cord-018907-c84t1bo5	33	21	blood	blood	NN
cord-018907-c84t1bo5	33	22	culture	culture	NN
cord-018907-c84t1bo5	33	23	from	from	IN
cord-018907-c84t1bo5	33	24	central	central	JJ
cord-018907-c84t1bo5	33	25	line	line	NN
cord-018907-c84t1bo5	33	26	(	(	-LRB-
cord-018907-c84t1bo5	33	27	if	if	IN
cord-018907-c84t1bo5	33	28	present	present	JJ
cord-018907-c84t1bo5	33	29	)	)	-RRB-
cord-018907-c84t1bo5	33	30	,	,	,
cord-018907-c84t1bo5	33	31	and	and	CC
cord-018907-c84t1bo5	33	32	peripheral	peripheral	JJ
cord-018907-c84t1bo5	33	33	culture	culture	NN
cord-018907-c84t1bo5	33	34	.	.	.
cord-018907-c84t1bo5	34	1	Chest	chest	NN
cord-018907-c84t1bo5	34	2	X	X	NNS
cord-018907-c84t1bo5	34	3	-	-	NNS
cord-018907-c84t1bo5	34	4	rays	ray	NNS
cord-018907-c84t1bo5	34	5	are	be	VBP
cord-018907-c84t1bo5	34	6	not	not	RB
cord-018907-c84t1bo5	34	7	done	do	VBN
cord-018907-c84t1bo5	34	8	routinely	routinely	RB
cord-018907-c84t1bo5	34	9	unless	unless	IN
cord-018907-c84t1bo5	34	10	the	the	DT
cord-018907-c84t1bo5	34	11	patients	patient	NNS
cord-018907-c84t1bo5	34	12	have	have	VBP
cord-018907-c84t1bo5	34	13	respiratory	respiratory	JJ
cord-018907-c84t1bo5	34	14	symptoms	symptom	NNS
cord-018907-c84t1bo5	34	15	.	.	.
cord-018907-c84t1bo5	35	1	Other	other	JJ
cord-018907-c84t1bo5	35	2	investigations	investigation	NNS
cord-018907-c84t1bo5	35	3	need	need	VBP
cord-018907-c84t1bo5	35	4	to	to	TO
cord-018907-c84t1bo5	35	5	be	be	VB
cord-018907-c84t1bo5	35	6	guided	guide	VBN
cord-018907-c84t1bo5	35	7	by	by	IN
cord-018907-c84t1bo5	35	8	the	the	DT
cord-018907-c84t1bo5	35	9	presentation	presentation	NN
cord-018907-c84t1bo5	35	10	of	of	IN
cord-018907-c84t1bo5	35	11	the	the	DT
cord-018907-c84t1bo5	35	12	patient	patient	NN
cord-018907-c84t1bo5	35	13	.	.	.
cord-018907-c84t1bo5	36	1	Patients	patient	NNS
cord-018907-c84t1bo5	36	2	with	with	IN
cord-018907-c84t1bo5	36	3	diarrhea	diarrhea	NN
cord-018907-c84t1bo5	36	4	should	should	MD
cord-018907-c84t1bo5	36	5	have	have	VB
cord-018907-c84t1bo5	36	6	stool	stool	NN
cord-018907-c84t1bo5	36	7	checked	check	VBN
cord-018907-c84t1bo5	36	8	for	for	IN
cord-018907-c84t1bo5	36	9	bacterial	bacterial	JJ
cord-018907-c84t1bo5	36	10	culture	culture	NN
cord-018907-c84t1bo5	36	11	,	,	,
cord-018907-c84t1bo5	36	12	ova	ova	NN
cord-018907-c84t1bo5	36	13	and	and	CC
cord-018907-c84t1bo5	36	14	parasite	parasite	NN
cord-018907-c84t1bo5	36	15	,	,	,
cord-018907-c84t1bo5	36	16	viral	viral	JJ
cord-018907-c84t1bo5	36	17	culture	culture	NN
cord-018907-c84t1bo5	36	18	,	,	,
cord-018907-c84t1bo5	36	19	rotavirus	rotavirus	NN
cord-018907-c84t1bo5	36	20	,	,	,
cord-018907-c84t1bo5	36	21	and	and	CC
cord-018907-c84t1bo5	36	22	electron	electron	NN
cord-018907-c84t1bo5	36	23	microscopy	microscopy	NN
cord-018907-c84t1bo5	36	24	for	for	IN
cord-018907-c84t1bo5	36	25	viral	viral	JJ
cord-018907-c84t1bo5	36	26	studies	study	NNS
cord-018907-c84t1bo5	36	27	,	,	,
cord-018907-c84t1bo5	36	28	in	in	IN
cord-018907-c84t1bo5	36	29	addition	addition	NN
cord-018907-c84t1bo5	36	30	to	to	IN
cord-018907-c84t1bo5	36	31	microspora	microspora	NNP
cord-018907-c84t1bo5	36	32	,	,	,
cord-018907-c84t1bo5	36	33	cryptosporidium	cryptosporidium	NN
cord-018907-c84t1bo5	36	34	,	,	,
cord-018907-c84t1bo5	36	35	and	and	CC
cord-018907-c84t1bo5	36	36	isospora	isospora	NNP
cord-018907-c84t1bo5	36	37	.	.	.
cord-018907-c84t1bo5	37	1	In	in	IN
cord-018907-c84t1bo5	37	2	addition	addition	NN
cord-018907-c84t1bo5	37	3	to	to	IN
cord-018907-c84t1bo5	37	4	chest	chest	NN
cord-018907-c84t1bo5	37	5	X	x	NN
cord-018907-c84t1bo5	37	6	-	-	NN
cord-018907-c84t1bo5	37	7	ray	ray	NN
cord-018907-c84t1bo5	37	8	,	,	,
cord-018907-c84t1bo5	37	9	patients	patient	NNS
cord-018907-c84t1bo5	37	10	with	with	IN
cord-018907-c84t1bo5	37	11	respiratory	respiratory	JJ
cord-018907-c84t1bo5	37	12	symptoms	symptom	NNS
cord-018907-c84t1bo5	37	13	required	require	VBD
cord-018907-c84t1bo5	37	14	nasopharyngeal	nasopharyngeal	JJ
cord-018907-c84t1bo5	37	15	aspirate	aspirate	NN
cord-018907-c84t1bo5	37	16	for	for	IN
cord-018907-c84t1bo5	37	17	rapid	rapid	JJ
cord-018907-c84t1bo5	37	18	test	test	NN
cord-018907-c84t1bo5	37	19	for	for	IN
cord-018907-c84t1bo5	37	20	viruses	virus	NNS
cord-018907-c84t1bo5	37	21	and	and	CC
cord-018907-c84t1bo5	37	22	PCR	PCR	NNP
cord-018907-c84t1bo5	37	23	multiplex	multiplex	NN
cord-018907-c84t1bo5	37	24	-a	-a	:
cord-018907-c84t1bo5	37	25	newly	newly	RB
cord-018907-c84t1bo5	37	26	developed	develop	VBN
cord-018907-c84t1bo5	37	27	laboratory	laboratory	NN
cord-018907-c84t1bo5	37	28	procedure	procedure	NN
cord-018907-c84t1bo5	37	29	that	that	WDT
cord-018907-c84t1bo5	37	30	can	can	MD
cord-018907-c84t1bo5	37	31	screen	screen	VB
cord-018907-c84t1bo5	37	32	multiple	multiple	JJ
cord-018907-c84t1bo5	37	33	viruses	virus	NNS
cord-018907-c84t1bo5	37	34	and	and	CC
cord-018907-c84t1bo5	37	35	other	other	JJ
cord-018907-c84t1bo5	37	36	respiratory	respiratory	JJ
cord-018907-c84t1bo5	37	37	pathogens	pathogen	NNS
cord-018907-c84t1bo5	37	38	in	in	IN
cord-018907-c84t1bo5	37	39	the	the	DT
cord-018907-c84t1bo5	37	40	same	same	JJ
cord-018907-c84t1bo5	37	41	setting	setting	NN
cord-018907-c84t1bo5	37	42	.	.	.
cord-018907-c84t1bo5	38	1	Patients	patient	NNS
cord-018907-c84t1bo5	38	2	with	with	IN
cord-018907-c84t1bo5	38	3	skin	skin	NN
cord-018907-c84t1bo5	38	4	lesions	lesion	NNS
cord-018907-c84t1bo5	38	5	should	should	MD
cord-018907-c84t1bo5	38	6	have	have	VB
cord-018907-c84t1bo5	38	7	skin	skin	NN
cord-018907-c84t1bo5	38	8	biopsy	biopsy	NN
cord-018907-c84t1bo5	38	9	from	from	IN
cord-018907-c84t1bo5	38	10	the	the	DT
cord-018907-c84t1bo5	38	11	lesion	lesion	NN
cord-018907-c84t1bo5	38	12	,	,	,
cord-018907-c84t1bo5	38	13	which	which	WDT
cord-018907-c84t1bo5	38	14	will	will	MD
cord-018907-c84t1bo5	38	15	be	be	VB
cord-018907-c84t1bo5	38	16	sent	send	VBN
cord-018907-c84t1bo5	38	17	for	for	IN
cord-018907-c84t1bo5	38	18	culture	culture	NN
cord-018907-c84t1bo5	38	19	(	(	-LRB-
cord-018907-c84t1bo5	38	20	bacterial	bacterial	JJ
cord-018907-c84t1bo5	38	21	,	,	,
cord-018907-c84t1bo5	38	22	fungal	fungal	JJ
cord-018907-c84t1bo5	38	23	,	,	,
cord-018907-c84t1bo5	38	24	and	and	CC
cord-018907-c84t1bo5	38	25	mycobacterium	mycobacterium	NN
cord-018907-c84t1bo5	38	26	)	)	-RRB-
cord-018907-c84t1bo5	38	27	in	in	IN
cord-018907-c84t1bo5	38	28	addition	addition	NN
cord-018907-c84t1bo5	38	29	to	to	IN
cord-018907-c84t1bo5	38	30	histopathology	histopathology	NN
cord-018907-c84t1bo5	38	31	for	for	IN
cord-018907-c84t1bo5	38	32	Gram	gram	NN
cord-018907-c84t1bo5	38	33	-	-	HYPH
cord-018907-c84t1bo5	38	34	stain	stain	NN
cord-018907-c84t1bo5	38	35	and	and	CC
cord-018907-c84t1bo5	38	36	special	special	JJ
cord-018907-c84t1bo5	38	37	staining	staining	NN
cord-018907-c84t1bo5	38	38	for	for	IN
cord-018907-c84t1bo5	38	39	fungal	fungal	NN
cord-018907-c84t1bo5	38	40	as	as	RB
cord-018907-c84t1bo5	38	41	well	well	RB
cord-018907-c84t1bo5	38	42	as	as	IN
cord-018907-c84t1bo5	38	43	acid	acid	NN
cord-018907-c84t1bo5	38	44	fast	fast	JJ
cord-018907-c84t1bo5	38	45	stain	stain	NN
cord-018907-c84t1bo5	38	46	(	(	-LRB-
cord-018907-c84t1bo5	38	47	AFB	AFB	NNP
cord-018907-c84t1bo5	38	48	stain	stain	NN
cord-018907-c84t1bo5	38	49	)	)	-RRB-
cord-018907-c84t1bo5	38	50	.	.	.
cord-018907-c84t1bo5	39	1	There	there	EX
cord-018907-c84t1bo5	39	2	are	be	VBP
cord-018907-c84t1bo5	39	3	several	several	JJ
cord-018907-c84t1bo5	39	4	objectives	objective	NNS
cord-018907-c84t1bo5	39	5	in	in	IN
cord-018907-c84t1bo5	39	6	managing	manage	VBG
cord-018907-c84t1bo5	39	7	infections	infection	NNS
cord-018907-c84t1bo5	39	8	in	in	IN
cord-018907-c84t1bo5	39	9	immunocompromised	immunocompromised	JJ
cord-018907-c84t1bo5	39	10	patients	patient	NNS
cord-018907-c84t1bo5	39	11	.	.	.
cord-018907-c84t1bo5	40	1	The	the	DT
cord-018907-c84t1bo5	40	2	first	first	JJ
cord-018907-c84t1bo5	40	3	and	and	CC
cord-018907-c84t1bo5	40	4	foremost	foremost	JJ
cord-018907-c84t1bo5	40	5	objective	objective	NN
cord-018907-c84t1bo5	40	6	is	be	VBZ
cord-018907-c84t1bo5	40	7	to	to	TO
cord-018907-c84t1bo5	40	8	assure	assure	VB
cord-018907-c84t1bo5	40	9	patients	patient	NNS
cord-018907-c84t1bo5	40	10	'	'	POS
cord-018907-c84t1bo5	40	11	survival	survival	NN
cord-018907-c84t1bo5	40	12	and	and	CC
cord-018907-c84t1bo5	40	13	prevent	prevent	VB
cord-018907-c84t1bo5	40	14	infectious	infectious	JJ
cord-018907-c84t1bo5	40	15	morbidity	morbidity	NN
cord-018907-c84t1bo5	40	16	.	.	.
cord-018907-c84t1bo5	41	1	Decrease	decrease	NN
cord-018907-c84t1bo5	41	2	days	day	NNS
cord-018907-c84t1bo5	41	3	of	of	IN
cord-018907-c84t1bo5	41	4	hospitalization	hospitalization	NN
cord-018907-c84t1bo5	41	5	and	and	CC
cord-018907-c84t1bo5	41	6	decrease	decrease	VB
cord-018907-c84t1bo5	41	7	exposure	exposure	NN
cord-018907-c84t1bo5	41	8	to	to	IN
cord-018907-c84t1bo5	41	9	multidrug	multidrug	NN
cord-018907-c84t1bo5	41	10	resistance	resistance	NN
cord-018907-c84t1bo5	41	11	organism	organism	NN
cord-018907-c84t1bo5	41	12	,	,	,
cord-018907-c84t1bo5	41	13	decrease	decrease	VB
cord-018907-c84t1bo5	41	14	number	number	NN
cord-018907-c84t1bo5	41	15	of	of	IN
cord-018907-c84t1bo5	41	16	days	day	NNS
cord-018907-c84t1bo5	41	17	of	of	IN
cord-018907-c84t1bo5	41	18	antibiotic	antibiotic	JJ
cord-018907-c84t1bo5	41	19	use	use	NN
cord-018907-c84t1bo5	41	20	to	to	TO
cord-018907-c84t1bo5	41	21	minimize	minimize	VB
cord-018907-c84t1bo5	41	22	selection	selection	NN
cord-018907-c84t1bo5	41	23	of	of	IN
cord-018907-c84t1bo5	41	24	resistance	resistance	NN
cord-018907-c84t1bo5	41	25	organism	organism	NN
cord-018907-c84t1bo5	41	26	.	.	.
cord-018907-c84t1bo5	42	1	Modification	modification	NN
cord-018907-c84t1bo5	42	2	of	of	IN
cord-018907-c84t1bo5	42	3	antimicrobial	antimicrobial	JJ
cord-018907-c84t1bo5	42	4	therapy	therapy	NN
cord-018907-c84t1bo5	42	5	in	in	IN
cord-018907-c84t1bo5	42	6	immunocompromised	immunocompromised	JJ
cord-018907-c84t1bo5	42	7	patients	patient	NNS
cord-018907-c84t1bo5	42	8	is	be	VBZ
cord-018907-c84t1bo5	42	9	the	the	DT
cord-018907-c84t1bo5	42	10	rule	rule	NN
cord-018907-c84t1bo5	42	11	rather	rather	RB
cord-018907-c84t1bo5	42	12	than	than	IN
cord-018907-c84t1bo5	42	13	the	the	DT
cord-018907-c84t1bo5	42	14	exception	exception	NN
cord-018907-c84t1bo5	42	15	.	.	.
cord-018907-c84t1bo5	43	1	Timely	timely	JJ
cord-018907-c84t1bo5	43	2	modification	modification	NN
cord-018907-c84t1bo5	43	3	of	of	IN
cord-018907-c84t1bo5	43	4	antibiotic	antibiotic	JJ
cord-018907-c84t1bo5	43	5	therapy	therapy	NN
cord-018907-c84t1bo5	43	6	is	be	VBZ
cord-018907-c84t1bo5	43	7	very	very	RB
cord-018907-c84t1bo5	43	8	important	important	JJ
cord-018907-c84t1bo5	43	9	to	to	TO
cord-018907-c84t1bo5	43	10	control	control	VB
cord-018907-c84t1bo5	43	11	breakthrough	breakthrough	NN
cord-018907-c84t1bo5	43	12	infection	infection	NN
cord-018907-c84t1bo5	43	13	.	.	.
cord-018907-c84t1bo5	44	1	There	there	EX
cord-018907-c84t1bo5	44	2	are	be	VBP
cord-018907-c84t1bo5	44	3	several	several	JJ
cord-018907-c84t1bo5	44	4	questions	question	NNS
cord-018907-c84t1bo5	44	5	to	to	TO
cord-018907-c84t1bo5	44	6	be	be	VB
cord-018907-c84t1bo5	44	7	addressed	address	VBN
cord-018907-c84t1bo5	44	8	to	to	TO
cord-018907-c84t1bo5	44	9	choose	choose	VB
cord-018907-c84t1bo5	44	10	the	the	DT
cord-018907-c84t1bo5	44	11	effective	effective	JJ
cord-018907-c84t1bo5	44	12	antimicrobial	antimicrobial	JJ
cord-018907-c84t1bo5	44	13	therapy	therapy	NN
cord-018907-c84t1bo5	44	14	when	when	WRB
cord-018907-c84t1bo5	44	15	evaluating	evaluate	VBG
cord-018907-c84t1bo5	44	16	patients	patient	NNS
cord-018907-c84t1bo5	44	17	.	.	.
cord-018907-c84t1bo5	45	1	In	in	IN
cord-018907-c84t1bo5	45	2	addition	addition	NN
cord-018907-c84t1bo5	45	3	to	to	IN
cord-018907-c84t1bo5	45	4	history	history	NN
cord-018907-c84t1bo5	45	5	and	and	CC
cord-018907-c84t1bo5	45	6	physical	physical	JJ
cord-018907-c84t1bo5	45	7	examination	examination	NN
cord-018907-c84t1bo5	45	8	,	,	,
cord-018907-c84t1bo5	45	9	it	-PRON-	PRP
cord-018907-c84t1bo5	45	10	is	be	VBZ
cord-018907-c84t1bo5	45	11	important	important	JJ
cord-018907-c84t1bo5	45	12	to	to	TO
cord-018907-c84t1bo5	45	13	determine	determine	VB
cord-018907-c84t1bo5	45	14	which	which	WDT
cord-018907-c84t1bo5	45	15	arm	arm	NN
cord-018907-c84t1bo5	45	16	/	/	SYM
cord-018907-c84t1bo5	45	17	arms	arm	NNS
cord-018907-c84t1bo5	45	18	of	of	IN
cord-018907-c84t1bo5	45	19	the	the	DT
cord-018907-c84t1bo5	45	20	immune	immune	JJ
cord-018907-c84t1bo5	45	21	systems	system	NNS
cord-018907-c84t1bo5	46	1	that	that	DT
cord-018907-c84t1bo5	46	2	is	be	VBZ
cord-018907-c84t1bo5	46	3	/	/	,
cord-018907-c84t1bo5	46	4	are	be	VBP
cord-018907-c84t1bo5	46	5	affected	affect	VBN
cord-018907-c84t1bo5	46	6	?	?	.
cord-018907-c84t1bo5	47	1	what	what	WP
cord-018907-c84t1bo5	47	2	the	the	DT
cord-018907-c84t1bo5	47	3	clinical	clinical	JJ
cord-018907-c84t1bo5	47	4	syndrome	syndrome	NN
cord-018907-c84t1bo5	47	5	/	/	SYM
cord-018907-c84t1bo5	47	6	site	site	NN
cord-018907-c84t1bo5	47	7	of	of	IN
cord-018907-c84t1bo5	47	8	infection	infection	NN
cord-018907-c84t1bo5	47	9	is	be	VBZ
cord-018907-c84t1bo5	47	10	?	?	.
cord-018907-c84t1bo5	48	1	(	(	-LRB-
cord-018907-c84t1bo5	48	2	to	to	TO
cord-018907-c84t1bo5	48	3	predict	predict	VB
cord-018907-c84t1bo5	48	4	what	what	WP
cord-018907-c84t1bo5	48	5	are	be	VBP
cord-018907-c84t1bo5	48	6	the	the	DT
cord-018907-c84t1bo5	48	7	likely	likely	JJ
cord-018907-c84t1bo5	48	8	pathogens	pathogen	NNS
cord-018907-c84t1bo5	48	9	)	)	-RRB-
cord-018907-c84t1bo5	48	10	,	,	,
cord-018907-c84t1bo5	48	11	what	what	WDT
cord-018907-c84t1bo5	48	12	clinical	clinical	JJ
cord-018907-c84t1bo5	48	13	specimen(s	specimen(s	NNP
cord-018907-c84t1bo5	48	14	)	)	-RRB-
cord-018907-c84t1bo5	48	15	should	should	MD
cord-018907-c84t1bo5	48	16	be	be	VB
cord-018907-c84t1bo5	48	17	obtained	obtain	VBN
cord-018907-c84t1bo5	48	18	(	(	-LRB-
cord-018907-c84t1bo5	48	19	empiric	empiric	JJ
cord-018907-c84t1bo5	48	20	/	/	SYM
cord-018907-c84t1bo5	48	21	definitive	definitive	JJ
cord-018907-c84t1bo5	48	22	therapy	therapy	NN
cord-018907-c84t1bo5	48	23	)	)	-RRB-
cord-018907-c84t1bo5	48	24	?	?	.
cord-018907-c84t1bo5	49	1	and	and	CC
cord-018907-c84t1bo5	49	2	which	which	WDT
cord-018907-c84t1bo5	49	3	antimicrobial	antimicrobial	JJ
cord-018907-c84t1bo5	49	4	agents	agent	NNS
cord-018907-c84t1bo5	49	5	have	have	VBP
cord-018907-c84t1bo5	49	6	predictable	predictable	JJ
cord-018907-c84t1bo5	49	7	activity	activity	NN
cord-018907-c84t1bo5	49	8	against	against	IN
cord-018907-c84t1bo5	49	9	pathogens	pathogen	NNS
cord-018907-c84t1bo5	49	10	?	?	.
cord-018907-c84t1bo5	50	1	With	with	IN
cord-018907-c84t1bo5	50	2	these	these	DT
cord-018907-c84t1bo5	50	3	in	in	IN
cord-018907-c84t1bo5	50	4	mind	mind	NN
cord-018907-c84t1bo5	50	5	,	,	,
cord-018907-c84t1bo5	50	6	one	one	PRP
cord-018907-c84t1bo5	50	7	can	can	MD
cord-018907-c84t1bo5	50	8	predict	predict	VB
cord-018907-c84t1bo5	50	9	pathogen	pathogen	NN
cord-018907-c84t1bo5	50	10	and	and	CC
cord-018907-c84t1bo5	50	11	choose	choose	VB
cord-018907-c84t1bo5	50	12	the	the	DT
cord-018907-c84t1bo5	50	13	right	right	JJ
cord-018907-c84t1bo5	50	14	antimicrobial	antimicrobial	JJ
cord-018907-c84t1bo5	50	15	agents	agent	NNS
cord-018907-c84t1bo5	50	16	.	.	.
cord-018907-c84t1bo5	51	1	Patients	patient	NNS
cord-018907-c84t1bo5	51	2	with	with	IN
cord-018907-c84t1bo5	51	3	Wiskott	Wiskott	NNP
cord-018907-c84t1bo5	51	4	-	-	HYPH
cord-018907-c84t1bo5	51	5	Aldrich	Aldrich	NNP
cord-018907-c84t1bo5	51	6	syndrome	syndrome	NN
cord-018907-c84t1bo5	51	7	are	be	VBP
cord-018907-c84t1bo5	51	8	at	at	IN
cord-018907-c84t1bo5	51	9	risk	risk	NN
cord-018907-c84t1bo5	51	10	of	of	IN
cord-018907-c84t1bo5	51	11	bacterial	bacterial	JJ
cord-018907-c84t1bo5	51	12	pneumonia	pneumonia	NN
cord-018907-c84t1bo5	51	13	as	as	RB
cord-018907-c84t1bo5	51	14	well	well	RB
cord-018907-c84t1bo5	51	15	as	as	IN
cord-018907-c84t1bo5	51	16	sepsis	sepsis	NN
cord-018907-c84t1bo5	51	17	with	with	IN
cord-018907-c84t1bo5	51	18	Gram	gram	NN
cord-018907-c84t1bo5	51	19	-	-	HYPH
cord-018907-c84t1bo5	51	20	positive	positive	JJ
cord-018907-c84t1bo5	51	21	organisms	organism	NNS
cord-018907-c84t1bo5	51	22	including	include	VBG
cord-018907-c84t1bo5	51	23	MRSA	MRSA	NNP
cord-018907-c84t1bo5	51	24	.	.	.
cord-018907-c84t1bo5	52	1	In	in	IN
cord-018907-c84t1bo5	52	2	this	this	DT
cord-018907-c84t1bo5	52	3	situation	situation	NN
cord-018907-c84t1bo5	52	4	,	,	,
cord-018907-c84t1bo5	52	5	medication	medication	NN
cord-018907-c84t1bo5	52	6	should	should	MD
cord-018907-c84t1bo5	52	7	include	include	VB
cord-018907-c84t1bo5	52	8	agents	agent	NNS
cord-018907-c84t1bo5	52	9	active	active	JJ
cord-018907-c84t1bo5	52	10	against	against	IN
cord-018907-c84t1bo5	52	11	Gram	gram	NN
cord-018907-c84t1bo5	52	12	-	-	HYPH
cord-018907-c84t1bo5	52	13	negative	negative	JJ
cord-018907-c84t1bo5	52	14	pathogen	pathogen	NN
cord-018907-c84t1bo5	52	15	plus	plus	CC
cord-018907-c84t1bo5	52	16	anti	anti	JJ
cord-018907-c84t1bo5	52	17	-	-	JJ
cord-018907-c84t1bo5	52	18	staphylococcus	staphylococcus	JJ
cord-018907-c84t1bo5	52	19	agents	agent	NNS
cord-018907-c84t1bo5	52	20	,	,	,
cord-018907-c84t1bo5	52	21	for	for	IN
cord-018907-c84t1bo5	52	22	example	example	NN
cord-018907-c84t1bo5	52	23	,	,	,
cord-018907-c84t1bo5	52	24	cefotaxime	cefotaxime	NN
cord-018907-c84t1bo5	52	25	or	or	CC
cord-018907-c84t1bo5	52	26	ceftriaxone	ceftriaxone	NNP
cord-018907-c84t1bo5	52	27	plus	plus	CC
cord-018907-c84t1bo5	52	28	naficillin	naficillin	NNP
cord-018907-c84t1bo5	52	29	;	;	:
cord-018907-c84t1bo5	52	30	if	if	IN
cord-018907-c84t1bo5	52	31	MRSA	MRSA	NNP
cord-018907-c84t1bo5	52	32	or	or	CC
cord-018907-c84t1bo5	52	33	penicillin	penicillin	NN
cord-018907-c84t1bo5	52	34	resistant	resistant	JJ
cord-018907-c84t1bo5	52	35	S.	S.	NNP
cord-018907-c84t1bo5	52	36	pneumonia	pneumonia	NN
cord-018907-c84t1bo5	52	37	is	be	VBZ
cord-018907-c84t1bo5	52	38	suspected	suspect	VBN
cord-018907-c84t1bo5	52	39	,	,	,
cord-018907-c84t1bo5	52	40	one	one	PRP
cord-018907-c84t1bo5	52	41	can	can	MD
cord-018907-c84t1bo5	52	42	use	use	VB
cord-018907-c84t1bo5	52	43	vancomycin	vancomycin	NN
cord-018907-c84t1bo5	52	44	.	.	.
cord-018907-c84t1bo5	53	1	The	the	DT
cord-018907-c84t1bo5	53	2	pathogen	pathogen	NN
cord-018907-c84t1bo5	53	3	in	in	IN
cord-018907-c84t1bo5	53	4	immunocompromised	immunocompromised	JJ
cord-018907-c84t1bo5	53	5	patients	patient	NNS
cord-018907-c84t1bo5	53	6	can	can	MD
cord-018907-c84t1bo5	53	7	be	be	VB
cord-018907-c84t1bo5	53	8	predicted	predict	VBN
cord-018907-c84t1bo5	53	9	by	by	IN
cord-018907-c84t1bo5	53	10	the	the	DT
cord-018907-c84t1bo5	53	11	system	system	NN
cord-018907-c84t1bo5	53	12	involved	involve	VBN
cord-018907-c84t1bo5	53	13	during	during	IN
cord-018907-c84t1bo5	53	14	the	the	DT
cord-018907-c84t1bo5	53	15	presentation	presentation	NN
cord-018907-c84t1bo5	53	16	.	.	.
cord-018907-c84t1bo5	54	1	For	for	IN
cord-018907-c84t1bo5	54	2	example	example	NN
cord-018907-c84t1bo5	54	3	,	,	,
cord-018907-c84t1bo5	54	4	the	the	DT
cord-018907-c84t1bo5	54	5	presentation	presentation	NN
cord-018907-c84t1bo5	54	6	and	and	CC
cord-018907-c84t1bo5	54	7	etiological	etiological	JJ
cord-018907-c84t1bo5	54	8	agents	agent	NNS
cord-018907-c84t1bo5	54	9	in	in	IN
cord-018907-c84t1bo5	54	10	pneumonia	pneumonia	NN
cord-018907-c84t1bo5	54	11	in	in	IN
cord-018907-c84t1bo5	54	12	immunocompromised	immunocompromised	JJ
cord-018907-c84t1bo5	54	13	patients	patient	NNS
cord-018907-c84t1bo5	54	14	are	be	VBP
cord-018907-c84t1bo5	54	15	different	different	JJ
cord-018907-c84t1bo5	54	16	than	than	IN
cord-018907-c84t1bo5	54	17	immunocompetent	immunocompetent	JJ
cord-018907-c84t1bo5	54	18	persons	person	NNS
cord-018907-c84t1bo5	54	19	.	.	.
cord-018907-c84t1bo5	55	1	In	in	IN
cord-018907-c84t1bo5	55	2	evaluating	evaluate	VBG
cord-018907-c84t1bo5	55	3	pneumonia	pneumonia	NN
cord-018907-c84t1bo5	55	4	in	in	IN
cord-018907-c84t1bo5	55	5	immunocompromised	immunocompromised	JJ
cord-018907-c84t1bo5	55	6	patients	patient	NNS
cord-018907-c84t1bo5	55	7	,	,	,
cord-018907-c84t1bo5	55	8	one	one	PRP
cord-018907-c84t1bo5	55	9	needs	need	VBZ
cord-018907-c84t1bo5	55	10	to	to	TO
cord-018907-c84t1bo5	55	11	know	know	VB
cord-018907-c84t1bo5	55	12	that	that	IN
cord-018907-c84t1bo5	55	13	the	the	DT
cord-018907-c84t1bo5	55	14	pulmonary	pulmonary	JJ
cord-018907-c84t1bo5	55	15	complication	complication	NN
cord-018907-c84t1bo5	55	16	is	be	VBZ
cord-018907-c84t1bo5	55	17	present	present	JJ
cord-018907-c84t1bo5	55	18	in	in	IN
cord-018907-c84t1bo5	56	1	up	up	IN
cord-018907-c84t1bo5	56	2	to	to	TO
cord-018907-c84t1bo5	56	3	60	60	CD
cord-018907-c84t1bo5	56	4	%	%	NN
cord-018907-c84t1bo5	56	5	of	of	IN
cord-018907-c84t1bo5	56	6	immunocompromised	immunocompromised	JJ
cord-018907-c84t1bo5	56	7	patients	patient	NNS
cord-018907-c84t1bo5	56	8	and	and	CC
cord-018907-c84t1bo5	56	9	mortality	mortality	NN
cord-018907-c84t1bo5	56	10	is	be	VBZ
cord-018907-c84t1bo5	56	11	up	up	IN
cord-018907-c84t1bo5	56	12	to	to	TO
cord-018907-c84t1bo5	56	13	80	80	CD
cord-018907-c84t1bo5	56	14	%	%	NN
cord-018907-c84t1bo5	56	15	of	of	IN
cord-018907-c84t1bo5	56	16	those	those	DT
cord-018907-c84t1bo5	56	17	who	who	WP
cord-018907-c84t1bo5	56	18	require	require	VBP
cord-018907-c84t1bo5	56	19	mechanical	mechanical	JJ
cord-018907-c84t1bo5	56	20	ventilation	ventilation	NN
cord-018907-c84t1bo5	56	21	.	.	.
cord-018907-c84t1bo5	57	1	The	the	DT
cord-018907-c84t1bo5	57	2	initial	initial	JJ
cord-018907-c84t1bo5	57	3	evaluation	evaluation	NN
cord-018907-c84t1bo5	57	4	needs	need	VBZ
cord-018907-c84t1bo5	57	5	rapid	rapid	JJ
cord-018907-c84t1bo5	57	6	assessment	assessment	NN
cord-018907-c84t1bo5	57	7	of	of	IN
cord-018907-c84t1bo5	57	8	the	the	DT
cord-018907-c84t1bo5	57	9	vital	vital	JJ
cord-018907-c84t1bo5	57	10	signs	sign	NNS
cord-018907-c84t1bo5	57	11	including	include	VBG
cord-018907-c84t1bo5	57	12	oxygen	oxygen	NN
cord-018907-c84t1bo5	57	13	saturation	saturation	NN
cord-018907-c84t1bo5	57	14	,	,	,
cord-018907-c84t1bo5	57	15	complete	complete	JJ
cord-018907-c84t1bo5	57	16	blood	blood	NN
cord-018907-c84t1bo5	57	17	count	count	NN
cord-018907-c84t1bo5	57	18	with	with	IN
cord-018907-c84t1bo5	57	19	differential	differential	JJ
cord-018907-c84t1bo5	57	20	,	,	,
cord-018907-c84t1bo5	57	21	renal	renal	JJ
cord-018907-c84t1bo5	57	22	profile	profile	NN
cord-018907-c84t1bo5	57	23	,	,	,
cord-018907-c84t1bo5	57	24	blood	blood	NN
cord-018907-c84t1bo5	57	25	culture	culture	NN
cord-018907-c84t1bo5	57	26	,	,	,
cord-018907-c84t1bo5	57	27	and	and	CC
cord-018907-c84t1bo5	57	28	imaging	imaging	NN
cord-018907-c84t1bo5	57	29	of	of	IN
cord-018907-c84t1bo5	57	30	the	the	DT
cord-018907-c84t1bo5	57	31	lung	lung	NN
cord-018907-c84t1bo5	57	32	either	either	CC
cord-018907-c84t1bo5	57	33	chest	chest	NN
cord-018907-c84t1bo5	57	34	X	x	NN
cord-018907-c84t1bo5	57	35	-	-	NN
cord-018907-c84t1bo5	57	36	ray	ray	NN
cord-018907-c84t1bo5	57	37	or	or	CC
cord-018907-c84t1bo5	57	38	CT	CT	NNP
cord-018907-c84t1bo5	57	39	scan	scan	NN
cord-018907-c84t1bo5	57	40	.	.	.
cord-018907-c84t1bo5	58	1	The	the	DT
cord-018907-c84t1bo5	58	2	organism	organism	NN
cord-018907-c84t1bo5	58	3	can	can	MD
cord-018907-c84t1bo5	58	4	be	be	VB
cord-018907-c84t1bo5	58	5	predicted	predict	VBN
cord-018907-c84t1bo5	58	6	based	base	VBN
cord-018907-c84t1bo5	58	7	on	on	IN
cord-018907-c84t1bo5	58	8	the	the	DT
cord-018907-c84t1bo5	58	9	primary	primary	JJ
cord-018907-c84t1bo5	58	10	immune	immune	JJ
cord-018907-c84t1bo5	58	11	defect	defect	NN
cord-018907-c84t1bo5	58	12	.	.	.
cord-018907-c84t1bo5	59	1	At	at	IN
cord-018907-c84t1bo5	59	2	certain	certain	JJ
cord-018907-c84t1bo5	59	3	point	point	NN
cord-018907-c84t1bo5	59	4	in	in	IN
cord-018907-c84t1bo5	59	5	the	the	DT
cord-018907-c84t1bo5	59	6	history	history	NN
cord-018907-c84t1bo5	59	7	,	,	,
cord-018907-c84t1bo5	59	8	the	the	DT
cord-018907-c84t1bo5	59	9	defect	defect	NN
cord-018907-c84t1bo5	59	10	in	in	IN
cord-018907-c84t1bo5	59	11	the	the	DT
cord-018907-c84t1bo5	59	12	immune	immune	JJ
cord-018907-c84t1bo5	59	13	system	system	NN
cord-018907-c84t1bo5	59	14	,	,	,
cord-018907-c84t1bo5	59	15	the	the	DT
cord-018907-c84t1bo5	59	16	presence	presence	NN
cord-018907-c84t1bo5	59	17	or	or	CC
cord-018907-c84t1bo5	59	18	absence	absence	NN
cord-018907-c84t1bo5	59	19	of	of	IN
cord-018907-c84t1bo5	59	20	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	59	21	,	,	,
cord-018907-c84t1bo5	59	22	history	history	NN
cord-018907-c84t1bo5	59	23	of	of	IN
cord-018907-c84t1bo5	59	24	antimicrobial	antimicrobial	JJ
cord-018907-c84t1bo5	59	25	exposure	exposure	NN
cord-018907-c84t1bo5	59	26	,	,	,
cord-018907-c84t1bo5	59	27	the	the	DT
cord-018907-c84t1bo5	59	28	presence	presence	NN
cord-018907-c84t1bo5	59	29	of	of	IN
cord-018907-c84t1bo5	59	30	potential	potential	JJ
cord-018907-c84t1bo5	59	31	pulmonary	pulmonary	JJ
cord-018907-c84t1bo5	59	32	pathogens	pathogen	NNS
cord-018907-c84t1bo5	59	33	in	in	IN
cord-018907-c84t1bo5	59	34	previous	previous	JJ
cord-018907-c84t1bo5	59	35	cultures	culture	NNS
cord-018907-c84t1bo5	59	36	,	,	,
cord-018907-c84t1bo5	59	37	and	and	CC
cord-018907-c84t1bo5	59	38	the	the	DT
cord-018907-c84t1bo5	59	39	presence	presence	NN
cord-018907-c84t1bo5	59	40	of	of	IN
cord-018907-c84t1bo5	59	41	indwelling	indwell	VBG
cord-018907-c84t1bo5	59	42	catheters	catheter	NNS
cord-018907-c84t1bo5	59	43	should	should	MD
cord-018907-c84t1bo5	59	44	be	be	VB
cord-018907-c84t1bo5	59	45	looked	look	VBN
cord-018907-c84t1bo5	59	46	at	at	IN
cord-018907-c84t1bo5	59	47	.	.	.
cord-018907-c84t1bo5	60	1	The	the	DT
cord-018907-c84t1bo5	60	2	pattern	pattern	NN
cord-018907-c84t1bo5	60	3	and	and	CC
cord-018907-c84t1bo5	60	4	distribution	distribution	NN
cord-018907-c84t1bo5	60	5	of	of	IN
cord-018907-c84t1bo5	60	6	radiological	radiological	JJ
cord-018907-c84t1bo5	60	7	abnormalities	abnormality	NNS
cord-018907-c84t1bo5	60	8	can	can	MD
cord-018907-c84t1bo5	60	9	predict	predict	VB
cord-018907-c84t1bo5	60	10	the	the	DT
cord-018907-c84t1bo5	60	11	pathogen	pathogen	NN
cord-018907-c84t1bo5	60	12	and	and	CC
cord-018907-c84t1bo5	60	13	the	the	DT
cord-018907-c84t1bo5	60	14	time	time	NN
cord-018907-c84t1bo5	60	15	and	and	CC
cord-018907-c84t1bo5	60	16	the	the	DT
cord-018907-c84t1bo5	60	17	rate	rate	NN
cord-018907-c84t1bo5	60	18	of	of	IN
cord-018907-c84t1bo5	60	19	progression	progression	NN
cord-018907-c84t1bo5	60	20	and	and	CC
cord-018907-c84t1bo5	60	21	time	time	NN
cord-018907-c84t1bo5	60	22	to	to	IN
cord-018907-c84t1bo5	60	23	resolution	resolution	NN
cord-018907-c84t1bo5	60	24	of	of	IN
cord-018907-c84t1bo5	60	25	pulmonary	pulmonary	JJ
cord-018907-c84t1bo5	60	26	abnormalities	abnormality	NNS
cord-018907-c84t1bo5	60	27	.	.	.
cord-018907-c84t1bo5	61	1	For	for	IN
cord-018907-c84t1bo5	61	2	definitive	definitive	JJ
cord-018907-c84t1bo5	61	3	diagnoses	diagnosis	NNS
cord-018907-c84t1bo5	61	4	invasive	invasive	JJ
cord-018907-c84t1bo5	61	5	procedures	procedure	NNS
cord-018907-c84t1bo5	61	6	may	may	MD
cord-018907-c84t1bo5	61	7	be	be	VB
cord-018907-c84t1bo5	61	8	needed	need	VBN
cord-018907-c84t1bo5	61	9	including	include	VBG
cord-018907-c84t1bo5	61	10	bronchoalveolar	bronchoalveolar	NNP
cord-018907-c84t1bo5	61	11	lavage	lavage	NNP
cord-018907-c84t1bo5	61	12	(	(	-LRB-
cord-018907-c84t1bo5	61	13	BAL	BAL	NNP
cord-018907-c84t1bo5	61	14	)	)	-RRB-
cord-018907-c84t1bo5	61	15	,	,	,
cord-018907-c84t1bo5	61	16	transbronchial	transbronchial	NNP
cord-018907-c84t1bo5	61	17	biopsy	biopsy	NN
cord-018907-c84t1bo5	61	18	,	,	,
cord-018907-c84t1bo5	61	19	needless	needless	JJ
cord-018907-c84t1bo5	61	20	biopsy	biopsy	NN
cord-018907-c84t1bo5	61	21	,	,	,
cord-018907-c84t1bo5	61	22	thorascopic	thorascopic	NNP
cord-018907-c84t1bo5	61	23	biopsy	biopsy	NNP
cord-018907-c84t1bo5	61	24	,	,	,
cord-018907-c84t1bo5	61	25	and	and	CC
cord-018907-c84t1bo5	61	26	open	open	JJ
cord-018907-c84t1bo5	61	27	lung	lung	NN
cord-018907-c84t1bo5	61	28	biopsy	biopsy	NN
cord-018907-c84t1bo5	61	29	.	.	.
cord-018907-c84t1bo5	62	1	In	in	IN
cord-018907-c84t1bo5	62	2	obtaining	obtain	VBG
cord-018907-c84t1bo5	62	3	the	the	DT
cord-018907-c84t1bo5	62	4	biopsy	biopsy	NN
cord-018907-c84t1bo5	62	5	from	from	IN
cord-018907-c84t1bo5	62	6	this	this	DT
cord-018907-c84t1bo5	62	7	patient	patient	NN
cord-018907-c84t1bo5	62	8	,	,	,
cord-018907-c84t1bo5	62	9	it	-PRON-	PRP
cord-018907-c84t1bo5	62	10	is	be	VBZ
cord-018907-c84t1bo5	62	11	very	very	RB
cord-018907-c84t1bo5	62	12	important	important	JJ
cord-018907-c84t1bo5	62	13	to	to	TO
cord-018907-c84t1bo5	62	14	send	send	VB
cord-018907-c84t1bo5	62	15	it	-PRON-	PRP
cord-018907-c84t1bo5	62	16	for	for	IN
cord-018907-c84t1bo5	62	17	histopathology	histopathology	NN
cord-018907-c84t1bo5	62	18	for	for	IN
cord-018907-c84t1bo5	62	19	special	special	JJ
cord-018907-c84t1bo5	62	20	staining	staining	NN
cord-018907-c84t1bo5	62	21	,	,	,
cord-018907-c84t1bo5	62	22	for	for	IN
cord-018907-c84t1bo5	62	23	viruses	virus	NNS
cord-018907-c84t1bo5	62	24	,	,	,
cord-018907-c84t1bo5	62	25	bacteria	bacteria	NNS
cord-018907-c84t1bo5	62	26	,	,	,
cord-018907-c84t1bo5	62	27	fungi	fungus	NNS
cord-018907-c84t1bo5	62	28	,	,	,
cord-018907-c84t1bo5	62	29	pneumocystis	pneumocystis	NN
cord-018907-c84t1bo5	62	30	,	,	,
cord-018907-c84t1bo5	62	31	mycobacterial	mycobacterial	JJ
cord-018907-c84t1bo5	62	32	pathogen	pathogen	NN
cord-018907-c84t1bo5	62	33	,	,	,
cord-018907-c84t1bo5	62	34	and	and	CC
cord-018907-c84t1bo5	62	35	also	also	RB
cord-018907-c84t1bo5	62	36	culture	culture	NN
cord-018907-c84t1bo5	62	37	for	for	IN
cord-018907-c84t1bo5	62	38	viral	viral	JJ
cord-018907-c84t1bo5	62	39	,	,	,
cord-018907-c84t1bo5	62	40	fungal	fungal	JJ
cord-018907-c84t1bo5	62	41	,	,	,
cord-018907-c84t1bo5	62	42	bacterial	bacterial	JJ
cord-018907-c84t1bo5	62	43	,	,	,
cord-018907-c84t1bo5	62	44	and	and	CC
cord-018907-c84t1bo5	62	45	mycobacterium	mycobacterium	NN
cord-018907-c84t1bo5	62	46	.	.	.
cord-018907-c84t1bo5	63	1	Other	other	JJ
cord-018907-c84t1bo5	63	2	laboratory	laboratory	NN
cord-018907-c84t1bo5	63	3	tests	test	NNS
cord-018907-c84t1bo5	63	4	that	that	WDT
cord-018907-c84t1bo5	63	5	will	will	MD
cord-018907-c84t1bo5	63	6	help	help	VB
cord-018907-c84t1bo5	63	7	in	in	IN
cord-018907-c84t1bo5	63	8	diagnosing	diagnose	VBG
cord-018907-c84t1bo5	63	9	pneumonia	pneumonia	NN
cord-018907-c84t1bo5	63	10	are	be	VBP
cord-018907-c84t1bo5	63	11	nasal	nasal	NN
cord-018907-c84t1bo5	63	12	washings	washing	NNS
cord-018907-c84t1bo5	63	13	or	or	CC
cord-018907-c84t1bo5	63	14	swabs	swab	NNS
cord-018907-c84t1bo5	63	15	for	for	IN
cord-018907-c84t1bo5	63	16	direct	direct	JJ
cord-018907-c84t1bo5	63	17	fluorescent	fluorescent	JJ
cord-018907-c84t1bo5	63	18	antibody	antibody	NN
cord-018907-c84t1bo5	63	19	,	,	,
cord-018907-c84t1bo5	63	20	PCR	PCR	NNP
cord-018907-c84t1bo5	63	21	for	for	IN
cord-018907-c84t1bo5	63	22	respiratory	respiratory	JJ
cord-018907-c84t1bo5	63	23	viruses	virus	NNS
cord-018907-c84t1bo5	63	24	and	and	CC
cord-018907-c84t1bo5	63	25	atypical	atypical	JJ
cord-018907-c84t1bo5	63	26	pneumonia	pneumonia	NN
cord-018907-c84t1bo5	63	27	,	,	,
cord-018907-c84t1bo5	63	28	culture	culture	NN
cord-018907-c84t1bo5	63	29	and	and	CC
cord-018907-c84t1bo5	63	30	staining	staining	NN
cord-018907-c84t1bo5	63	31	,	,	,
cord-018907-c84t1bo5	63	32	CMV	CMV	NNP
cord-018907-c84t1bo5	63	33	antigenemia	antigenemia	NN
cord-018907-c84t1bo5	63	34	or	or	CC
cord-018907-c84t1bo5	63	35	CMV	CMV	NNP
cord-018907-c84t1bo5	63	36	viral	viral	JJ
cord-018907-c84t1bo5	63	37	load	load	NN
cord-018907-c84t1bo5	63	38	testing	testing	NN
cord-018907-c84t1bo5	63	39	,	,	,
cord-018907-c84t1bo5	63	40	Aspergillus	Aspergillus	NNP
cord-018907-c84t1bo5	63	41	galactomannan	galactomannan	NNP
cord-018907-c84t1bo5	63	42	assay	assay	NN
cord-018907-c84t1bo5	63	43	,	,	,
cord-018907-c84t1bo5	63	44	and	and	CC
cord-018907-c84t1bo5	63	45	1,3	1,3	CD
cord-018907-c84t1bo5	63	46	beta	beta	NN
cord-018907-c84t1bo5	63	47	D	d	NN
cord-018907-c84t1bo5	63	48	glucan	glucan	NN
cord-018907-c84t1bo5	63	49	.	.	.
cord-018907-c84t1bo5	64	1	The	the	DT
cord-018907-c84t1bo5	64	2	radiological	radiological	JJ
cord-018907-c84t1bo5	64	3	finding	finding	NN
cord-018907-c84t1bo5	64	4	in	in	IN
cord-018907-c84t1bo5	64	5	immunocompromised	immunocompromised	JJ
cord-018907-c84t1bo5	64	6	patient	patient	NN
cord-018907-c84t1bo5	64	7	can	can	MD
cord-018907-c84t1bo5	64	8	be	be	VB
cord-018907-c84t1bo5	64	9	focal	focal	JJ
cord-018907-c84t1bo5	64	10	(	(	-LRB-
cord-018907-c84t1bo5	64	11	lobar	lobar	JJ
cord-018907-c84t1bo5	64	12	or	or	CC
cord-018907-c84t1bo5	64	13	segmental	segmental	JJ
cord-018907-c84t1bo5	64	14	infiltrate	infiltrate	NN
cord-018907-c84t1bo5	64	15	)	)	-RRB-
cord-018907-c84t1bo5	64	16	,	,	,
cord-018907-c84t1bo5	64	17	diffuse	diffuse	VB
cord-018907-c84t1bo5	64	18	interstitial	interstitial	JJ
cord-018907-c84t1bo5	64	19	infiltrate	infiltrate	NN
cord-018907-c84t1bo5	64	20	or	or	CC
cord-018907-c84t1bo5	64	21	nodular	nodular	JJ
cord-018907-c84t1bo5	64	22	(	(	-LRB-
cord-018907-c84t1bo5	64	23	with	with	IN
cord-018907-c84t1bo5	64	24	or	or	CC
cord-018907-c84t1bo5	64	25	without	without	IN
cord-018907-c84t1bo5	64	26	cavitation	cavitation	NN
cord-018907-c84t1bo5	64	27	)	)	-RRB-
cord-018907-c84t1bo5	64	28	.	.	.
cord-018907-c84t1bo5	65	1	Focal	focal	JJ
cord-018907-c84t1bo5	65	2	infiltrate	infiltrate	NN
cord-018907-c84t1bo5	65	3	can	can	MD
cord-018907-c84t1bo5	65	4	be	be	VB
cord-018907-c84t1bo5	65	5	due	due	JJ
cord-018907-c84t1bo5	65	6	to	to	IN
cord-018907-c84t1bo5	65	7	Gram	gram	NN
cord-018907-c84t1bo5	65	8	-	-	HYPH
cord-018907-c84t1bo5	65	9	positive	positive	JJ
cord-018907-c84t1bo5	65	10	or	or	CC
cord-018907-c84t1bo5	65	11	Gram	gram	NN
cord-018907-c84t1bo5	65	12	-	-	HYPH
cord-018907-c84t1bo5	65	13	negative	negative	JJ
cord-018907-c84t1bo5	65	14	bacteria	bacteria	NNS
cord-018907-c84t1bo5	65	15	,	,	,
cord-018907-c84t1bo5	65	16	Legionella	Legionella	NNP
cord-018907-c84t1bo5	65	17	,	,	,
cord-018907-c84t1bo5	65	18	mycobacteria	mycobacterium	NNS
cord-018907-c84t1bo5	65	19	,	,	,
cord-018907-c84t1bo5	65	20	and	and	CC
cord-018907-c84t1bo5	65	21	fungal	fungal	JJ
cord-018907-c84t1bo5	65	22	infection	infection	NN
cord-018907-c84t1bo5	65	23	.	.	.
cord-018907-c84t1bo5	66	1	Also	also	RB
cord-018907-c84t1bo5	66	2	the	the	DT
cord-018907-c84t1bo5	66	3	noninfectious	noninfectious	JJ
cord-018907-c84t1bo5	66	4	etiology	etiology	NN
cord-018907-c84t1bo5	66	5	includes	include	VBZ
cord-018907-c84t1bo5	66	6	infarction	infarction	NN
cord-018907-c84t1bo5	66	7	,	,	,
cord-018907-c84t1bo5	66	8	radiation	radiation	NN
cord-018907-c84t1bo5	66	9	,	,	,
cord-018907-c84t1bo5	66	10	and	and	CC
cord-018907-c84t1bo5	66	11	drug	drug	NN
cord-018907-c84t1bo5	66	12	-	-	HYPH
cord-018907-c84t1bo5	66	13	related	relate	VBN
cord-018907-c84t1bo5	66	14	bronchiolitis	bronchiolitis	NN
cord-018907-c84t1bo5	66	15	obliterans	obliteran	NNS
cord-018907-c84t1bo5	66	16	organizing	organize	VBG
cord-018907-c84t1bo5	66	17	pneumonia	pneumonia	NN
cord-018907-c84t1bo5	66	18	(	(	-LRB-
cord-018907-c84t1bo5	66	19	BOOP	BOOP	NNP
cord-018907-c84t1bo5	66	20	)	)	-RRB-
cord-018907-c84t1bo5	66	21	.	.	.
cord-018907-c84t1bo5	67	1	Diffuse	diffuse	JJ
cord-018907-c84t1bo5	67	2	interstitial	interstitial	JJ
cord-018907-c84t1bo5	67	3	infiltrate	infiltrate	NN
cord-018907-c84t1bo5	67	4	is	be	VBZ
cord-018907-c84t1bo5	67	5	caused	cause	VBN
cord-018907-c84t1bo5	67	6	by	by	IN
cord-018907-c84t1bo5	67	7	viral	viral	JJ
cord-018907-c84t1bo5	67	8	infection	infection	NN
cord-018907-c84t1bo5	67	9	,	,	,
cord-018907-c84t1bo5	67	10	Pneumocystis	Pneumocystis	NNP
cord-018907-c84t1bo5	67	11	jiroveci	jiroveci	NNS
cord-018907-c84t1bo5	67	12	,	,	,
cord-018907-c84t1bo5	67	13	less	less	RBR
cord-018907-c84t1bo5	67	14	likely	likely	JJ
cord-018907-c84t1bo5	67	15	mycobacterium	mycobacterium	NN
cord-018907-c84t1bo5	67	16	,	,	,
cord-018907-c84t1bo5	67	17	disseminated	disseminate	VBN
cord-018907-c84t1bo5	67	18	fungal	fungal	JJ
cord-018907-c84t1bo5	67	19	infection	infection	NN
cord-018907-c84t1bo5	67	20	,	,	,
cord-018907-c84t1bo5	67	21	atypical	atypical	JJ
cord-018907-c84t1bo5	67	22	pneumonium	pneumonium	NN
cord-018907-c84t1bo5	67	23	including	include	VBG
cord-018907-c84t1bo5	67	24	Chlamydia	Chlamydia	NNP
cord-018907-c84t1bo5	67	25	,	,	,
cord-018907-c84t1bo5	67	26	Legionella	Legionella	NNP
cord-018907-c84t1bo5	67	27	,	,	,
cord-018907-c84t1bo5	67	28	and	and	CC
cord-018907-c84t1bo5	67	29	mycoplasma	mycoplasma	NN
cord-018907-c84t1bo5	67	30	.	.	.
cord-018907-c84t1bo5	68	1	Other	other	JJ
cord-018907-c84t1bo5	68	2	noninfectious	noninfectious	JJ
cord-018907-c84t1bo5	68	3	etiology	etiology	NN
cord-018907-c84t1bo5	68	4	causing	cause	VBG
cord-018907-c84t1bo5	68	5	diffuse	diffuse	JJ
cord-018907-c84t1bo5	68	6	interstitial	interstitial	JJ
cord-018907-c84t1bo5	68	7	infiltrate	infiltrate	NN
cord-018907-c84t1bo5	68	8	include	include	VBP
cord-018907-c84t1bo5	68	9	edema	edema	NN
cord-018907-c84t1bo5	68	10	,	,	,
cord-018907-c84t1bo5	68	11	acute	acute	JJ
cord-018907-c84t1bo5	68	12	respiratory	respiratory	JJ
cord-018907-c84t1bo5	68	13	distress	distress	NN
cord-018907-c84t1bo5	68	14	syndrome	syndrome	NN
cord-018907-c84t1bo5	68	15	(	(	-LRB-
cord-018907-c84t1bo5	68	16	ARDS	ARDS	NNP
cord-018907-c84t1bo5	68	17	)	)	-RRB-
cord-018907-c84t1bo5	68	18	,	,	,
cord-018907-c84t1bo5	68	19	and	and	CC
cord-018907-c84t1bo5	68	20	drug	drug	NN
cord-018907-c84t1bo5	68	21	-	-	HYPH
cord-018907-c84t1bo5	68	22	related	relate	VBN
cord-018907-c84t1bo5	68	23	radiation	radiation	NN
cord-018907-c84t1bo5	68	24	.	.	.
cord-018907-c84t1bo5	69	1	For	for	IN
cord-018907-c84t1bo5	69	2	nodular	nodular	JJ
cord-018907-c84t1bo5	69	3	infiltrate	infiltrate	NN
cord-018907-c84t1bo5	69	4	with	with	IN
cord-018907-c84t1bo5	69	5	or	or	CC
cord-018907-c84t1bo5	69	6	without	without	IN
cord-018907-c84t1bo5	69	7	cavitation	cavitation	NN
cord-018907-c84t1bo5	69	8	the	the	DT
cord-018907-c84t1bo5	69	9	infectious	infectious	JJ
cord-018907-c84t1bo5	69	10	etiology	etiology	NN
cord-018907-c84t1bo5	69	11	include	include	VBP
cord-018907-c84t1bo5	69	12	Aspergillus	aspergillus	NN
cord-018907-c84t1bo5	69	13	infection	infection	NN
cord-018907-c84t1bo5	69	14	,	,	,
cord-018907-c84t1bo5	69	15	and	and	CC
cord-018907-c84t1bo5	69	16	other	other	JJ
cord-018907-c84t1bo5	69	17	mycoses	mycose	NNS
cord-018907-c84t1bo5	69	18	,	,	,
cord-018907-c84t1bo5	69	19	Nocardia	Nocardia	NNP
cord-018907-c84t1bo5	69	20	,	,	,
cord-018907-c84t1bo5	69	21	bacteria	bacteria	NNS
cord-018907-c84t1bo5	69	22	either	either	CC
cord-018907-c84t1bo5	69	23	Gram	gram	NN
cord-018907-c84t1bo5	69	24	-	-	HYPH
cord-018907-c84t1bo5	69	25	positive	positive	JJ
cord-018907-c84t1bo5	69	26	or	or	CC
cord-018907-c84t1bo5	69	27	Gram	gram	NN
cord-018907-c84t1bo5	69	28	-	-	HYPH
cord-018907-c84t1bo5	69	29	negative	negative	JJ
cord-018907-c84t1bo5	69	30	,	,	,
cord-018907-c84t1bo5	69	31	anaerobes	anaerobe	NNS
cord-018907-c84t1bo5	69	32	,	,	,
cord-018907-c84t1bo5	69	33	and	and	CC
cord-018907-c84t1bo5	69	34	Mycobacterium	Mycobacterium	NNP
cord-018907-c84t1bo5	69	35	TB	TB	NNP
cord-018907-c84t1bo5	69	36	,	,	,
cord-018907-c84t1bo5	69	37	as	as	RB
cord-018907-c84t1bo5	69	38	well	well	RB
cord-018907-c84t1bo5	69	39	as	as	IN
cord-018907-c84t1bo5	69	40	noninfectious	noninfectious	JJ
cord-018907-c84t1bo5	69	41	etiology	etiology	NN
cord-018907-c84t1bo5	69	42	including	include	VBG
cord-018907-c84t1bo5	69	43	disease	disease	NN
cord-018907-c84t1bo5	69	44	progression	progression	NN
cord-018907-c84t1bo5	69	45	like	like	IN
cord-018907-c84t1bo5	69	46	metastasis	metastasis	NN
cord-018907-c84t1bo5	69	47	and	and	CC
cord-018907-c84t1bo5	69	48	drug	drug	NN
cord-018907-c84t1bo5	69	49	toxicity	toxicity	NN
cord-018907-c84t1bo5	69	50	.	.	.
cord-018907-c84t1bo5	70	1	The	the	DT
cord-018907-c84t1bo5	70	2	management	management	NN
cord-018907-c84t1bo5	70	3	of	of	IN
cord-018907-c84t1bo5	70	4	immunocompromised	immunocompromised	JJ
cord-018907-c84t1bo5	70	5	patients	patient	NNS
cord-018907-c84t1bo5	70	6	with	with	IN
cord-018907-c84t1bo5	70	7	pulmonary	pulmonary	JJ
cord-018907-c84t1bo5	70	8	infiltrate	infiltrate	NN
cord-018907-c84t1bo5	70	9	will	will	MD
cord-018907-c84t1bo5	70	10	depend	depend	VB
cord-018907-c84t1bo5	70	11	on	on	IN
cord-018907-c84t1bo5	70	12	the	the	DT
cord-018907-c84t1bo5	70	13	patient	patient	JJ
cord-018907-c84t1bo5	70	14	presentation	presentation	NN
cord-018907-c84t1bo5	70	15	.	.	.
cord-018907-c84t1bo5	71	1	If	if	IN
cord-018907-c84t1bo5	71	2	the	the	DT
cord-018907-c84t1bo5	71	3	patient	patient	NN
cord-018907-c84t1bo5	71	4	is	be	VBZ
cord-018907-c84t1bo5	71	5	acutely	acutely	RB
cord-018907-c84t1bo5	71	6	ill	ill	JJ
cord-018907-c84t1bo5	71	7	,	,	,
cord-018907-c84t1bo5	71	8	it	-PRON-	PRP
cord-018907-c84t1bo5	71	9	is	be	VBZ
cord-018907-c84t1bo5	71	10	very	very	RB
cord-018907-c84t1bo5	71	11	important	important	JJ
cord-018907-c84t1bo5	71	12	to	to	TO
cord-018907-c84t1bo5	71	13	begin	begin	VB
cord-018907-c84t1bo5	71	14	empiric	empiric	JJ
cord-018907-c84t1bo5	71	15	therapy	therapy	NN
cord-018907-c84t1bo5	71	16	to	to	TO
cord-018907-c84t1bo5	71	17	cover	cover	VB
cord-018907-c84t1bo5	71	18	the	the	DT
cord-018907-c84t1bo5	71	19	likely	likely	JJ
cord-018907-c84t1bo5	71	20	pathogen	pathogen	NN
cord-018907-c84t1bo5	71	21	based	base	VBN
cord-018907-c84t1bo5	71	22	on	on	IN
cord-018907-c84t1bo5	71	23	the	the	DT
cord-018907-c84t1bo5	71	24	presentation	presentation	NN
cord-018907-c84t1bo5	71	25	of	of	IN
cord-018907-c84t1bo5	71	26	the	the	DT
cord-018907-c84t1bo5	71	27	patient	patient	NN
cord-018907-c84t1bo5	71	28	and	and	CC
cord-018907-c84t1bo5	71	29	the	the	DT
cord-018907-c84t1bo5	71	30	primary	primary	JJ
cord-018907-c84t1bo5	71	31	immune	immune	JJ
cord-018907-c84t1bo5	71	32	defect	defect	NN
cord-018907-c84t1bo5	71	33	with	with	IN
cord-018907-c84t1bo5	71	34	simultaneously	simultaneously	RB
cord-018907-c84t1bo5	71	35	comprehensive	comprehensive	JJ
cord-018907-c84t1bo5	71	36	evaluation	evaluation	NN
cord-018907-c84t1bo5	71	37	.	.	.
cord-018907-c84t1bo5	72	1	Subsequently	subsequently	RB
cord-018907-c84t1bo5	72	2	,	,	,
cord-018907-c84t1bo5	72	3	therapy	therapy	NN
cord-018907-c84t1bo5	72	4	should	should	MD
cord-018907-c84t1bo5	72	5	be	be	VB
cord-018907-c84t1bo5	72	6	adjusted	adjust	VBN
cord-018907-c84t1bo5	72	7	based	base	VBN
cord-018907-c84t1bo5	72	8	on	on	IN
cord-018907-c84t1bo5	72	9	culture	culture	NN
cord-018907-c84t1bo5	72	10	and	and	CC
cord-018907-c84t1bo5	72	11	clinical	clinical	JJ
cord-018907-c84t1bo5	72	12	response	response	NN
cord-018907-c84t1bo5	72	13	.	.	.
cord-018907-c84t1bo5	73	1	In	in	IN
cord-018907-c84t1bo5	73	2	providing	provide	VBG
cord-018907-c84t1bo5	73	3	empirical	empirical	JJ
cord-018907-c84t1bo5	73	4	antibiotic	antibiotic	JJ
cord-018907-c84t1bo5	73	5	therapy	therapy	NN
cord-018907-c84t1bo5	73	6	in	in	IN
cord-018907-c84t1bo5	73	7	patient	patient	NN
cord-018907-c84t1bo5	73	8	with	with	IN
cord-018907-c84t1bo5	73	9	pulmonary	pulmonary	JJ
cord-018907-c84t1bo5	73	10	infiltrate	infiltrate	NN
cord-018907-c84t1bo5	73	11	and	and	CC
cord-018907-c84t1bo5	73	12	defect	defect	VB
cord-018907-c84t1bo5	73	13	in	in	IN
cord-018907-c84t1bo5	73	14	cell	cell	NN
cord-018907-c84t1bo5	73	15	-	-	HYPH
cord-018907-c84t1bo5	73	16	mediated	mediate	VBN
cord-018907-c84t1bo5	73	17	immunity	immunity	NN
cord-018907-c84t1bo5	73	18	one	one	CD
cord-018907-c84t1bo5	73	19	need	need	NN
cord-018907-c84t1bo5	73	20	to	to	TO
cord-018907-c84t1bo5	73	21	consider	consider	VB
cord-018907-c84t1bo5	73	22	Pneumocystis	Pneumocystis	NNP
cord-018907-c84t1bo5	73	23	jiroveci	jiroveci	NNS
cord-018907-c84t1bo5	73	24	,	,	,
cord-018907-c84t1bo5	73	25	nocardia	nocardia	NNP
cord-018907-c84t1bo5	73	26	,	,	,
cord-018907-c84t1bo5	73	27	legionella	legionella	NN
cord-018907-c84t1bo5	73	28	,	,	,
cord-018907-c84t1bo5	73	29	mycoplasma	mycoplasma	NN
cord-018907-c84t1bo5	73	30	,	,	,
cord-018907-c84t1bo5	73	31	in	in	IN
cord-018907-c84t1bo5	73	32	addition	addition	NN
cord-018907-c84t1bo5	73	33	to	to	IN
cord-018907-c84t1bo5	73	34	aerobic	aerobic	JJ
cord-018907-c84t1bo5	73	35	Gram	gram	NN
cord-018907-c84t1bo5	73	36	-	-	HYPH
cord-018907-c84t1bo5	73	37	positive	positive	JJ
cord-018907-c84t1bo5	73	38	cocci	coccus	NNS
cord-018907-c84t1bo5	73	39	and	and	CC
cord-018907-c84t1bo5	73	40	Gram	gram	NN
cord-018907-c84t1bo5	73	41	-	-	HYPH
cord-018907-c84t1bo5	73	42	negative	negative	JJ
cord-018907-c84t1bo5	73	43	bacilli	bacilli	NN
cord-018907-c84t1bo5	73	44	therefore	therefore	RB
cord-018907-c84t1bo5	73	45	it	-PRON-	PRP
cord-018907-c84t1bo5	73	46	is	be	VBZ
cord-018907-c84t1bo5	73	47	advised	advise	VBN
cord-018907-c84t1bo5	73	48	to	to	TO
cord-018907-c84t1bo5	73	49	use	use	VB
cord-018907-c84t1bo5	73	50	trimethoprim	trimethoprim	NNP
cord-018907-c84t1bo5	73	51	-	-	HYPH
cord-018907-c84t1bo5	73	52	sulfamethoxazole	sulfamethoxazole	NNP
cord-018907-c84t1bo5	73	53	,	,	,
cord-018907-c84t1bo5	73	54	macrolides	macrolide	NNS
cord-018907-c84t1bo5	73	55	including	include	VBG
cord-018907-c84t1bo5	73	56	erythromycin	erythromycin	NNS
cord-018907-c84t1bo5	73	57	or	or	CC
cord-018907-c84t1bo5	73	58	clarithromycin	clarithromycin	NNS
cord-018907-c84t1bo5	73	59	and	and	CC
cord-018907-c84t1bo5	73	60	agent	agent	NN
cord-018907-c84t1bo5	73	61	active	active	JJ
cord-018907-c84t1bo5	73	62	against	against	IN
cord-018907-c84t1bo5	73	63	Gram	gram	NN
cord-018907-c84t1bo5	73	64	-	-	HYPH
cord-018907-c84t1bo5	73	65	positive	positive	JJ
cord-018907-c84t1bo5	73	66	and	and	CC
cord-018907-c84t1bo5	73	67	Gram	gram	NN
cord-018907-c84t1bo5	73	68	-	-	HYPH
cord-018907-c84t1bo5	73	69	negative	negative	JJ
cord-018907-c84t1bo5	73	70	;	;	:
cord-018907-c84t1bo5	73	71	for	for	IN
cord-018907-c84t1bo5	73	72	example	example	NN
cord-018907-c84t1bo5	73	73	,	,	,
cord-018907-c84t1bo5	73	74	thirdgeneration	thirdgeneration	NNP
cord-018907-c84t1bo5	73	75	cephalosporin	cephalosporin	NNP
cord-018907-c84t1bo5	73	76	with	with	IN
cord-018907-c84t1bo5	73	77	or	or	CC
cord-018907-c84t1bo5	73	78	without	without	IN
cord-018907-c84t1bo5	73	79	aminoglycoside	aminoglycoside	NNP
cord-018907-c84t1bo5	73	80	with	with	IN
cord-018907-c84t1bo5	73	81	anti	anti	JJ
cord-018907-c84t1bo5	73	82	-	-	JJ
cord-018907-c84t1bo5	73	83	Gram	gram	JJ
cord-018907-c84t1bo5	73	84	-	-	HYPH
cord-018907-c84t1bo5	73	85	positive	positive	JJ
cord-018907-c84t1bo5	73	86	either	either	CC
cord-018907-c84t1bo5	73	87	nafcillin	nafcillin	NN
cord-018907-c84t1bo5	73	88	or	or	CC
cord-018907-c84t1bo5	73	89	vancomycin	vancomycin	NN
cord-018907-c84t1bo5	73	90	based	base	VBN
cord-018907-c84t1bo5	73	91	on	on	IN
cord-018907-c84t1bo5	73	92	the	the	DT
cord-018907-c84t1bo5	73	93	incidence	incidence	NN
cord-018907-c84t1bo5	73	94	of	of	IN
cord-018907-c84t1bo5	73	95	methicillin	methicillin	NN
cord-018907-c84t1bo5	73	96	-	-	HYPH
cord-018907-c84t1bo5	73	97	resistant	resistant	JJ
cord-018907-c84t1bo5	73	98	Staphylococcus	Staphylococcus	NNP
cord-018907-c84t1bo5	73	99	aureus	aureus	NN
cord-018907-c84t1bo5	73	100	(	(	-LRB-
cord-018907-c84t1bo5	73	101	MRSA	MRSA	NNP
cord-018907-c84t1bo5	73	102	)	)	-RRB-
cord-018907-c84t1bo5	73	103	and	and	CC
cord-018907-c84t1bo5	73	104	penicillin	penicillin	NN
cord-018907-c84t1bo5	73	105	resistant	resistant	JJ
cord-018907-c84t1bo5	73	106	Streptococcus	Streptococcus	NNP
cord-018907-c84t1bo5	73	107	pneumoniae	pneumoniae	NN
cord-018907-c84t1bo5	73	108	.	.	.
cord-018907-c84t1bo5	74	1	The	the	DT
cord-018907-c84t1bo5	74	2	fever	fever	NN
cord-018907-c84t1bo5	74	3	is	be	VBZ
cord-018907-c84t1bo5	74	4	defined	define	VBN
cord-018907-c84t1bo5	74	5	in	in	IN
cord-018907-c84t1bo5	74	6	the	the	DT
cord-018907-c84t1bo5	74	7	context	context	NN
cord-018907-c84t1bo5	74	8	of	of	IN
cord-018907-c84t1bo5	74	9	febrile	febrile	JJ
cord-018907-c84t1bo5	74	10	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	74	11	as	as	IN
cord-018907-c84t1bo5	74	12	a	a	DT
cord-018907-c84t1bo5	74	13	single	single	JJ
cord-018907-c84t1bo5	74	14	oral	oral	JJ
cord-018907-c84t1bo5	74	15	temperature	temperature	NN
cord-018907-c84t1bo5	74	16	of	of	IN
cord-018907-c84t1bo5	74	17	more	more	JJR
cord-018907-c84t1bo5	74	18	than	than	IN
cord-018907-c84t1bo5	74	19	38.3	38.3	CD
cord-018907-c84t1bo5	74	20	C	c	NN
cord-018907-c84t1bo5	74	21	or	or	CC
cord-018907-c84t1bo5	74	22	more	more	JJR
cord-018907-c84t1bo5	74	23	than	than	IN
cord-018907-c84t1bo5	74	24	38.0	38.0	CD
cord-018907-c84t1bo5	74	25	C	c	NN
cord-018907-c84t1bo5	74	26	for	for	IN
cord-018907-c84t1bo5	74	27	at	at	RB
cord-018907-c84t1bo5	74	28	least	least	JJS
cord-018907-c84t1bo5	74	29	1	1	CD
cord-018907-c84t1bo5	74	30	h	h	NN
cord-018907-c84t1bo5	74	31	and	and	CC
cord-018907-c84t1bo5	74	32	is	be	VBZ
cord-018907-c84t1bo5	74	33	not	not	RB
cord-018907-c84t1bo5	74	34	related	relate	VBN
cord-018907-c84t1bo5	74	35	to	to	IN
cord-018907-c84t1bo5	74	36	the	the	DT
cord-018907-c84t1bo5	74	37	administration	administration	NN
cord-018907-c84t1bo5	74	38	of	of	IN
cord-018907-c84t1bo5	74	39	pyrexial	pyrexial	JJ
cord-018907-c84t1bo5	74	40	agents	agent	NNS
cord-018907-c84t1bo5	74	41	including	include	VBG
cord-018907-c84t1bo5	74	42	blood	blood	NN
cord-018907-c84t1bo5	74	43	,	,	,
cord-018907-c84t1bo5	74	44	blood	blood	NN
cord-018907-c84t1bo5	74	45	product	product	NN
cord-018907-c84t1bo5	74	46	,	,	,
cord-018907-c84t1bo5	74	47	IVIG	IVIG	NNP
cord-018907-c84t1bo5	74	48	,	,	,
cord-018907-c84t1bo5	74	49	and	and	CC
cord-018907-c84t1bo5	74	50	pyrogenic	pyrogenic	JJ
cord-018907-c84t1bo5	74	51	drugs	drug	NNS
cord-018907-c84t1bo5	74	52	,	,	,
cord-018907-c84t1bo5	74	53	especially	especially	RB
cord-018907-c84t1bo5	74	54	Ara	Ara	NNP
cord-018907-c84t1bo5	74	55	C.	C.	NNP
cord-018907-c84t1bo5	74	56	Neutropenia	Neutropenia	NNP
cord-018907-c84t1bo5	74	57	is	be	VBZ
cord-018907-c84t1bo5	74	58	defined	define	VBN
cord-018907-c84t1bo5	74	59	as	as	IN
cord-018907-c84t1bo5	74	60	absolute	absolute	JJ
cord-018907-c84t1bo5	74	61	neutrophil	neutrophil	NN
cord-018907-c84t1bo5	74	62	count	count	NN
cord-018907-c84t1bo5	74	63	(	(	-LRB-
cord-018907-c84t1bo5	74	64	ANC	ANC	NNP
cord-018907-c84t1bo5	74	65	)	)	-RRB-
cord-018907-c84t1bo5	75	1	less	less	JJR
cord-018907-c84t1bo5	75	2	than	than	IN
cord-018907-c84t1bo5	75	3	500	500	CD
cord-018907-c84t1bo5	75	4	/	/	SYM
cord-018907-c84t1bo5	75	5	mm	mm	NN
cord-018907-c84t1bo5	75	6	3	3	CD
cord-018907-c84t1bo5	75	7	or	or	CC
cord-018907-c84t1bo5	75	8	less	less	JJR
cord-018907-c84t1bo5	75	9	than	than	IN
cord-018907-c84t1bo5	75	10	1,000	1,000	CD
cord-018907-c84t1bo5	75	11	/	/	SYM
cord-018907-c84t1bo5	75	12	mm	mm	NN
cord-018907-c84t1bo5	75	13	3	3	CD
cord-018907-c84t1bo5	76	1	with	with	IN
cord-018907-c84t1bo5	76	2	predictive	predictive	JJ
cord-018907-c84t1bo5	76	3	decline	decline	NN
cord-018907-c84t1bo5	76	4	to	to	IN
cord-018907-c84t1bo5	76	5	less	less	JJR
cord-018907-c84t1bo5	76	6	500	500	CD
cord-018907-c84t1bo5	76	7	/	/	SYM
cord-018907-c84t1bo5	76	8	mm	mm	NN
cord-018907-c84t1bo5	76	9	3	3	CD
cord-018907-c84t1bo5	76	10	48	48	CD
cord-018907-c84t1bo5	76	11	h.	h.	NN
cord-018907-c84t1bo5	77	1	The	the	DT
cord-018907-c84t1bo5	77	2	most	most	RBS
cord-018907-c84t1bo5	77	3	important	important	JJ
cord-018907-c84t1bo5	77	4	risk	risk	NN
cord-018907-c84t1bo5	77	5	factor	factor	NN
cord-018907-c84t1bo5	77	6	is	be	VBZ
cord-018907-c84t1bo5	77	7	the	the	DT
cord-018907-c84t1bo5	77	8	presence	presence	NN
cord-018907-c84t1bo5	77	9	of	of	IN
cord-018907-c84t1bo5	77	10	neutropenia	neutropenia	NNP
cord-018907-c84t1bo5	77	11	as	as	RB
cord-018907-c84t1bo5	77	12	well	well	RB
cord-018907-c84t1bo5	77	13	as	as	IN
cord-018907-c84t1bo5	77	14	the	the	DT
cord-018907-c84t1bo5	77	15	degree	degree	NN
cord-018907-c84t1bo5	77	16	and	and	CC
cord-018907-c84t1bo5	77	17	duration	duration	NN
cord-018907-c84t1bo5	77	18	of	of	IN
cord-018907-c84t1bo5	77	19	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	77	20	.	.	.
cord-018907-c84t1bo5	78	1	The	the	DT
cord-018907-c84t1bo5	78	2	lower	low	JJR
cord-018907-c84t1bo5	78	3	the	the	DT
cord-018907-c84t1bo5	78	4	neutrophil	neutrophil	NN
cord-018907-c84t1bo5	78	5	count	count	NN
cord-018907-c84t1bo5	78	6	,	,	,
cord-018907-c84t1bo5	78	7	the	the	DT
cord-018907-c84t1bo5	78	8	higher	high	JJR
cord-018907-c84t1bo5	78	9	the	the	DT
cord-018907-c84t1bo5	78	10	risk	risk	NN
cord-018907-c84t1bo5	78	11	of	of	IN
cord-018907-c84t1bo5	78	12	infection	infection	NN
cord-018907-c84t1bo5	78	13	.	.	.
cord-018907-c84t1bo5	79	1	The	the	DT
cord-018907-c84t1bo5	79	2	longer	long	RBR
cord-018907-c84t1bo5	79	3	the	the	DT
cord-018907-c84t1bo5	79	4	duration	duration	NN
cord-018907-c84t1bo5	79	5	of	of	IN
cord-018907-c84t1bo5	79	6	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	79	7	,	,	,
cord-018907-c84t1bo5	79	8	the	the	DT
cord-018907-c84t1bo5	79	9	higher	high	JJR
cord-018907-c84t1bo5	79	10	the	the	DT
cord-018907-c84t1bo5	79	11	risk	risk	NN
cord-018907-c84t1bo5	79	12	of	of	IN
cord-018907-c84t1bo5	79	13	infection	infection	NN
cord-018907-c84t1bo5	79	14	.	.	.
cord-018907-c84t1bo5	80	1	Usually	usually	RB
cord-018907-c84t1bo5	80	2	,	,	,
cord-018907-c84t1bo5	80	3	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	80	4	is	be	VBZ
cord-018907-c84t1bo5	80	5	considered	consider	VBN
cord-018907-c84t1bo5	80	6	high	high	JJ
cord-018907-c84t1bo5	80	7	risk	risk	NN
cord-018907-c84t1bo5	80	8	if	if	IN
cord-018907-c84t1bo5	80	9	7	7	CD
cord-018907-c84t1bo5	80	10	days	day	NNS
cord-018907-c84t1bo5	80	11	and	and	CC
cord-018907-c84t1bo5	80	12	low	low	JJ
cord-018907-c84t1bo5	80	13	risk	risk	NN
cord-018907-c84t1bo5	80	14	<	<	XX
cord-018907-c84t1bo5	80	15	7	7	CD
cord-018907-c84t1bo5	80	16	days	day	NNS
cord-018907-c84t1bo5	80	17	.	.	.
cord-018907-c84t1bo5	81	1	Other	other	JJ
cord-018907-c84t1bo5	81	2	risk	risk	NN
cord-018907-c84t1bo5	81	3	factors	factor	NNS
cord-018907-c84t1bo5	81	4	include	include	VBP
cord-018907-c84t1bo5	81	5	associated	associate	VBN
cord-018907-c84t1bo5	81	6	medical	medical	JJ
cord-018907-c84t1bo5	81	7	comorbidity	comorbidity	NN
cord-018907-c84t1bo5	81	8	,	,	,
cord-018907-c84t1bo5	81	9	primary	primary	JJ
cord-018907-c84t1bo5	81	10	disease	disease	NN
cord-018907-c84t1bo5	81	11	,	,	,
cord-018907-c84t1bo5	81	12	and	and	CC
cord-018907-c84t1bo5	81	13	status	status	NN
cord-018907-c84t1bo5	81	14	(	(	-LRB-
cord-018907-c84t1bo5	81	15	remission	remission	NN
cord-018907-c84t1bo5	81	16	or	or	CC
cord-018907-c84t1bo5	81	17	relapse	relapse	NN
cord-018907-c84t1bo5	81	18	)	)	-RRB-
cord-018907-c84t1bo5	81	19	.	.	.
cord-018907-c84t1bo5	82	1	Low	low	JJ
cord-018907-c84t1bo5	82	2	-	-	HYPH
cord-018907-c84t1bo5	82	3	risk	risk	NN
cord-018907-c84t1bo5	82	4	patients	patient	NNS
cord-018907-c84t1bo5	82	5	are	be	VBP
cord-018907-c84t1bo5	82	6	clinically	clinically	RB
cord-018907-c84t1bo5	82	7	defined	define	VBN
cord-018907-c84t1bo5	82	8	by	by	IN
cord-018907-c84t1bo5	82	9	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	82	10	as	as	IN
cord-018907-c84t1bo5	82	11	anticipated	anticipate	VBN
cord-018907-c84t1bo5	82	12	lasting	last	VBG
cord-018907-c84t1bo5	82	13	less	less	JJR
cord-018907-c84t1bo5	82	14	than	than	IN
cord-018907-c84t1bo5	82	15	7	7	CD
cord-018907-c84t1bo5	82	16	days	day	NNS
cord-018907-c84t1bo5	82	17	,	,	,
cord-018907-c84t1bo5	82	18	clinically	clinically	RB
cord-018907-c84t1bo5	82	19	stable	stable	JJ
cord-018907-c84t1bo5	82	20	,	,	,
cord-018907-c84t1bo5	82	21	and	and	CC
cord-018907-c84t1bo5	82	22	having	have	VBG
cord-018907-c84t1bo5	82	23	no	no	DT
cord-018907-c84t1bo5	82	24	medical	medical	JJ
cord-018907-c84t1bo5	82	25	comorbid	comorbid	NN
cord-018907-c84t1bo5	82	26	conditions	condition	NNS
cord-018907-c84t1bo5	82	27	.	.	.
cord-018907-c84t1bo5	83	1	About	about	RB
cord-018907-c84t1bo5	83	2	50	50	CD
cord-018907-c84t1bo5	83	3	%	%	NN
cord-018907-c84t1bo5	83	4	of	of	IN
cord-018907-c84t1bo5	83	5	neutropenic	neutropenic	JJ
cord-018907-c84t1bo5	83	6	patients	patient	NNS
cord-018907-c84t1bo5	83	7	who	who	WP
cord-018907-c84t1bo5	83	8	become	become	VBP
cord-018907-c84t1bo5	83	9	febrile	febrile	JJ
cord-018907-c84t1bo5	83	10	have	have	VBP
cord-018907-c84t1bo5	83	11	established	establish	VBN
cord-018907-c84t1bo5	83	12	or	or	CC
cord-018907-c84t1bo5	83	13	occult	occult	JJ
cord-018907-c84t1bo5	83	14	infections	infection	NNS
cord-018907-c84t1bo5	83	15	and	and	CC
cord-018907-c84t1bo5	83	16	about	about	RB
cord-018907-c84t1bo5	83	17	25	25	CD
cord-018907-c84t1bo5	83	18	%	%	NN
cord-018907-c84t1bo5	83	19	of	of	IN
cord-018907-c84t1bo5	83	20	patients	patient	NNS
cord-018907-c84t1bo5	83	21	with	with	IN
cord-018907-c84t1bo5	83	22	ANC	ANC	NNP
cord-018907-c84t1bo5	83	23	less	less	JJR
cord-018907-c84t1bo5	83	24	than	than	IN
cord-018907-c84t1bo5	83	25	100	100	CD
cord-018907-c84t1bo5	83	26	cells	cell	NNS
cord-018907-c84t1bo5	83	27	/	/	SYM
cord-018907-c84t1bo5	83	28	mm	mm	NN
cord-018907-c84t1bo5	83	29	3	3	CD
cord-018907-c84t1bo5	83	30	have	have	VBP
cord-018907-c84t1bo5	83	31	bacteremia	bacteremia	NN
cord-018907-c84t1bo5	83	32	.	.	.
cord-018907-c84t1bo5	84	1	The	the	DT
cord-018907-c84t1bo5	84	2	risk	risk	NN
cord-018907-c84t1bo5	84	3	varies	vary	VBZ
cord-018907-c84t1bo5	84	4	depending	depend	VBG
cord-018907-c84t1bo5	84	5	on	on	IN
cord-018907-c84t1bo5	84	6	the	the	DT
cord-018907-c84t1bo5	84	7	underlying	underlie	VBG
cord-018907-c84t1bo5	84	8	disease	disease	NN
cord-018907-c84t1bo5	84	9	,	,	,
cord-018907-c84t1bo5	84	10	for	for	IN
cord-018907-c84t1bo5	84	11	example	example	NN
cord-018907-c84t1bo5	84	12	,	,	,
cord-018907-c84t1bo5	84	13	patients	patient	NNS
cord-018907-c84t1bo5	84	14	post	post	VBP
cord-018907-c84t1bo5	84	15	allogenic	allogenic	JJ
cord-018907-c84t1bo5	84	16	bone	bone	NN
cord-018907-c84t1bo5	84	17	marrow	marrow	NN
cord-018907-c84t1bo5	84	18	transplantation	transplantation	NN
cord-018907-c84t1bo5	84	19	are	be	VBP
cord-018907-c84t1bo5	84	20	at	at	IN
cord-018907-c84t1bo5	84	21	higher	high	JJR
cord-018907-c84t1bo5	84	22	risk	risk	NN
cord-018907-c84t1bo5	84	23	than	than	IN
cord-018907-c84t1bo5	84	24	autologous	autologous	JJ
cord-018907-c84t1bo5	84	25	bone	bone	NN
cord-018907-c84t1bo5	84	26	marrow	marrow	NN
cord-018907-c84t1bo5	84	27	transplantation	transplantation	NN
cord-018907-c84t1bo5	84	28	while	while	IN
cord-018907-c84t1bo5	84	29	AML	AML	NNP
cord-018907-c84t1bo5	84	30	has	have	VBZ
cord-018907-c84t1bo5	84	31	the	the	DT
cord-018907-c84t1bo5	84	32	higher	high	JJR
cord-018907-c84t1bo5	84	33	risk	risk	NN
cord-018907-c84t1bo5	84	34	than	than	IN
cord-018907-c84t1bo5	84	35	ALL	all	DT
cord-018907-c84t1bo5	84	36	.	.	.
cord-018907-c84t1bo5	85	1	The	the	DT
cord-018907-c84t1bo5	85	2	lowest	low	JJS
cord-018907-c84t1bo5	85	3	risk	risk	NN
cord-018907-c84t1bo5	85	4	is	be	VBZ
cord-018907-c84t1bo5	85	5	in	in	IN
cord-018907-c84t1bo5	85	6	patients	patient	NNS
cord-018907-c84t1bo5	85	7	with	with	IN
cord-018907-c84t1bo5	85	8	cyclic	cyclic	JJ
cord-018907-c84t1bo5	85	9	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	85	10	.	.	.
cord-018907-c84t1bo5	86	1	In	in	IN
cord-018907-c84t1bo5	86	2	evaluating	evaluate	VBG
cord-018907-c84t1bo5	86	3	a	a	DT
cord-018907-c84t1bo5	86	4	patient	patient	NN
cord-018907-c84t1bo5	86	5	with	with	IN
cord-018907-c84t1bo5	86	6	fever	fever	NN
cord-018907-c84t1bo5	86	7	and	and	CC
cord-018907-c84t1bo5	86	8	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	86	9	,	,	,
cord-018907-c84t1bo5	86	10	it	-PRON-	PRP
cord-018907-c84t1bo5	86	11	is	be	VBZ
cord-018907-c84t1bo5	86	12	important	important	JJ
cord-018907-c84t1bo5	86	13	to	to	TO
cord-018907-c84t1bo5	86	14	keep	keep	VB
cord-018907-c84t1bo5	86	15	in	in	IN
cord-018907-c84t1bo5	86	16	mind	mind	NN
cord-018907-c84t1bo5	86	17	that	that	IN
cord-018907-c84t1bo5	86	18	signs	sign	NNS
cord-018907-c84t1bo5	86	19	and	and	CC
cord-018907-c84t1bo5	86	20	symptoms	symptom	NNS
cord-018907-c84t1bo5	86	21	can	can	MD
cord-018907-c84t1bo5	86	22	be	be	VB
cord-018907-c84t1bo5	86	23	muted	mute	VBN
cord-018907-c84t1bo5	86	24	or	or	CC
cord-018907-c84t1bo5	86	25	subtle	subtle	JJ
cord-018907-c84t1bo5	86	26	.	.	.
cord-018907-c84t1bo5	87	1	Profoundly	profoundly	RB
cord-018907-c84t1bo5	87	2	neutropenic	neutropenic	JJ
cord-018907-c84t1bo5	87	3	patients	patient	NNS
cord-018907-c84t1bo5	87	4	can	can	MD
cord-018907-c84t1bo5	87	5	sometime	sometime	RB
cord-018907-c84t1bo5	87	6	have	have	VB
cord-018907-c84t1bo5	87	7	life	life	NN
cord-018907-c84t1bo5	87	8	-	-	HYPH
cord-018907-c84t1bo5	87	9	threatening	threaten	VBG
cord-018907-c84t1bo5	87	10	infections	infection	NNS
cord-018907-c84t1bo5	87	11	and	and	CC
cord-018907-c84t1bo5	87	12	yet	yet	RB
cord-018907-c84t1bo5	87	13	be	be	VB
cord-018907-c84t1bo5	87	14	afebrile	afebrile	JJ
cord-018907-c84t1bo5	87	15	especially	especially	RB
cord-018907-c84t1bo5	87	16	if	if	IN
cord-018907-c84t1bo5	87	17	they	-PRON-	PRP
cord-018907-c84t1bo5	87	18	presented	present	VBD
cord-018907-c84t1bo5	87	19	with	with	IN
cord-018907-c84t1bo5	87	20	abdominal	abdominal	JJ
cord-018907-c84t1bo5	87	21	pain	pain	NN
cord-018907-c84t1bo5	87	22	.	.	.
cord-018907-c84t1bo5	88	1	Careful	careful	JJ
cord-018907-c84t1bo5	88	2	and	and	CC
cord-018907-c84t1bo5	88	3	comprehensive	comprehensive	JJ
cord-018907-c84t1bo5	88	4	physical	physical	JJ
cord-018907-c84t1bo5	88	5	examination	examination	NN
cord-018907-c84t1bo5	88	6	is	be	VBZ
cord-018907-c84t1bo5	88	7	critical	critical	JJ
cord-018907-c84t1bo5	88	8	and	and	CC
cord-018907-c84t1bo5	88	9	should	should	MD
cord-018907-c84t1bo5	88	10	be	be	VB
cord-018907-c84t1bo5	88	11	repeated	repeat	VBN
cord-018907-c84t1bo5	88	12	at	at	IN
cord-018907-c84t1bo5	88	13	least	least	JJS
cord-018907-c84t1bo5	88	14	daily	daily	RB
cord-018907-c84t1bo5	88	15	because	because	IN
cord-018907-c84t1bo5	88	16	these	these	DT
cord-018907-c84t1bo5	88	17	patients	patient	NNS
cord-018907-c84t1bo5	88	18	are	be	VBP
cord-018907-c84t1bo5	88	19	dynamic	dynamic	JJ
cord-018907-c84t1bo5	88	20	and	and	CC
cord-018907-c84t1bo5	88	21	their	-PRON-	PRP$
cord-018907-c84t1bo5	88	22	condition	condition	NN
cord-018907-c84t1bo5	88	23	can	can	MD
cord-018907-c84t1bo5	88	24	change	change	VB
cord-018907-c84t1bo5	88	25	rapidly	rapidly	RB
cord-018907-c84t1bo5	88	26	.	.	.
cord-018907-c84t1bo5	89	1	Other	other	JJ
cord-018907-c84t1bo5	89	2	important	important	JJ
cord-018907-c84t1bo5	89	3	points	point	NNS
cord-018907-c84t1bo5	89	4	in	in	IN
cord-018907-c84t1bo5	89	5	the	the	DT
cord-018907-c84t1bo5	89	6	history	history	NN
cord-018907-c84t1bo5	89	7	include	include	VBP
cord-018907-c84t1bo5	89	8	the	the	DT
cord-018907-c84t1bo5	89	9	nature	nature	NN
cord-018907-c84t1bo5	89	10	of	of	IN
cord-018907-c84t1bo5	89	11	chemotherapeutic	chemotherapeutic	JJ
cord-018907-c84t1bo5	89	12	agents	agent	NNS
cord-018907-c84t1bo5	89	13	,	,	,
cord-018907-c84t1bo5	89	14	steroids	steroid	NNS
cord-018907-c84t1bo5	89	15	,	,	,
cord-018907-c84t1bo5	89	16	or	or	CC
cord-018907-c84t1bo5	89	17	other	other	JJ
cord-018907-c84t1bo5	89	18	immunosuppressive	immunosuppressive	JJ
cord-018907-c84t1bo5	89	19	agents	agent	NNS
cord-018907-c84t1bo5	89	20	because	because	IN
cord-018907-c84t1bo5	89	21	these	these	DT
cord-018907-c84t1bo5	89	22	can	can	MD
cord-018907-c84t1bo5	89	23	predict	predict	VB
cord-018907-c84t1bo5	89	24	the	the	DT
cord-018907-c84t1bo5	89	25	degree	degree	NN
cord-018907-c84t1bo5	89	26	of	of	IN
cord-018907-c84t1bo5	89	27	immunosuppression	immunosuppression	NN
cord-018907-c84t1bo5	89	28	,	,	,
cord-018907-c84t1bo5	89	29	the	the	DT
cord-018907-c84t1bo5	89	30	duration	duration	NN
cord-018907-c84t1bo5	89	31	of	of	IN
cord-018907-c84t1bo5	89	32	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	89	33	,	,	,
cord-018907-c84t1bo5	89	34	and	and	CC
cord-018907-c84t1bo5	89	35	the	the	DT
cord-018907-c84t1bo5	89	36	severity	severity	NN
cord-018907-c84t1bo5	89	37	of	of	IN
cord-018907-c84t1bo5	89	38	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	89	39	.	.	.
cord-018907-c84t1bo5	90	1	The	the	DT
cord-018907-c84t1bo5	90	2	history	history	NN
cord-018907-c84t1bo5	90	3	of	of	IN
cord-018907-c84t1bo5	90	4	antibiotic	antibiotic	JJ
cord-018907-c84t1bo5	90	5	prophylaxis	prophylaxis	NN
cord-018907-c84t1bo5	90	6	is	be	VBZ
cord-018907-c84t1bo5	90	7	also	also	RB
cord-018907-c84t1bo5	90	8	important	important	JJ
cord-018907-c84t1bo5	90	9	because	because	IN
cord-018907-c84t1bo5	90	10	the	the	DT
cord-018907-c84t1bo5	90	11	antibiotic	antibiotic	NN
cord-018907-c84t1bo5	90	12	used	use	VBN
cord-018907-c84t1bo5	90	13	as	as	IN
cord-018907-c84t1bo5	90	14	prophylaxis	prophylaxis	NN
cord-018907-c84t1bo5	90	15	should	should	MD
cord-018907-c84t1bo5	90	16	be	be	VB
cord-018907-c84t1bo5	90	17	avoided	avoid	VBN
cord-018907-c84t1bo5	90	18	in	in	IN
cord-018907-c84t1bo5	90	19	treating	treat	VBG
cord-018907-c84t1bo5	90	20	these	these	DT
cord-018907-c84t1bo5	90	21	patients	patient	NNS
cord-018907-c84t1bo5	90	22	.	.	.
cord-018907-c84t1bo5	91	1	Reviewing	review	VBG
cord-018907-c84t1bo5	91	2	the	the	DT
cord-018907-c84t1bo5	91	3	recent	recent	JJ
cord-018907-c84t1bo5	91	4	documented	document	VBN
cord-018907-c84t1bo5	91	5	infection	infection	NN
cord-018907-c84t1bo5	91	6	with	with	IN
cord-018907-c84t1bo5	91	7	susceptibility	susceptibility	NN
cord-018907-c84t1bo5	91	8	can	can	MD
cord-018907-c84t1bo5	91	9	help	help	VB
cord-018907-c84t1bo5	91	10	in	in	IN
cord-018907-c84t1bo5	91	11	determining	determine	VBG
cord-018907-c84t1bo5	91	12	the	the	DT
cord-018907-c84t1bo5	91	13	empiric	empiric	JJ
cord-018907-c84t1bo5	91	14	therapy	therapy	NN
cord-018907-c84t1bo5	91	15	.	.	.
cord-018907-c84t1bo5	92	1	For	for	IN
cord-018907-c84t1bo5	92	2	example	example	NN
cord-018907-c84t1bo5	92	3	,	,	,
cord-018907-c84t1bo5	92	4	if	if	IN
cord-018907-c84t1bo5	92	5	the	the	DT
cord-018907-c84t1bo5	92	6	patient	patient	NN
cord-018907-c84t1bo5	92	7	has	have	VBZ
cord-018907-c84t1bo5	92	8	a	a	DT
cord-018907-c84t1bo5	92	9	previous	previous	JJ
cord-018907-c84t1bo5	92	10	infection	infection	NN
cord-018907-c84t1bo5	92	11	with	with	IN
cord-018907-c84t1bo5	92	12	multidrug	multidrug	NN
cord-018907-c84t1bo5	92	13	resistance	resistance	NN
cord-018907-c84t1bo5	92	14	pathogen	pathogen	NN
cord-018907-c84t1bo5	92	15	,	,	,
cord-018907-c84t1bo5	92	16	empiric	empiric	JJ
cord-018907-c84t1bo5	92	17	therapy	therapy	NN
cord-018907-c84t1bo5	92	18	can	can	MD
cord-018907-c84t1bo5	92	19	be	be	VB
cord-018907-c84t1bo5	92	20	used	use	VBN
cord-018907-c84t1bo5	92	21	to	to	TO
cord-018907-c84t1bo5	92	22	cover	cover	VB
cord-018907-c84t1bo5	92	23	these	these	DT
cord-018907-c84t1bo5	92	24	pathogens	pathogen	NNS
cord-018907-c84t1bo5	92	25	.	.	.
cord-018907-c84t1bo5	93	1	If	if	IN
cord-018907-c84t1bo5	93	2	the	the	DT
cord-018907-c84t1bo5	93	3	patient	patient	NN
cord-018907-c84t1bo5	93	4	had	have	VBD
cord-018907-c84t1bo5	93	5	recent	recent	JJ
cord-018907-c84t1bo5	93	6	surgical	surgical	JJ
cord-018907-c84t1bo5	93	7	procedure	procedure	NN
cord-018907-c84t1bo5	93	8	,	,	,
cord-018907-c84t1bo5	93	9	this	this	DT
cord-018907-c84t1bo5	93	10	means	mean	VBZ
cord-018907-c84t1bo5	93	11	there	there	EX
cord-018907-c84t1bo5	93	12	is	be	VBZ
cord-018907-c84t1bo5	93	13	break	break	NN
cord-018907-c84t1bo5	93	14	of	of	IN
cord-018907-c84t1bo5	93	15	the	the	DT
cord-018907-c84t1bo5	93	16	skin	skin	NN
cord-018907-c84t1bo5	93	17	and	and	CC
cord-018907-c84t1bo5	93	18	is	be	VBZ
cord-018907-c84t1bo5	93	19	at	at	IN
cord-018907-c84t1bo5	93	20	risk	risk	NN
cord-018907-c84t1bo5	93	21	for	for	IN
cord-018907-c84t1bo5	93	22	certain	certain	JJ
cord-018907-c84t1bo5	93	23	pathogens	pathogen	NNS
cord-018907-c84t1bo5	93	24	including	include	VBG
cord-018907-c84t1bo5	93	25	Grampositive	Grampositive	NNP
cord-018907-c84t1bo5	93	26	cocci	coccus	NNS
cord-018907-c84t1bo5	93	27	(	(	-LRB-
cord-018907-c84t1bo5	93	28	coagulase	coagulase	NN
cord-018907-c84t1bo5	93	29	negative	negative	JJ
cord-018907-c84t1bo5	93	30	Staphylococci	Staphylococci	NNP
cord-018907-c84t1bo5	93	31	and	and	CC
cord-018907-c84t1bo5	93	32	Staphylococcus	Staphylococcus	NNP
cord-018907-c84t1bo5	93	33	aureus	aureus	NN
cord-018907-c84t1bo5	93	34	)	)	-RRB-
cord-018907-c84t1bo5	93	35	.	.	.
cord-018907-c84t1bo5	94	1	Allergy	allergy	NN
cord-018907-c84t1bo5	94	2	history	history	NN
cord-018907-c84t1bo5	94	3	is	be	VBZ
cord-018907-c84t1bo5	94	4	an	an	DT
cord-018907-c84t1bo5	94	5	important	important	JJ
cord-018907-c84t1bo5	94	6	factor	factor	NN
cord-018907-c84t1bo5	94	7	in	in	IN
cord-018907-c84t1bo5	94	8	selecting	select	VBG
cord-018907-c84t1bo5	94	9	empirical	empirical	JJ
cord-018907-c84t1bo5	94	10	therapy	therapy	NN
cord-018907-c84t1bo5	94	11	as	as	IN
cord-018907-c84t1bo5	94	12	allergic	allergic	JJ
cord-018907-c84t1bo5	94	13	medications	medication	NNS
cord-018907-c84t1bo5	94	14	need	need	VBP
cord-018907-c84t1bo5	94	15	to	to	TO
cord-018907-c84t1bo5	94	16	be	be	VB
cord-018907-c84t1bo5	94	17	avoided	avoid	VBN
cord-018907-c84t1bo5	94	18	.	.	.
cord-018907-c84t1bo5	95	1	Detailed	detailed	JJ
cord-018907-c84t1bo5	95	2	and	and	CC
cord-018907-c84t1bo5	95	3	thorough	thorough	JJ
cord-018907-c84t1bo5	95	4	physical	physical	JJ
cord-018907-c84t1bo5	95	5	examination	examination	NN
cord-018907-c84t1bo5	95	6	is	be	VBZ
cord-018907-c84t1bo5	95	7	important	important	JJ
cord-018907-c84t1bo5	95	8	with	with	IN
cord-018907-c84t1bo5	95	9	focus	focus	NN
cord-018907-c84t1bo5	95	10	on	on	IN
cord-018907-c84t1bo5	95	11	certain	certain	JJ
cord-018907-c84t1bo5	95	12	sites	site	NNS
cord-018907-c84t1bo5	95	13	that	that	WDT
cord-018907-c84t1bo5	95	14	can	can	MD
cord-018907-c84t1bo5	95	15	be	be	VB
cord-018907-c84t1bo5	95	16	a	a	DT
cord-018907-c84t1bo5	95	17	portal	portal	NN
cord-018907-c84t1bo5	95	18	of	of	IN
cord-018907-c84t1bo5	95	19	entry	entry	NN
cord-018907-c84t1bo5	95	20	of	of	IN
cord-018907-c84t1bo5	95	21	pathogens	pathogen	NNS
cord-018907-c84t1bo5	95	22	including	include	VBG
cord-018907-c84t1bo5	95	23	periodontium	periodontium	NN
cord-018907-c84t1bo5	95	24	,	,	,
cord-018907-c84t1bo5	95	25	pharynx	pharynx	NN
cord-018907-c84t1bo5	95	26	,	,	,
cord-018907-c84t1bo5	95	27	lower	lower	VB
cord-018907-c84t1bo5	95	28	esophagus	esophagus	NN
cord-018907-c84t1bo5	95	29	,	,	,
cord-018907-c84t1bo5	95	30	lung	lung	NN
cord-018907-c84t1bo5	95	31	,	,	,
cord-018907-c84t1bo5	95	32	skin	skin	NN
cord-018907-c84t1bo5	95	33	,	,	,
cord-018907-c84t1bo5	95	34	perineum	perineum	NN
cord-018907-c84t1bo5	95	35	,	,	,
cord-018907-c84t1bo5	95	36	bone	bone	NN
cord-018907-c84t1bo5	95	37	marrow	marrow	NN
cord-018907-c84t1bo5	95	38	aspiration	aspiration	NN
cord-018907-c84t1bo5	95	39	site	site	NN
cord-018907-c84t1bo5	95	40	,	,	,
cord-018907-c84t1bo5	95	41	and	and	CC
cord-018907-c84t1bo5	95	42	catheter	catheter	NN
cord-018907-c84t1bo5	95	43	entry	entry	NN
cord-018907-c84t1bo5	95	44	and	and	CC
cord-018907-c84t1bo5	95	45	exit	exit	NN
cord-018907-c84t1bo5	95	46	sites	site	NNS
cord-018907-c84t1bo5	95	47	.	.	.
cord-018907-c84t1bo5	96	1	After	after	IN
cord-018907-c84t1bo5	96	2	history	history	NN
cord-018907-c84t1bo5	96	3	and	and	CC
cord-018907-c84t1bo5	96	4	thorough	thorough	JJ
cord-018907-c84t1bo5	96	5	physical	physical	JJ
cord-018907-c84t1bo5	96	6	examinations	examination	NNS
cord-018907-c84t1bo5	96	7	,	,	,
cord-018907-c84t1bo5	96	8	blood	blood	NN
cord-018907-c84t1bo5	96	9	culture	culture	NN
cord-018907-c84t1bo5	96	10	from	from	IN
cord-018907-c84t1bo5	96	11	central	central	JJ
cord-018907-c84t1bo5	96	12	and	and	CC
cord-018907-c84t1bo5	96	13	peripheral	peripheral	JJ
cord-018907-c84t1bo5	96	14	lines	line	NNS
cord-018907-c84t1bo5	96	15	should	should	MD
cord-018907-c84t1bo5	96	16	done	do	VBN
cord-018907-c84t1bo5	96	17	in	in	IN
cord-018907-c84t1bo5	96	18	order	order	NN
cord-018907-c84t1bo5	96	19	to	to	TO
cord-018907-c84t1bo5	96	20	identify	identify	VB
cord-018907-c84t1bo5	96	21	the	the	DT
cord-018907-c84t1bo5	96	22	source	source	NN
cord-018907-c84t1bo5	96	23	of	of	IN
cord-018907-c84t1bo5	96	24	infection	infection	NN
cord-018907-c84t1bo5	96	25	.	.	.
cord-018907-c84t1bo5	97	1	For	for	IN
cord-018907-c84t1bo5	97	2	example	example	NN
cord-018907-c84t1bo5	97	3	,	,	,
cord-018907-c84t1bo5	97	4	if	if	IN
cord-018907-c84t1bo5	97	5	the	the	DT
cord-018907-c84t1bo5	97	6	blood	blood	NN
cord-018907-c84t1bo5	97	7	culture	culture	NN
cord-018907-c84t1bo5	97	8	is	be	VBZ
cord-018907-c84t1bo5	97	9	positive	positive	JJ
cord-018907-c84t1bo5	97	10	from	from	IN
cord-018907-c84t1bo5	97	11	the	the	DT
cord-018907-c84t1bo5	97	12	central	central	JJ
cord-018907-c84t1bo5	97	13	culture	culture	NN
cord-018907-c84t1bo5	97	14	but	but	CC
cord-018907-c84t1bo5	97	15	negative	negative	JJ
cord-018907-c84t1bo5	97	16	from	from	IN
cord-018907-c84t1bo5	97	17	peripheral	peripheral	JJ
cord-018907-c84t1bo5	97	18	culture	culture	NN
cord-018907-c84t1bo5	97	19	,	,	,
cord-018907-c84t1bo5	97	20	the	the	DT
cord-018907-c84t1bo5	97	21	likely	likely	JJ
cord-018907-c84t1bo5	97	22	source	source	NN
cord-018907-c84t1bo5	97	23	is	be	VBZ
cord-018907-c84t1bo5	97	24	the	the	DT
cord-018907-c84t1bo5	97	25	central	central	JJ
cord-018907-c84t1bo5	97	26	line	line	NN
cord-018907-c84t1bo5	97	27	.	.	.
cord-018907-c84t1bo5	98	1	If	if	IN
cord-018907-c84t1bo5	98	2	both	both	DT
cord-018907-c84t1bo5	98	3	are	be	VBP
cord-018907-c84t1bo5	98	4	positive	positive	JJ
cord-018907-c84t1bo5	98	5	,	,	,
cord-018907-c84t1bo5	98	6	time	time	NN
cord-018907-c84t1bo5	98	7	is	be	VBZ
cord-018907-c84t1bo5	98	8	needed	need	VBN
cord-018907-c84t1bo5	98	9	to	to	TO
cord-018907-c84t1bo5	98	10	positively	positively	RB
cord-018907-c84t1bo5	98	11	determine	determine	VB
cord-018907-c84t1bo5	98	12	the	the	DT
cord-018907-c84t1bo5	98	13	source	source	NN
cord-018907-c84t1bo5	98	14	of	of	IN
cord-018907-c84t1bo5	98	15	infection	infection	NN
cord-018907-c84t1bo5	98	16	.	.	.
cord-018907-c84t1bo5	99	1	Routine	routine	JJ
cord-018907-c84t1bo5	99	2	surveillance	surveillance	NN
cord-018907-c84t1bo5	99	3	culture	culture	NN
cord-018907-c84t1bo5	99	4	is	be	VBZ
cord-018907-c84t1bo5	99	5	not	not	RB
cord-018907-c84t1bo5	99	6	indicated	indicate	VBN
cord-018907-c84t1bo5	99	7	as	as	IN
cord-018907-c84t1bo5	99	8	it	-PRON-	PRP
cord-018907-c84t1bo5	99	9	is	be	VBZ
cord-018907-c84t1bo5	99	10	not	not	RB
cord-018907-c84t1bo5	99	11	cost	cost	VBN
cord-018907-c84t1bo5	99	12	effective	effective	JJ
cord-018907-c84t1bo5	99	13	and	and	CC
cord-018907-c84t1bo5	99	14	has	have	VBZ
cord-018907-c84t1bo5	99	15	low	low	JJ
cord-018907-c84t1bo5	99	16	predictive	predictive	JJ
cord-018907-c84t1bo5	99	17	value	value	NN
cord-018907-c84t1bo5	99	18	.	.	.
cord-018907-c84t1bo5	100	1	Other	other	JJ
cord-018907-c84t1bo5	100	2	cultures	culture	NNS
cord-018907-c84t1bo5	100	3	should	should	MD
cord-018907-c84t1bo5	100	4	be	be	VB
cord-018907-c84t1bo5	100	5	guided	guide	VBN
cord-018907-c84t1bo5	100	6	by	by	IN
cord-018907-c84t1bo5	100	7	the	the	DT
cord-018907-c84t1bo5	100	8	sites	site	NNS
cord-018907-c84t1bo5	100	9	of	of	IN
cord-018907-c84t1bo5	100	10	infection	infection	NN
cord-018907-c84t1bo5	100	11	.	.	.
cord-018907-c84t1bo5	101	1	For	for	IN
cord-018907-c84t1bo5	101	2	example	example	NN
cord-018907-c84t1bo5	101	3	,	,	,
cord-018907-c84t1bo5	101	4	a	a	DT
cord-018907-c84t1bo5	101	5	patient	patient	NN
cord-018907-c84t1bo5	101	6	with	with	IN
cord-018907-c84t1bo5	101	7	respiratory	respiratory	JJ
cord-018907-c84t1bo5	101	8	symptoms	symptom	NNS
cord-018907-c84t1bo5	101	9	needs	need	VBZ
cord-018907-c84t1bo5	101	10	to	to	TO
cord-018907-c84t1bo5	101	11	have	have	VB
cord-018907-c84t1bo5	101	12	nasapharyngeal	nasapharyngeal	JJ
cord-018907-c84t1bo5	101	13	aspirate	aspirate	NN
cord-018907-c84t1bo5	101	14	for	for	IN
cord-018907-c84t1bo5	101	15	viral	viral	JJ
cord-018907-c84t1bo5	101	16	study	study	NN
cord-018907-c84t1bo5	101	17	,	,	,
cord-018907-c84t1bo5	101	18	PCR	PCR	NNP
cord-018907-c84t1bo5	101	19	multiplex	multiplex	NN
cord-018907-c84t1bo5	101	20	,	,	,
cord-018907-c84t1bo5	101	21	and	and	CC
cord-018907-c84t1bo5	101	22	atypical	atypical	JJ
cord-018907-c84t1bo5	101	23	pneumonia	pneumonia	NN
cord-018907-c84t1bo5	101	24	.	.	.
cord-018907-c84t1bo5	102	1	Patients	patient	NNS
cord-018907-c84t1bo5	102	2	with	with	IN
cord-018907-c84t1bo5	102	3	gastrointestinal	gastrointestinal	JJ
cord-018907-c84t1bo5	102	4	symptoms	symptom	NNS
cord-018907-c84t1bo5	102	5	,	,	,
cord-018907-c84t1bo5	102	6	for	for	IN
cord-018907-c84t1bo5	102	7	example	example	NN
cord-018907-c84t1bo5	102	8	,	,	,
cord-018907-c84t1bo5	102	9	with	with	IN
cord-018907-c84t1bo5	102	10	diarrhea	diarrhea	NN
cord-018907-c84t1bo5	102	11	,	,	,
cord-018907-c84t1bo5	102	12	the	the	DT
cord-018907-c84t1bo5	102	13	stool	stool	NN
cord-018907-c84t1bo5	102	14	needs	need	VBZ
cord-018907-c84t1bo5	102	15	to	to	TO
cord-018907-c84t1bo5	102	16	be	be	VB
cord-018907-c84t1bo5	102	17	sent	send	VBN
cord-018907-c84t1bo5	102	18	for	for	IN
cord-018907-c84t1bo5	102	19	viral	viral	JJ
cord-018907-c84t1bo5	102	20	study	study	NN
cord-018907-c84t1bo5	102	21	,	,	,
cord-018907-c84t1bo5	102	22	culture	culture	NN
cord-018907-c84t1bo5	102	23	and	and	CC
cord-018907-c84t1bo5	102	24	sensitivity	sensitivity	NN
cord-018907-c84t1bo5	102	25	,	,	,
cord-018907-c84t1bo5	102	26	ova	ova	NN
cord-018907-c84t1bo5	102	27	and	and	CC
cord-018907-c84t1bo5	102	28	parasite	parasite	NN
cord-018907-c84t1bo5	102	29	.	.	.
cord-018907-c84t1bo5	103	1	Chest	chest	NN
cord-018907-c84t1bo5	103	2	X	x	NN
cord-018907-c84t1bo5	103	3	-	-	NN
cord-018907-c84t1bo5	103	4	ray	ray	NN
cord-018907-c84t1bo5	103	5	should	should	MD
cord-018907-c84t1bo5	103	6	not	not	RB
cord-018907-c84t1bo5	103	7	be	be	VB
cord-018907-c84t1bo5	103	8	done	do	VBN
cord-018907-c84t1bo5	103	9	routinely	routinely	RB
cord-018907-c84t1bo5	103	10	in	in	IN
cord-018907-c84t1bo5	103	11	all	all	DT
cord-018907-c84t1bo5	103	12	patients	patient	NNS
cord-018907-c84t1bo5	103	13	with	with	IN
cord-018907-c84t1bo5	103	14	fever	fever	NN
cord-018907-c84t1bo5	103	15	and	and	CC
cord-018907-c84t1bo5	103	16	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	103	17	because	because	IN
cord-018907-c84t1bo5	103	18	it	-PRON-	PRP
cord-018907-c84t1bo5	103	19	has	have	VBZ
cord-018907-c84t1bo5	103	20	low	low	JJ
cord-018907-c84t1bo5	103	21	yield	yield	NN
cord-018907-c84t1bo5	103	22	in	in	IN
cord-018907-c84t1bo5	103	23	patients	patient	NNS
cord-018907-c84t1bo5	103	24	without	without	IN
cord-018907-c84t1bo5	103	25	respiratory	respiratory	JJ
cord-018907-c84t1bo5	103	26	symptoms	symptom	NNS
cord-018907-c84t1bo5	103	27	.	.	.
cord-018907-c84t1bo5	104	1	It	-PRON-	PRP
cord-018907-c84t1bo5	104	2	is	be	VBZ
cord-018907-c84t1bo5	104	3	only	only	RB
cord-018907-c84t1bo5	104	4	done	do	VBN
cord-018907-c84t1bo5	104	5	in	in	IN
cord-018907-c84t1bo5	104	6	children	child	NNS
cord-018907-c84t1bo5	104	7	who	who	WP
cord-018907-c84t1bo5	104	8	have	have	VBP
cord-018907-c84t1bo5	104	9	respiratory	respiratory	JJ
cord-018907-c84t1bo5	104	10	symptoms	symptom	NNS
cord-018907-c84t1bo5	104	11	.	.	.
cord-018907-c84t1bo5	105	1	If	if	IN
cord-018907-c84t1bo5	105	2	negative	negative	JJ
cord-018907-c84t1bo5	105	3	,	,	,
cord-018907-c84t1bo5	105	4	a	a	DT
cord-018907-c84t1bo5	105	5	chest	chest	NN
cord-018907-c84t1bo5	105	6	CT	CT	NNP
cord-018907-c84t1bo5	105	7	scan	scan	NN
cord-018907-c84t1bo5	105	8	to	to	TO
cord-018907-c84t1bo5	105	9	be	be	VB
cord-018907-c84t1bo5	105	10	considered	consider	VBN
cord-018907-c84t1bo5	105	11	to	to	TO
cord-018907-c84t1bo5	105	12	better	better	RB
cord-018907-c84t1bo5	105	13	evaluate	evaluate	VB
cord-018907-c84t1bo5	105	14	patient	patient	NN
cord-018907-c84t1bo5	105	15	not	not	RB
cord-018907-c84t1bo5	105	16	responding	respond	VBG
cord-018907-c84t1bo5	105	17	to	to	IN
cord-018907-c84t1bo5	105	18	therapy	therapy	NN
cord-018907-c84t1bo5	105	19	.	.	.
cord-018907-c84t1bo5	106	1	Most	Most	JJS
cord-018907-c84t1bo5	106	2	patients	patient	NNS
cord-018907-c84t1bo5	106	3	with	with	IN
cord-018907-c84t1bo5	106	4	fever	fever	NN
cord-018907-c84t1bo5	106	5	and	and	CC
cord-018907-c84t1bo5	106	6	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	106	7	have	have	VBP
cord-018907-c84t1bo5	106	8	no	no	DT
cord-018907-c84t1bo5	106	9	identifiable	identifiable	JJ
cord-018907-c84t1bo5	106	10	site	site	NN
cord-018907-c84t1bo5	106	11	of	of	IN
cord-018907-c84t1bo5	106	12	infection	infection	NN
cord-018907-c84t1bo5	106	13	and	and	CC
cord-018907-c84t1bo5	106	14	no	no	DT
cord-018907-c84t1bo5	106	15	positive	positive	JJ
cord-018907-c84t1bo5	106	16	culture	culture	NN
cord-018907-c84t1bo5	106	17	results	result	NNS
cord-018907-c84t1bo5	106	18	.	.	.
cord-018907-c84t1bo5	107	1	Bloodstream	bloodstream	NN
cord-018907-c84t1bo5	107	2	infection	infection	NN
cord-018907-c84t1bo5	107	3	is	be	VBZ
cord-018907-c84t1bo5	107	4	documented	document	VBN
cord-018907-c84t1bo5	107	5	in	in	IN
cord-018907-c84t1bo5	107	6	about	about	RB
cord-018907-c84t1bo5	107	7	20	20	CD
cord-018907-c84t1bo5	107	8	%	%	NN
cord-018907-c84t1bo5	107	9	of	of	IN
cord-018907-c84t1bo5	107	10	patients	patient	NNS
cord-018907-c84t1bo5	107	11	with	with	IN
cord-018907-c84t1bo5	107	12	fever	fever	NN
cord-018907-c84t1bo5	107	13	and	and	CC
cord-018907-c84t1bo5	107	14	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	107	15	.	.	.
cord-018907-c84t1bo5	108	1	Disruption	disruption	NN
cord-018907-c84t1bo5	108	2	of	of	IN
cord-018907-c84t1bo5	108	3	the	the	DT
cord-018907-c84t1bo5	108	4	skin	skin	NN
cord-018907-c84t1bo5	108	5	or	or	CC
cord-018907-c84t1bo5	108	6	soft	soft	JJ
cord-018907-c84t1bo5	108	7	tissue	tissue	NN
cord-018907-c84t1bo5	108	8	including	include	VBG
cord-018907-c84t1bo5	108	9	vascular	vascular	JJ
cord-018907-c84t1bo5	108	10	access	access	NN
cord-018907-c84t1bo5	108	11	or	or	CC
cord-018907-c84t1bo5	108	12	catheter	catheter	NN
cord-018907-c84t1bo5	108	13	insertion	insertion	NN
cord-018907-c84t1bo5	108	14	site	site	NN
cord-018907-c84t1bo5	108	15	can	can	MD
cord-018907-c84t1bo5	108	16	be	be	VB
cord-018907-c84t1bo5	108	17	a	a	DT
cord-018907-c84t1bo5	108	18	point	point	NN
cord-018907-c84t1bo5	108	19	of	of	IN
cord-018907-c84t1bo5	108	20	entry	entry	NN
cord-018907-c84t1bo5	108	21	.	.	.
cord-018907-c84t1bo5	109	1	In	in	IN
cord-018907-c84t1bo5	109	2	those	those	DT
cord-018907-c84t1bo5	109	3	centers	center	NNS
cord-018907-c84t1bo5	109	4	,	,	,
cord-018907-c84t1bo5	109	5	who	who	WP
cord-018907-c84t1bo5	109	6	are	be	VBP
cord-018907-c84t1bo5	109	7	dealing	deal	VBG
cord-018907-c84t1bo5	109	8	with	with	IN
cord-018907-c84t1bo5	109	9	cancer	cancer	NN
cord-018907-c84t1bo5	109	10	patients	patient	NNS
cord-018907-c84t1bo5	109	11	,	,	,
cord-018907-c84t1bo5	109	12	it	-PRON-	PRP
cord-018907-c84t1bo5	109	13	is	be	VBZ
cord-018907-c84t1bo5	109	14	very	very	RB
cord-018907-c84t1bo5	109	15	important	important	JJ
cord-018907-c84t1bo5	109	16	to	to	TO
cord-018907-c84t1bo5	109	17	monitor	monitor	VB
cord-018907-c84t1bo5	109	18	the	the	DT
cord-018907-c84t1bo5	109	19	infection	infection	NN
cord-018907-c84t1bo5	109	20	rate	rate	NN
cord-018907-c84t1bo5	109	21	and	and	CC
cord-018907-c84t1bo5	109	22	pathogen	pathogen	NN
cord-018907-c84t1bo5	109	23	as	as	RB
cord-018907-c84t1bo5	109	24	well	well	RB
cord-018907-c84t1bo5	109	25	as	as	IN
cord-018907-c84t1bo5	109	26	the	the	DT
cord-018907-c84t1bo5	109	27	resistance	resistance	NN
cord-018907-c84t1bo5	109	28	pattern	pattern	NN
cord-018907-c84t1bo5	109	29	in	in	IN
cord-018907-c84t1bo5	109	30	the	the	DT
cord-018907-c84t1bo5	109	31	same	same	JJ
cord-018907-c84t1bo5	109	32	center	center	NN
cord-018907-c84t1bo5	109	33	.	.	.
cord-018907-c84t1bo5	110	1	The	the	DT
cord-018907-c84t1bo5	110	2	local	local	JJ
cord-018907-c84t1bo5	110	3	data	datum	NNS
cord-018907-c84t1bo5	110	4	will	will	MD
cord-018907-c84t1bo5	110	5	help	help	VB
cord-018907-c84t1bo5	110	6	to	to	TO
cord-018907-c84t1bo5	110	7	select	select	VB
cord-018907-c84t1bo5	110	8	the	the	DT
cord-018907-c84t1bo5	110	9	appropriate	appropriate	JJ
cord-018907-c84t1bo5	110	10	empirical	empirical	JJ
cord-018907-c84t1bo5	110	11	antimicrobial	antimicrobial	JJ
cord-018907-c84t1bo5	110	12	therapy	therapy	NN
cord-018907-c84t1bo5	110	13	(	(	-LRB-
cord-018907-c84t1bo5	110	14	>	>	XX
cord-018907-c84t1bo5	111	1	Table	table	NN
cord-018907-c84t1bo5	111	2	68	68	CD
cord-018907-c84t1bo5	111	3	.1	.1	CD
cord-018907-c84t1bo5	111	4	)	)	-RRB-
cord-018907-c84t1bo5	111	5	.	.	.
cord-018907-c84t1bo5	112	1	There	there	EX
cord-018907-c84t1bo5	112	2	is	be	VBZ
cord-018907-c84t1bo5	112	3	no	no	DT
cord-018907-c84t1bo5	112	4	ideal	ideal	JJ
cord-018907-c84t1bo5	112	5	regimen	regimen	NN
cord-018907-c84t1bo5	112	6	because	because	IN
cord-018907-c84t1bo5	112	7	there	there	EX
cord-018907-c84t1bo5	112	8	are	be	VBP
cord-018907-c84t1bo5	112	9	variables	variable	NNS
cord-018907-c84t1bo5	112	10	which	which	WDT
cord-018907-c84t1bo5	112	11	include	include	VBP
cord-018907-c84t1bo5	112	12	the	the	DT
cord-018907-c84t1bo5	112	13	risk	risk	NN
cord-018907-c84t1bo5	112	14	status	status	NN
cord-018907-c84t1bo5	112	15	of	of	IN
cord-018907-c84t1bo5	112	16	the	the	DT
cord-018907-c84t1bo5	112	17	patient	patient	NN
cord-018907-c84t1bo5	112	18	,	,	,
cord-018907-c84t1bo5	112	19	microflora	microflora	NN
cord-018907-c84t1bo5	112	20	and	and	CC
cord-018907-c84t1bo5	112	21	their	-PRON-	PRP$
cord-018907-c84t1bo5	112	22	sensitivity	sensitivity	NN
cord-018907-c84t1bo5	112	23	patterns	pattern	NNS
cord-018907-c84t1bo5	112	24	,	,	,
cord-018907-c84t1bo5	112	25	toxicity	toxicity	NN
cord-018907-c84t1bo5	112	26	indication	indication	NN
cord-018907-c84t1bo5	112	27	,	,	,
cord-018907-c84t1bo5	112	28	preference	preference	NN
cord-018907-c84t1bo5	112	29	,	,	,
cord-018907-c84t1bo5	112	30	and	and	CC
cord-018907-c84t1bo5	112	31	the	the	DT
cord-018907-c84t1bo5	112	32	cost	cost	NN
cord-018907-c84t1bo5	112	33	.	.	.
cord-018907-c84t1bo5	113	1	Prompt	prompt	JJ
cord-018907-c84t1bo5	113	2	initiation	initiation	NN
cord-018907-c84t1bo5	113	3	of	of	IN
cord-018907-c84t1bo5	113	4	broad	broad	JJ
cord-018907-c84t1bo5	113	5	-	-	HYPH
cord-018907-c84t1bo5	113	6	spectrum	spectrum	NN
cord-018907-c84t1bo5	113	7	therapy	therapy	NN
cord-018907-c84t1bo5	113	8	when	when	WRB
cord-018907-c84t1bo5	113	9	neutropenic	neutropenic	JJ
cord-018907-c84t1bo5	113	10	patients	patient	NNS
cord-018907-c84t1bo5	113	11	became	become	VBD
cord-018907-c84t1bo5	113	12	febrile	febrile	JJ
cord-018907-c84t1bo5	113	13	is	be	VBZ
cord-018907-c84t1bo5	113	14	the	the	DT
cord-018907-c84t1bo5	113	15	key	key	NN
cord-018907-c84t1bo5	113	16	to	to	IN
cord-018907-c84t1bo5	113	17	successful	successful	JJ
cord-018907-c84t1bo5	113	18	management	management	NN
cord-018907-c84t1bo5	113	19	.	.	.
cord-018907-c84t1bo5	114	1	In	in	IN
cord-018907-c84t1bo5	114	2	1960	1960	CD
cord-018907-c84t1bo5	114	3	the	the	DT
cord-018907-c84t1bo5	114	4	mortality	mortality	NN
cord-018907-c84t1bo5	114	5	rate	rate	NN
cord-018907-c84t1bo5	114	6	was	be	VBD
cord-018907-c84t1bo5	114	7	up	up	RB
cord-018907-c84t1bo5	114	8	to	to	TO
cord-018907-c84t1bo5	114	9	80	80	CD
cord-018907-c84t1bo5	114	10	%	%	NN
cord-018907-c84t1bo5	114	11	initially	initially	RB
cord-018907-c84t1bo5	114	12	but	but	CC
cord-018907-c84t1bo5	114	13	with	with	IN
cord-018907-c84t1bo5	114	14	the	the	DT
cord-018907-c84t1bo5	114	15	introduction	introduction	NN
cord-018907-c84t1bo5	114	16	of	of	IN
cord-018907-c84t1bo5	114	17	empiric	empiric	JJ
cord-018907-c84t1bo5	114	18	therapy	therapy	NN
cord-018907-c84t1bo5	114	19	against	against	IN
cord-018907-c84t1bo5	114	20	gram	gram	NN
cord-018907-c84t1bo5	114	21	-	-	HYPH
cord-018907-c84t1bo5	114	22	negative	negative	JJ
cord-018907-c84t1bo5	114	23	organism	organism	NN
cord-018907-c84t1bo5	115	1	the	the	DT
cord-018907-c84t1bo5	115	2	mortality	mortality	NN
cord-018907-c84t1bo5	115	3	rate	rate	NN
cord-018907-c84t1bo5	115	4	now	now	RB
cord-018907-c84t1bo5	115	5	is	be	VBZ
cord-018907-c84t1bo5	115	6	close	close	JJ
cord-018907-c84t1bo5	115	7	to	to	IN
cord-018907-c84t1bo5	115	8	5	5	CD
cord-018907-c84t1bo5	115	9	%	%	NN
cord-018907-c84t1bo5	115	10	.	.	.
cord-018907-c84t1bo5	116	1	There	there	EX
cord-018907-c84t1bo5	116	2	is	be	VBZ
cord-018907-c84t1bo5	116	3	no	no	DT
cord-018907-c84t1bo5	116	4	ideal	ideal	JJ
cord-018907-c84t1bo5	116	5	regimen	regimen	NN
cord-018907-c84t1bo5	116	6	because	because	IN
cord-018907-c84t1bo5	116	7	this	this	DT
cord-018907-c84t1bo5	116	8	can	can	MD
cord-018907-c84t1bo5	116	9	be	be	VB
cord-018907-c84t1bo5	116	10	determined	determine	VBN
cord-018907-c84t1bo5	116	11	based	base	VBN
cord-018907-c84t1bo5	116	12	on	on	IN
cord-018907-c84t1bo5	116	13	the	the	DT
cord-018907-c84t1bo5	116	14	isolate	isolate	NN
cord-018907-c84t1bo5	116	15	and	and	CC
cord-018907-c84t1bo5	116	16	its	-PRON-	PRP$
cord-018907-c84t1bo5	116	17	susceptibility	susceptibility	NN
cord-018907-c84t1bo5	116	18	in	in	IN
cord-018907-c84t1bo5	116	19	the	the	DT
cord-018907-c84t1bo5	116	20	same	same	JJ
cord-018907-c84t1bo5	116	21	center	center	NN
cord-018907-c84t1bo5	116	22	as	as	IN
cord-018907-c84t1bo5	116	23	each	each	DT
cord-018907-c84t1bo5	116	24	center	center	NN
cord-018907-c84t1bo5	116	25	for	for	IN
cord-018907-c84t1bo5	116	26	example	example	NN
cord-018907-c84t1bo5	116	27	,	,	,
cord-018907-c84t1bo5	116	28	one	one	PRP
cord-018907-c84t1bo5	116	29	can	can	MD
cord-018907-c84t1bo5	116	30	not	not	RB
cord-018907-c84t1bo5	116	31	extrapolate	extrapolate	VB
cord-018907-c84t1bo5	116	32	from	from	IN
cord-018907-c84t1bo5	116	33	different	different	JJ
cord-018907-c84t1bo5	116	34	centers	center	NNS
cord-018907-c84t1bo5	116	35	the	the	DT
cord-018907-c84t1bo5	116	36	likely	likely	JJ
cord-018907-c84t1bo5	116	37	pathogen	pathogen	NN
cord-018907-c84t1bo5	116	38	,	,	,
cord-018907-c84t1bo5	116	39	the	the	DT
cord-018907-c84t1bo5	116	40	same	same	JJ
cord-018907-c84t1bo5	116	41	thing	thing	NN
cord-018907-c84t1bo5	116	42	that	that	WDT
cord-018907-c84t1bo5	116	43	a	a	DT
cord-018907-c84t1bo5	116	44	center	center	NN
cord-018907-c84t1bo5	116	45	can	can	MD
cord-018907-c84t1bo5	116	46	have	have	VB
cord-018907-c84t1bo5	116	47	a	a	DT
cord-018907-c84t1bo5	116	48	different	different	JJ
cord-018907-c84t1bo5	116	49	pathogen	pathogen	NN
cord-018907-c84t1bo5	116	50	and	and	CC
cord-018907-c84t1bo5	116	51	different	different	JJ
cord-018907-c84t1bo5	116	52	susceptibility	susceptibility	NN
cord-018907-c84t1bo5	116	53	pattern	pattern	NN
cord-018907-c84t1bo5	116	54	in	in	IN
cord-018907-c84t1bo5	116	55	adult	adult	NN
cord-018907-c84t1bo5	116	56	versus	versus	IN
cord-018907-c84t1bo5	116	57	pediatric	pediatric	JJ
cord-018907-c84t1bo5	116	58	population	population	NN
cord-018907-c84t1bo5	116	59	with	with	IN
cord-018907-c84t1bo5	116	60	febrile	febrile	JJ
cord-018907-c84t1bo5	116	61	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	117	1	(	(	-LRB-
cord-018907-c84t1bo5	117	2	>	>	XX
cord-018907-c84t1bo5	117	3	Table	table	NN
cord-018907-c84t1bo5	117	4	68	68	CD
cord-018907-c84t1bo5	117	5	.2	.2	CD
cord-018907-c84t1bo5	117	6	)	)	-RRB-
cord-018907-c84t1bo5	117	7	.	.	.
cord-018907-c84t1bo5	118	1	Monotherapy	Monotherapy	NNP
cord-018907-c84t1bo5	118	2	and	and	CC
cord-018907-c84t1bo5	118	3	combination	combination	NN
cord-018907-c84t1bo5	118	4	therapy	therapy	NN
cord-018907-c84t1bo5	118	5	has	have	VBZ
cord-018907-c84t1bo5	118	6	equal	equal	JJ
cord-018907-c84t1bo5	118	7	efficacy	efficacy	NN
cord-018907-c84t1bo5	118	8	.	.	.
cord-018907-c84t1bo5	119	1	The	the	DT
cord-018907-c84t1bo5	119	2	monotherapy	monotherapy	NN
cord-018907-c84t1bo5	119	3	needs	need	VBZ
cord-018907-c84t1bo5	119	4	to	to	TO
cord-018907-c84t1bo5	119	5	have	have	VB
cord-018907-c84t1bo5	119	6	antipseudomonal	antipseudomonal	JJ
cord-018907-c84t1bo5	119	7	activities	activity	NNS
cord-018907-c84t1bo5	119	8	including	include	VBG
cord-018907-c84t1bo5	119	9	antipseudomonal	antipseudomonal	JJ
cord-018907-c84t1bo5	119	10	penicillin	penicillin	NN
cord-018907-c84t1bo5	119	11	with	with	IN
cord-018907-c84t1bo5	119	12	or	or	CC
cord-018907-c84t1bo5	119	13	without	without	IN
cord-018907-c84t1bo5	119	14	beta	beta	NN
cord-018907-c84t1bo5	119	15	-	-	HYPH
cord-018907-c84t1bo5	119	16	lactamase	lactamase	NN
cord-018907-c84t1bo5	119	17	inhibitor	inhibitor	NN
cord-018907-c84t1bo5	119	18	,	,	,
cord-018907-c84t1bo5	119	19	carbapenem	carbapenem	NNP
cord-018907-c84t1bo5	119	20	,	,	,
cord-018907-c84t1bo5	119	21	and	and	CC
cord-018907-c84t1bo5	119	22	third	third	JJ
cord-018907-c84t1bo5	119	23	-	-	HYPH
cord-018907-c84t1bo5	119	24	or	or	CC
cord-018907-c84t1bo5	119	25	fourth	fourth	JJ
cord-018907-c84t1bo5	119	26	-	-	HYPH
cord-018907-c84t1bo5	119	27	generation	generation	NN
cord-018907-c84t1bo5	119	28	antipseudomonal	antipseudomonal	JJ
cord-018907-c84t1bo5	119	29	cephalosporins	cephalosporin	NNS
cord-018907-c84t1bo5	119	30	.	.	.
cord-018907-c84t1bo5	120	1	The	the	DT
cord-018907-c84t1bo5	120	2	combination	combination	NN
cord-018907-c84t1bo5	120	3	therapy	therapy	NN
cord-018907-c84t1bo5	120	4	includes	include	VBZ
cord-018907-c84t1bo5	120	5	antipseudomonal	antipseudomonal	JJ
cord-018907-c84t1bo5	120	6	betalactam	betalactam	NNP
cord-018907-c84t1bo5	120	7	with	with	IN
cord-018907-c84t1bo5	120	8	Aminoglycoside	Aminoglycoside	NNP
cord-018907-c84t1bo5	120	9	.	.	.
cord-018907-c84t1bo5	121	1	Both	both	CC
cord-018907-c84t1bo5	121	2	monotherapy	monotherapy	NN
cord-018907-c84t1bo5	121	3	and	and	CC
cord-018907-c84t1bo5	121	4	combination	combination	NN
cord-018907-c84t1bo5	121	5	therapy	therapy	NN
cord-018907-c84t1bo5	121	6	have	have	VBP
cord-018907-c84t1bo5	121	7	equal	equal	JJ
cord-018907-c84t1bo5	121	8	efficacy	efficacy	NN
cord-018907-c84t1bo5	121	9	but	but	CC
cord-018907-c84t1bo5	121	10	it	-PRON-	PRP
cord-018907-c84t1bo5	121	11	is	be	VBZ
cord-018907-c84t1bo5	121	12	important	important	JJ
cord-018907-c84t1bo5	121	13	to	to	TO
cord-018907-c84t1bo5	121	14	look	look	VB
cord-018907-c84t1bo5	121	15	at	at	IN
cord-018907-c84t1bo5	121	16	the	the	DT
cord-018907-c84t1bo5	121	17	local	local	JJ
cord-018907-c84t1bo5	121	18	data	datum	NNS
cord-018907-c84t1bo5	121	19	to	to	TO
cord-018907-c84t1bo5	121	20	be	be	VB
cord-018907-c84t1bo5	121	21	able	able	JJ
cord-018907-c84t1bo5	121	22	to	to	TO
cord-018907-c84t1bo5	121	23	predict	predict	VB
cord-018907-c84t1bo5	121	24	the	the	DT
cord-018907-c84t1bo5	121	25	empiric	empiric	JJ
cord-018907-c84t1bo5	121	26	therapy	therapy	NN
cord-018907-c84t1bo5	121	27	either	either	CC
cord-018907-c84t1bo5	121	28	combination	combination	NN
cord-018907-c84t1bo5	121	29	therapy	therapy	NN
cord-018907-c84t1bo5	121	30	or	or	CC
cord-018907-c84t1bo5	121	31	monotherapy	monotherapy	NN
cord-018907-c84t1bo5	121	32	.	.	.
cord-018907-c84t1bo5	122	1	It	-PRON-	PRP
cord-018907-c84t1bo5	122	2	is	be	VBZ
cord-018907-c84t1bo5	122	3	worth	worth	JJ
cord-018907-c84t1bo5	122	4	stressing	stress	VBG
cord-018907-c84t1bo5	122	5	that	that	IN
cord-018907-c84t1bo5	122	6	vancomycin	vancomycin	NN
cord-018907-c84t1bo5	122	7	should	should	MD
cord-018907-c84t1bo5	122	8	not	not	RB
cord-018907-c84t1bo5	122	9	be	be	VB
cord-018907-c84t1bo5	122	10	used	use	VBN
cord-018907-c84t1bo5	122	11	routinely	routinely	RB
cord-018907-c84t1bo5	122	12	for	for	IN
cord-018907-c84t1bo5	122	13	empiric	empiric	JJ
cord-018907-c84t1bo5	122	14	therapy	therapy	NN
cord-018907-c84t1bo5	122	15	in	in	IN
cord-018907-c84t1bo5	122	16	febrile	febrile	JJ
cord-018907-c84t1bo5	122	17	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	122	18	and	and	CC
cord-018907-c84t1bo5	122	19	there	there	EX
cord-018907-c84t1bo5	122	20	is	be	VBZ
cord-018907-c84t1bo5	122	21	a	a	DT
cord-018907-c84t1bo5	122	22	special	special	JJ
cord-018907-c84t1bo5	122	23	indication	indication	NN
cord-018907-c84t1bo5	122	24	for	for	IN
cord-018907-c84t1bo5	122	25	vancomycin	vancomycin	NN
cord-018907-c84t1bo5	122	26	.	.	.
cord-018907-c84t1bo5	123	1	The	the	DT
cord-018907-c84t1bo5	123	2	vancomycin	vancomycin	NN
cord-018907-c84t1bo5	123	3	indication	indication	NN
cord-018907-c84t1bo5	123	4	includes	include	VBZ
cord-018907-c84t1bo5	123	5	hemodynamic	hemodynamic	JJ
cord-018907-c84t1bo5	123	6	instability	instability	NN
cord-018907-c84t1bo5	123	7	or	or	CC
cord-018907-c84t1bo5	123	8	other	other	JJ
cord-018907-c84t1bo5	123	9	evidence	evidence	NN
cord-018907-c84t1bo5	123	10	of	of	IN
cord-018907-c84t1bo5	123	11	severe	severe	JJ
cord-018907-c84t1bo5	123	12	sepsis	sepsis	NN
cord-018907-c84t1bo5	123	13	,	,	,
cord-018907-c84t1bo5	123	14	pneumonia	pneumonia	NN
cord-018907-c84t1bo5	123	15	documented	document	VBD
cord-018907-c84t1bo5	123	16	radiographically	radiographically	RB
cord-018907-c84t1bo5	123	17	,	,	,
cord-018907-c84t1bo5	123	18	positive	positive	JJ
cord-018907-c84t1bo5	123	19	blood	blood	NN
cord-018907-c84t1bo5	123	20	culture	culture	NN
cord-018907-c84t1bo5	123	21	for	for	IN
cord-018907-c84t1bo5	123	22	gram	gram	NN
cord-018907-c84t1bo5	123	23	-	-	HYPH
cord-018907-c84t1bo5	123	24	positive	positive	JJ
cord-018907-c84t1bo5	123	25	bacteria	bacteria	NNS
cord-018907-c84t1bo5	123	26	before	before	IN
cord-018907-c84t1bo5	123	27	final	final	JJ
cord-018907-c84t1bo5	123	28	identification	identification	NN
cord-018907-c84t1bo5	123	29	and	and	CC
cord-018907-c84t1bo5	123	30	susceptibility	susceptibility	NN
cord-018907-c84t1bo5	123	31	testing	testing	NN
cord-018907-c84t1bo5	123	32	is	be	VBZ
cord-018907-c84t1bo5	123	33	available	available	JJ
cord-018907-c84t1bo5	123	34	,	,	,
cord-018907-c84t1bo5	123	35	clinically	clinically	RB
cord-018907-c84t1bo5	123	36	suspected	suspect	VBN
cord-018907-c84t1bo5	123	37	catheter	catheter	NN
cord-018907-c84t1bo5	123	38	-	-	HYPH
cord-018907-c84t1bo5	123	39	related	relate	VBN
cord-018907-c84t1bo5	123	40	infections	infection	NNS
cord-018907-c84t1bo5	123	41	(	(	-LRB-
cord-018907-c84t1bo5	123	42	e.	e.	NNP
cord-018907-c84t1bo5	123	43	g.	g.	NNP
cord-018907-c84t1bo5	123	44	,	,	,
cord-018907-c84t1bo5	124	1	chills	chill	NNS
cord-018907-c84t1bo5	124	2	or	or	CC
cord-018907-c84t1bo5	124	3	rigors	rigor	NNS
cord-018907-c84t1bo5	124	4	with	with	IN
cord-018907-c84t1bo5	124	5	infusion	infusion	NN
cord-018907-c84t1bo5	124	6	through	through	IN
cord-018907-c84t1bo5	124	7	catheter	catheter	NN
cord-018907-c84t1bo5	124	8	and	and	CC
cord-018907-c84t1bo5	124	9	cellulitis	cellulitis	NN
cord-018907-c84t1bo5	124	10	around	around	IN
cord-018907-c84t1bo5	124	11	the	the	DT
cord-018907-c84t1bo5	124	12	catheter	catheter	NN
cord-018907-c84t1bo5	124	13	entry	entry	NN
cord-018907-c84t1bo5	124	14	/	/	SYM
cord-018907-c84t1bo5	124	15	exit	exit	NN
cord-018907-c84t1bo5	124	16	site	site	NN
cord-018907-c84t1bo5	124	17	)	)	-RRB-
cord-018907-c84t1bo5	124	18	,	,	,
cord-018907-c84t1bo5	124	19	skin	skin	NN
cord-018907-c84t1bo5	124	20	or	or	CC
cord-018907-c84t1bo5	124	21	soft	soft	JJ
cord-018907-c84t1bo5	124	22	-	-	HYPH
cord-018907-c84t1bo5	124	23	tissue	tissue	NN
cord-018907-c84t1bo5	124	24	infection	infection	NN
cord-018907-c84t1bo5	124	25	at	at	IN
cord-018907-c84t1bo5	124	26	any	any	DT
cord-018907-c84t1bo5	124	27	site	site	NN
cord-018907-c84t1bo5	124	28	,	,	,
cord-018907-c84t1bo5	124	29	colonization	colonization	NN
cord-018907-c84t1bo5	124	30	with	with	IN
cord-018907-c84t1bo5	124	31	methicillin	methicillin	NN
cord-018907-c84t1bo5	124	32	-	-	HYPH
cord-018907-c84t1bo5	124	33	resistant	resistant	JJ
cord-018907-c84t1bo5	124	34	Staphylococcus	Staphylococcus	NNP
cord-018907-c84t1bo5	124	35	aureus	aureus	NN
cord-018907-c84t1bo5	124	36	,	,	,
cord-018907-c84t1bo5	124	37	vancomycin	vancomycin	NN
cord-018907-c84t1bo5	124	38	-	-	HYPH
cord-018907-c84t1bo5	124	39	resistant	resistant	JJ
cord-018907-c84t1bo5	124	40	enterococcus	enterococcus	NN
cord-018907-c84t1bo5	124	41	,	,	,
cord-018907-c84t1bo5	124	42	or	or	CC
cord-018907-c84t1bo5	124	43	penicillin	penicillin	NN
cord-018907-c84t1bo5	124	44	-	-	HYPH
cord-018907-c84t1bo5	124	45	resistant	resistant	JJ
cord-018907-c84t1bo5	124	46	Streptococcus	streptococcus	NN
cord-018907-c84t1bo5	124	47	pneumoniae	pneumoniae	NN
cord-018907-c84t1bo5	124	48	,	,	,
cord-018907-c84t1bo5	124	49	and	and	CC
cord-018907-c84t1bo5	124	50	severe	severe	JJ
cord-018907-c84t1bo5	124	51	mucositis	mucositis	NNP
cord-018907-c84t1bo5	124	52	,	,	,
cord-018907-c84t1bo5	124	53	if	if	IN
cord-018907-c84t1bo5	124	54	fluoroquinolone	fluoroquinolone	NN
cord-018907-c84t1bo5	124	55	prophylaxis	prophylaxis	NN
cord-018907-c84t1bo5	124	56	has	have	VBZ
cord-018907-c84t1bo5	124	57	been	be	VBN
cord-018907-c84t1bo5	124	58	given	give	VBN
cord-018907-c84t1bo5	124	59	and	and	CC
cord-018907-c84t1bo5	124	60	ceftazidime	ceftazidime	NN
cord-018907-c84t1bo5	124	61	is	be	VBZ
cord-018907-c84t1bo5	124	62	employed	employ	VBN
cord-018907-c84t1bo5	124	63	as	as	IN
cord-018907-c84t1bo5	124	64	empirical	empirical	JJ
cord-018907-c84t1bo5	124	65	therapy	therapy	NN
cord-018907-c84t1bo5	124	66	.	.	.
cord-018907-c84t1bo5	125	1	If	if	IN
cord-018907-c84t1bo5	125	2	the	the	DT
cord-018907-c84t1bo5	125	3	patient	patient	NN
cord-018907-c84t1bo5	125	4	started	start	VBD
cord-018907-c84t1bo5	125	5	empirically	empirically	RB
cord-018907-c84t1bo5	125	6	on	on	IN
cord-018907-c84t1bo5	125	7	vancomycin	vancomycin	FW
cord-018907-c84t1bo5	125	8	the	the	DT
cord-018907-c84t1bo5	125	9	need	need	NN
cord-018907-c84t1bo5	125	10	for	for	IN
cord-018907-c84t1bo5	125	11	continuation	continuation	NN
cord-018907-c84t1bo5	125	12	of	of	IN
cord-018907-c84t1bo5	125	13	vancomycin	vancomycin	NN
cord-018907-c84t1bo5	125	14	should	should	MD
cord-018907-c84t1bo5	125	15	be	be	VB
cord-018907-c84t1bo5	125	16	re	re	VBN
cord-018907-c84t1bo5	125	17	-	-	VBN
cord-018907-c84t1bo5	125	18	assessed	assess	VBN
cord-018907-c84t1bo5	125	19	on	on	IN
cord-018907-c84t1bo5	125	20	daily	daily	JJ
cord-018907-c84t1bo5	125	21	basis	basis	NN
cord-018907-c84t1bo5	125	22	.	.	.
cord-018907-c84t1bo5	126	1	Overuse	overuse	NN
cord-018907-c84t1bo5	126	2	of	of	IN
cord-018907-c84t1bo5	126	3	vancomycin	vancomycin	NN
cord-018907-c84t1bo5	126	4	in	in	IN
cord-018907-c84t1bo5	126	5	more	more	JJR
cord-018907-c84t1bo5	126	6	than	than	IN
cord-018907-c84t1bo5	126	7	90	90	CD
cord-018907-c84t1bo5	126	8	%	%	NN
cord-018907-c84t1bo5	126	9	,	,	,
cord-018907-c84t1bo5	126	10	and	and	CC
cord-018907-c84t1bo5	126	11	selection	selection	NN
cord-018907-c84t1bo5	126	12	for	for	IN
cord-018907-c84t1bo5	126	13	resistant	resistant	JJ
cord-018907-c84t1bo5	126	14	organism	organism	NN
cord-018907-c84t1bo5	126	15	and	and	CC
cord-018907-c84t1bo5	126	16	emergence	emergence	NN
cord-018907-c84t1bo5	126	17	of	of	IN
cord-018907-c84t1bo5	126	18	vancomycin	vancomycin	NN
cord-018907-c84t1bo5	126	19	resistance	resistance	NN
cord-018907-c84t1bo5	126	20	enterococci	enterococci	NNP
cord-018907-c84t1bo5	126	21	.	.	.
cord-018907-c84t1bo5	127	1	The	the	DT
cord-018907-c84t1bo5	127	2	factors	factor	NNS
cord-018907-c84t1bo5	127	3	influencing	influence	VBG
cord-018907-c84t1bo5	127	4	antimicrobial	antimicrobial	JJ
cord-018907-c84t1bo5	127	5	selection	selection	NN
cord-018907-c84t1bo5	127	6	include	include	VBP
cord-018907-c84t1bo5	127	7	the	the	DT
cord-018907-c84t1bo5	127	8	types	type	NNS
cord-018907-c84t1bo5	127	9	of	of	IN
cord-018907-c84t1bo5	127	10	bacterial	bacterial	JJ
cord-018907-c84t1bo5	127	11	isolates	isolate	NNS
cord-018907-c84t1bo5	127	12	found	find	VBN
cord-018907-c84t1bo5	127	13	in	in	IN
cord-018907-c84t1bo5	127	14	the	the	DT
cord-018907-c84t1bo5	127	15	institution	institution	NN
cord-018907-c84t1bo5	127	16	,	,	,
cord-018907-c84t1bo5	127	17	antibiotic	antibiotic	JJ
cord-018907-c84t1bo5	127	18	susceptibility	susceptibility	NN
cord-018907-c84t1bo5	127	19	patterns	pattern	NNS
cord-018907-c84t1bo5	127	20	,	,	,
cord-018907-c84t1bo5	127	21	drug	drug	NN
cord-018907-c84t1bo5	127	22	allergies	allergy	NNS
cord-018907-c84t1bo5	127	23	,	,	,
cord-018907-c84t1bo5	127	24	presence	presence	NN
cord-018907-c84t1bo5	127	25	of	of	IN
cord-018907-c84t1bo5	127	26	organ	organ	NN
cord-018907-c84t1bo5	127	27	dysfunction	dysfunction	NN
cord-018907-c84t1bo5	127	28	,	,	,
cord-018907-c84t1bo5	127	29	chemotherapeutic	chemotherapeutic	JJ
cord-018907-c84t1bo5	127	30	regimen	regimen	NN
cord-018907-c84t1bo5	127	31	whether	whether	IN
cord-018907-c84t1bo5	127	32	the	the	DT
cord-018907-c84t1bo5	127	33	patient	patient	NN
cord-018907-c84t1bo5	127	34	was	be	VBD
cord-018907-c84t1bo5	127	35	receiving	receive	VBG
cord-018907-c84t1bo5	127	36	prophylactic	prophylactic	JJ
cord-018907-c84t1bo5	127	37	antibiotics	antibiotic	NNS
cord-018907-c84t1bo5	127	38	,	,	,
cord-018907-c84t1bo5	127	39	and	and	CC
cord-018907-c84t1bo5	127	40	condition	condition	NN
cord-018907-c84t1bo5	127	41	of	of	IN
cord-018907-c84t1bo5	127	42	the	the	DT
cord-018907-c84t1bo5	127	43	patient	patient	NN
cord-018907-c84t1bo5	127	44	at	at	IN
cord-018907-c84t1bo5	127	45	diagnosis	diagnosis	NN
cord-018907-c84t1bo5	127	46	,	,	,
cord-018907-c84t1bo5	127	47	for	for	IN
cord-018907-c84t1bo5	127	48	example	example	NN
cord-018907-c84t1bo5	127	49	,	,	,
cord-018907-c84t1bo5	127	50	presence	presence	NN
cord-018907-c84t1bo5	127	51	of	of	IN
cord-018907-c84t1bo5	127	52	signs	sign	NNS
cord-018907-c84t1bo5	127	53	and	and	CC
cord-018907-c84t1bo5	127	54	symptoms	symptom	NNS
cord-018907-c84t1bo5	127	55	at	at	IN
cord-018907-c84t1bo5	127	56	initial	initial	JJ
cord-018907-c84t1bo5	127	57	evaluation	evaluation	NN
cord-018907-c84t1bo5	127	58	and	and	CC
cord-018907-c84t1bo5	127	59	presence	presence	NN
cord-018907-c84t1bo5	127	60	of	of	IN
cord-018907-c84t1bo5	127	61	documented	document	VBN
cord-018907-c84t1bo5	127	62	sites	site	NNS
cord-018907-c84t1bo5	127	63	requiring	require	VBG
cord-018907-c84t1bo5	127	64	additional	additional	JJ
cord-018907-c84t1bo5	127	65	therapy	therapy	NN
cord-018907-c84t1bo5	127	66	.	.	.
cord-018907-c84t1bo5	128	1	The	the	DT
cord-018907-c84t1bo5	128	2	center	center	NN
cord-018907-c84t1bo5	128	3	-	-	HYPH
cord-018907-c84t1bo5	128	4	specific	specific	JJ
cord-018907-c84t1bo5	128	5	factors	factor	NNS
cord-018907-c84t1bo5	128	6	include	include	VBP
cord-018907-c84t1bo5	128	7	the	the	DT
cord-018907-c84t1bo5	128	8	patterns	pattern	NNS
cord-018907-c84t1bo5	128	9	of	of	IN
cord-018907-c84t1bo5	128	10	resistance	resistance	NN
cord-018907-c84t1bo5	128	11	,	,	,
cord-018907-c84t1bo5	128	12	effect	effect	NN
cord-018907-c84t1bo5	128	13	on	on	IN
cord-018907-c84t1bo5	128	14	microbial	microbial	JJ
cord-018907-c84t1bo5	128	15	ecology	ecology	NN
cord-018907-c84t1bo5	128	16	,	,	,
cord-018907-c84t1bo5	128	17	high	high	JJ
cord-018907-c84t1bo5	128	18	presence	presence	NN
cord-018907-c84t1bo5	128	19	of	of	IN
cord-018907-c84t1bo5	128	20	vancomycin	vancomycin	NN
cord-018907-c84t1bo5	128	21	resistance	resistance	NN
cord-018907-c84t1bo5	128	22	enterococci	enterococci	NNP
cord-018907-c84t1bo5	128	23	(	(	-LRB-
cord-018907-c84t1bo5	128	24	VRE	VRE	NNP
cord-018907-c84t1bo5	128	25	)	)	-RRB-
cord-018907-c84t1bo5	128	26	,	,	,
cord-018907-c84t1bo5	128	27	or	or	CC
cord-018907-c84t1bo5	128	28	extended	extend	VBN
cord-018907-c84t1bo5	128	29	spectrum	spectrum	NN
cord-018907-c84t1bo5	128	30	beta	beta	NN
cord-018907-c84t1bo5	128	31	-	-	HYPH
cord-018907-c84t1bo5	128	32	lactamase	lactamase	NN
cord-018907-c84t1bo5	128	33	(	(	-LRB-
cord-018907-c84t1bo5	128	34	ESBL	ESBL	NNP
cord-018907-c84t1bo5	128	35	)	)	-RRB-
cord-018907-c84t1bo5	128	36	producing	produce	VBG
cord-018907-c84t1bo5	128	37	organism	organism	NN
cord-018907-c84t1bo5	128	38	.	.	.
cord-018907-c84t1bo5	129	1	The	the	DT
cord-018907-c84t1bo5	129	2	patient	patient	NN
cord-018907-c84t1bo5	129	3	-	-	HYPH
cord-018907-c84t1bo5	129	4	specific	specific	JJ
cord-018907-c84t1bo5	129	5	factors	factor	NNS
cord-018907-c84t1bo5	129	6	including	include	VBG
cord-018907-c84t1bo5	129	7	recent	recent	JJ
cord-018907-c84t1bo5	129	8	antibiotic	antibiotic	JJ
cord-018907-c84t1bo5	129	9	use	use	NN
cord-018907-c84t1bo5	129	10	such	such	JJ
cord-018907-c84t1bo5	129	11	as	as	IN
cord-018907-c84t1bo5	129	12	current	current	JJ
cord-018907-c84t1bo5	129	13	prophylaxis	prophylaxis	NN
cord-018907-c84t1bo5	129	14	as	as	IN
cord-018907-c84t1bo5	129	15	drug	drug	NN
cord-018907-c84t1bo5	129	16	allergy	allergy	NN
cord-018907-c84t1bo5	129	17	,	,	,
cord-018907-c84t1bo5	129	18	and	and	CC
cord-018907-c84t1bo5	129	19	the	the	DT
cord-018907-c84t1bo5	129	20	underlying	underlying	JJ
cord-018907-c84t1bo5	129	21	organ	organ	NN
cord-018907-c84t1bo5	129	22	dysfunction	dysfunction	NN
cord-018907-c84t1bo5	129	23	.	.	.
cord-018907-c84t1bo5	130	1	The	the	DT
cord-018907-c84t1bo5	130	2	signs	sign	NNS
cord-018907-c84t1bo5	130	3	and	and	CC
cord-018907-c84t1bo5	130	4	symptoms	symptom	NNS
cord-018907-c84t1bo5	130	5	present	present	JJ
cord-018907-c84t1bo5	130	6	at	at	IN
cord-018907-c84t1bo5	130	7	the	the	DT
cord-018907-c84t1bo5	130	8	initial	initial	JJ
cord-018907-c84t1bo5	130	9	evaluation	evaluation	NN
cord-018907-c84t1bo5	130	10	determine	determine	NN
cord-018907-c84t1bo5	130	11	.	.	.
cord-018907-c84t1bo5	131	1	In	in	IN
cord-018907-c84t1bo5	131	2	the	the	DT
cord-018907-c84t1bo5	131	3	recent	recent	JJ
cord-018907-c84t1bo5	131	4	year	year	NN
cord-018907-c84t1bo5	131	5	more	more	JJR
cord-018907-c84t1bo5	131	6	interest	interest	NN
cord-018907-c84t1bo5	131	7	in	in	IN
cord-018907-c84t1bo5	131	8	the	the	DT
cord-018907-c84t1bo5	131	9	outpatient	outpatient	NN
cord-018907-c84t1bo5	131	10	therapy	therapy	NN
cord-018907-c84t1bo5	131	11	for	for	IN
cord-018907-c84t1bo5	131	12	patient	patient	NN
cord-018907-c84t1bo5	131	13	with	with	IN
cord-018907-c84t1bo5	131	14	fever	fever	NN
cord-018907-c84t1bo5	131	15	and	and	CC
cord-018907-c84t1bo5	131	16	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	131	17	.	.	.
cord-018907-c84t1bo5	132	1	The	the	DT
cord-018907-c84t1bo5	132	2	advantages	advantage	NNS
cord-018907-c84t1bo5	132	3	of	of	IN
cord-018907-c84t1bo5	132	4	ambulatory	ambulatory	JJ
cord-018907-c84t1bo5	132	5	management	management	NN
cord-018907-c84t1bo5	132	6	of	of	IN
cord-018907-c84t1bo5	132	7	febrile	febrile	JJ
cord-018907-c84t1bo5	132	8	patients	patient	NNS
cord-018907-c84t1bo5	132	9	with	with	IN
cord-018907-c84t1bo5	132	10	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	132	11	especially	especially	RB
cord-018907-c84t1bo5	132	12	those	those	DT
cord-018907-c84t1bo5	132	13	at	at	IN
cord-018907-c84t1bo5	132	14	low	low	JJ
cord-018907-c84t1bo5	132	15	risk	risk	NN
cord-018907-c84t1bo5	132	16	include	include	VBP
cord-018907-c84t1bo5	132	17	lower	low	JJR
cord-018907-c84t1bo5	132	18	cost	cost	NN
cord-018907-c84t1bo5	132	19	particularly	particularly	RB
cord-018907-c84t1bo5	132	20	with	with	IN
cord-018907-c84t1bo5	132	21	oral	oral	JJ
cord-018907-c84t1bo5	132	22	outpatient	outpatient	NN
cord-018907-c84t1bo5	132	23	therapy	therapy	NN
cord-018907-c84t1bo5	132	24	,	,	,
cord-018907-c84t1bo5	132	25	fewer	few	JJR
cord-018907-c84t1bo5	132	26	superinfections	superinfection	NNS
cord-018907-c84t1bo5	132	27	caused	cause	VBN
cord-018907-c84t1bo5	132	28	by	by	IN
cord-018907-c84t1bo5	132	29	multidrug	multidrug	NN
cord-018907-c84t1bo5	132	30	-	-	HYPH
cord-018907-c84t1bo5	132	31	resistant	resistant	JJ
cord-018907-c84t1bo5	132	32	nosocomial	nosocomial	JJ
cord-018907-c84t1bo5	132	33	pathogens	pathogen	NNS
cord-018907-c84t1bo5	132	34	,	,	,
cord-018907-c84t1bo5	132	35	improved	improve	VBN
cord-018907-c84t1bo5	132	36	quality	quality	NN
cord-018907-c84t1bo5	132	37	of	of	IN
cord-018907-c84t1bo5	132	38	life	life	NN
cord-018907-c84t1bo5	132	39	for	for	IN
cord-018907-c84t1bo5	132	40	patient	patient	NN
cord-018907-c84t1bo5	132	41	,	,	,
cord-018907-c84t1bo5	132	42	greater	great	JJR
cord-018907-c84t1bo5	132	43	.	.	.
cord-018907-c84t1bo5	133	1	Not	not	RB
cord-018907-c84t1bo5	133	2	recommended	recommend	VBN
cord-018907-c84t1bo5	133	3	for	for	IN
cord-018907-c84t1bo5	133	4	routine	routine	JJ
cord-018907-c84t1bo5	133	5	use	use	NN
cord-018907-c84t1bo5	133	6	*	*	NFP
cord-018907-c84t1bo5	134	1	Other	other	JJ
cord-018907-c84t1bo5	134	2	antimicrobials	antimicrobial	NNS
cord-018907-c84t1bo5	134	3	(	(	-LRB-
cord-018907-c84t1bo5	134	4	aminoglycosides	aminoglycoside	NNS
cord-018907-c84t1bo5	134	5	,	,	,
cord-018907-c84t1bo5	134	6	fluoropuinolone	fluoropuinolone	NNP
cord-018907-c84t1bo5	134	7	,	,	,
cord-018907-c84t1bo5	134	8	and/or	and/or	CC
cord-018907-c84t1bo5	134	9	vancomycin	vancomycin	NN
cord-018907-c84t1bo5	134	10	)	)	-RRB-
cord-018907-c84t1bo5	134	11	may	may	MD
cord-018907-c84t1bo5	134	12	be	be	VB
cord-018907-c84t1bo5	134	13	added	add	VBN
cord-018907-c84t1bo5	134	14	to	to	IN
cord-018907-c84t1bo5	134	15	initial	initial	JJ
cord-018907-c84t1bo5	134	16	regimen	regimen	NN
cord-018907-c84t1bo5	134	17	for	for	IN
cord-018907-c84t1bo5	134	18	complicated	complicated	JJ
cord-018907-c84t1bo5	134	19	presentation	presentation	NN
cord-018907-c84t1bo5	134	20	or	or	CC
cord-018907-c84t1bo5	134	21	if	if	IN
cord-018907-c84t1bo5	134	22	resistance	resistance	NN
cord-018907-c84t1bo5	134	23	is	be	VBZ
cord-018907-c84t1bo5	134	24	suspected	suspect	VBN
cord-018907-c84t1bo5	134	25	or	or	CC
cord-018907-c84t1bo5	134	26	proven	prove	VBN
cord-018907-c84t1bo5	134	27	Infections	infection	NNS
cord-018907-c84t1bo5	134	28	in	in	IN
cord-018907-c84t1bo5	134	29	the	the	DT
cord-018907-c84t1bo5	134	30	Immunocompromised	Immunocompromised	NNP
cord-018907-c84t1bo5	134	31	Host	Host	NNP
cord-018907-c84t1bo5	134	32	convenience	convenience	NN
cord-018907-c84t1bo5	134	33	for	for	IN
cord-018907-c84t1bo5	134	34	family	family	NN
cord-018907-c84t1bo5	134	35	or	or	CC
cord-018907-c84t1bo5	134	36	other	other	JJ
cord-018907-c84t1bo5	134	37	caregivers	caregiver	NNS
cord-018907-c84t1bo5	134	38	,	,	,
cord-018907-c84t1bo5	134	39	and	and	CC
cord-018907-c84t1bo5	134	40	more	more	RBR
cord-018907-c84t1bo5	134	41	efficient	efficient	JJ
cord-018907-c84t1bo5	134	42	utilization	utilization	NN
cord-018907-c84t1bo5	134	43	of	of	IN
cord-018907-c84t1bo5	134	44	valuable	valuable	JJ
cord-018907-c84t1bo5	134	45	and	and	CC
cord-018907-c84t1bo5	134	46	expensive	expensive	JJ
cord-018907-c84t1bo5	134	47	resources	resource	NNS
cord-018907-c84t1bo5	134	48	.	.	.
cord-018907-c84t1bo5	135	1	The	the	DT
cord-018907-c84t1bo5	135	2	disadvantage	disadvantage	NN
cord-018907-c84t1bo5	135	3	includes	include	VBZ
cord-018907-c84t1bo5	135	4	the	the	DT
cord-018907-c84t1bo5	135	5	potential	potential	JJ
cord-018907-c84t1bo5	135	6	risk	risk	NN
cord-018907-c84t1bo5	135	7	for	for	IN
cord-018907-c84t1bo5	135	8	developing	develop	VBG
cord-018907-c84t1bo5	135	9	serious	serious	JJ
cord-018907-c84t1bo5	135	10	complications	complication	NNS
cord-018907-c84t1bo5	135	11	such	such	JJ
cord-018907-c84t1bo5	135	12	as	as	IN
cord-018907-c84t1bo5	135	13	septic	septic	JJ
cord-018907-c84t1bo5	135	14	shock	shock	NN
cord-018907-c84t1bo5	135	15	at	at	IN
cord-018907-c84t1bo5	135	16	home	home	NN
cord-018907-c84t1bo5	135	17	,	,	,
cord-018907-c84t1bo5	135	18	risk	risk	NN
cord-018907-c84t1bo5	135	19	of	of	IN
cord-018907-c84t1bo5	135	20	noncompliance	noncompliance	NN
cord-018907-c84t1bo5	135	21	particularly	particularly	RB
cord-018907-c84t1bo5	135	22	with	with	IN
cord-018907-c84t1bo5	135	23	oral	oral	JJ
cord-018907-c84t1bo5	135	24	therapy	therapy	NN
cord-018907-c84t1bo5	135	25	,	,	,
cord-018907-c84t1bo5	135	26	false	false	JJ
cord-018907-c84t1bo5	135	27	sense	sense	NN
cord-018907-c84t1bo5	135	28	of	of	IN
cord-018907-c84t1bo5	135	29	security	security	NN
cord-018907-c84t1bo5	135	30	or	or	CC
cord-018907-c84t1bo5	135	31	inadequate	inadequate	JJ
cord-018907-c84t1bo5	135	32	monitoring	monitoring	NN
cord-018907-c84t1bo5	135	33	for	for	IN
cord-018907-c84t1bo5	135	34	response	response	NN
cord-018907-c84t1bo5	135	35	to	to	IN
cord-018907-c84t1bo5	135	36	therapy	therapy	NN
cord-018907-c84t1bo5	135	37	or	or	CC
cord-018907-c84t1bo5	135	38	toxicity	toxicity	NN
cord-018907-c84t1bo5	135	39	,	,	,
cord-018907-c84t1bo5	135	40	and	and	CC
cord-018907-c84t1bo5	135	41	the	the	DT
cord-018907-c84t1bo5	135	42	need	need	NN
cord-018907-c84t1bo5	135	43	to	to	TO
cord-018907-c84t1bo5	135	44	develop	develop	VB
cord-018907-c84t1bo5	135	45	a	a	DT
cord-018907-c84t1bo5	135	46	team	team	NN
cord-018907-c84t1bo5	135	47	and	and	CC
cord-018907-c84t1bo5	135	48	infrastructure	infrastructure	NN
cord-018907-c84t1bo5	135	49	capable	capable	JJ
cord-018907-c84t1bo5	135	50	of	of	IN
cord-018907-c84t1bo5	135	51	treating	treat	VBG
cord-018907-c84t1bo5	135	52	substantial	substantial	JJ
cord-018907-c84t1bo5	135	53	numbers	number	NNS
cord-018907-c84t1bo5	135	54	of	of	IN
cord-018907-c84t1bo5	135	55	low	low	JJ
cord-018907-c84t1bo5	135	56	-	-	HYPH
cord-018907-c84t1bo5	135	57	risk	risk	NN
cord-018907-c84t1bo5	135	58	patients	patient	NNS
cord-018907-c84t1bo5	135	59	.	.	.
cord-018907-c84t1bo5	136	1	There	there	EX
cord-018907-c84t1bo5	136	2	are	be	VBP
cord-018907-c84t1bo5	136	3	several	several	JJ
cord-018907-c84t1bo5	136	4	requirements	requirement	NNS
cord-018907-c84t1bo5	136	5	for	for	IN
cord-018907-c84t1bo5	136	6	successful	successful	JJ
cord-018907-c84t1bo5	136	7	outpatient	outpatient	NN
cord-018907-c84t1bo5	136	8	treatment	treatment	NN
cord-018907-c84t1bo5	136	9	programs	program	NNS
cord-018907-c84t1bo5	136	10	for	for	IN
cord-018907-c84t1bo5	136	11	patients	patient	NNS
cord-018907-c84t1bo5	136	12	with	with	IN
cord-018907-c84t1bo5	136	13	febrile	febrile	JJ
cord-018907-c84t1bo5	136	14	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	136	15	which	which	WDT
cord-018907-c84t1bo5	136	16	include	include	VBP
cord-018907-c84t1bo5	136	17	institutional	institutional	JJ
cord-018907-c84t1bo5	136	18	infrastructure	infrastructure	NN
cord-018907-c84t1bo5	136	19	and	and	CC
cord-018907-c84t1bo5	136	20	support	support	NN
cord-018907-c84t1bo5	136	21	,	,	,
cord-018907-c84t1bo5	136	22	a	a	DT
cord-018907-c84t1bo5	136	23	dedicated	dedicated	JJ
cord-018907-c84t1bo5	136	24	and	and	CC
cord-018907-c84t1bo5	136	25	experienced	experienced	JJ
cord-018907-c84t1bo5	136	26	team	team	NN
cord-018907-c84t1bo5	136	27	of	of	IN
cord-018907-c84t1bo5	136	28	healthcare	healthcare	NN
cord-018907-c84t1bo5	136	29	providers	provider	NNS
cord-018907-c84t1bo5	136	30	,	,	,
cord-018907-c84t1bo5	136	31	availability	availability	NN
cord-018907-c84t1bo5	136	32	of	of	IN
cord-018907-c84t1bo5	136	33	institution	institution	NN
cord-018907-c84t1bo5	136	34	-	-	HYPH
cord-018907-c84t1bo5	136	35	specific	specific	JJ
cord-018907-c84t1bo5	136	36	epidemiological	epidemiological	JJ
cord-018907-c84t1bo5	136	37	data	datum	NNS
cord-018907-c84t1bo5	136	38	and	and	CC
cord-018907-c84t1bo5	136	39	susceptibility	susceptibility	NN
cord-018907-c84t1bo5	136	40	and	and	CC
cord-018907-c84t1bo5	136	41	resistance	resistance	NN
cord-018907-c84t1bo5	136	42	data	datum	NNS
cord-018907-c84t1bo5	136	43	,	,	,
cord-018907-c84t1bo5	136	44	microbiologically	microbiologically	RB
cord-018907-c84t1bo5	136	45	appropriate	appropriate	JJ
cord-018907-c84t1bo5	136	46	treatment	treatment	NN
cord-018907-c84t1bo5	136	47	regimen	regimen	NN
cord-018907-c84t1bo5	136	48	,	,	,
cord-018907-c84t1bo5	136	49	frequent	frequent	JJ
cord-018907-c84t1bo5	136	50	follow	follow	NN
cord-018907-c84t1bo5	136	51	-	-	HYPH
cord-018907-c84t1bo5	136	52	up	up	NN
cord-018907-c84t1bo5	136	53	monitoring	monitoring	NN
cord-018907-c84t1bo5	136	54	of	of	IN
cord-018907-c84t1bo5	136	55	outpatient	outpatient	NN
cord-018907-c84t1bo5	136	56	,	,	,
cord-018907-c84t1bo5	136	57	adequate	adequate	JJ
cord-018907-c84t1bo5	136	58	transportation	transportation	NN
cord-018907-c84t1bo5	136	59	and	and	CC
cord-018907-c84t1bo5	136	60	communication	communication	NN
cord-018907-c84t1bo5	136	61	capabilities	capability	NNS
cord-018907-c84t1bo5	136	62	,	,	,
cord-018907-c84t1bo5	136	63	and	and	CC
cord-018907-c84t1bo5	136	64	access	access	NN
cord-018907-c84t1bo5	136	65	to	to	IN
cord-018907-c84t1bo5	136	66	management	management	NN
cord-018907-c84t1bo5	136	67	team	team	NN
cord-018907-c84t1bo5	136	68	24	24	CD
cord-018907-c84t1bo5	136	69	h	h	NN
cord-018907-c84t1bo5	136	70	a	a	DT
cord-018907-c84t1bo5	136	71	day	day	NN
cord-018907-c84t1bo5	136	72	,	,	,
cord-018907-c84t1bo5	136	73	7	7	CD
cord-018907-c84t1bo5	136	74	days	day	NNS
cord-018907-c84t1bo5	136	75	a	a	DT
cord-018907-c84t1bo5	136	76	week	week	NN
cord-018907-c84t1bo5	136	77	.	.	.
cord-018907-c84t1bo5	137	1	There	there	EX
cord-018907-c84t1bo5	137	2	are	be	VBP
cord-018907-c84t1bo5	137	3	certain	certain	JJ
cord-018907-c84t1bo5	137	4	clinical	clinical	JJ
cord-018907-c84t1bo5	137	5	events	event	NNS
cord-018907-c84t1bo5	137	6	or	or	CC
cord-018907-c84t1bo5	137	7	manifestations	manifestation	NNS
cord-018907-c84t1bo5	137	8	that	that	WDT
cord-018907-c84t1bo5	137	9	require	require	VBP
cord-018907-c84t1bo5	137	10	modifying	modify	VBG
cord-018907-c84t1bo5	137	11	the	the	DT
cord-018907-c84t1bo5	137	12	initial	initial	JJ
cord-018907-c84t1bo5	137	13	antimicrobial	antimicrobial	JJ
cord-018907-c84t1bo5	137	14	therapy	therapy	NN
cord-018907-c84t1bo5	137	15	;	;	:
cord-018907-c84t1bo5	137	16	for	for	IN
cord-018907-c84t1bo5	137	17	example	example	NN
cord-018907-c84t1bo5	137	18	,	,	,
cord-018907-c84t1bo5	137	19	if	if	IN
cord-018907-c84t1bo5	137	20	a	a	DT
cord-018907-c84t1bo5	137	21	patient	patient	NN
cord-018907-c84t1bo5	137	22	has	have	VBZ
cord-018907-c84t1bo5	137	23	breakthrough	breakthrough	JJ
cord-018907-c84t1bo5	137	24	bacteremia	bacteremia	NN
cord-018907-c84t1bo5	137	25	and	and	CC
cord-018907-c84t1bo5	137	26	if	if	IN
cord-018907-c84t1bo5	137	27	Gram	gram	NN
cord-018907-c84t1bo5	137	28	-	-	HYPH
cord-018907-c84t1bo5	137	29	positive	positive	JJ
cord-018907-c84t1bo5	137	30	is	be	VBZ
cord-018907-c84t1bo5	137	31	isolated	isolate	VBN
cord-018907-c84t1bo5	137	32	(	(	-LRB-
cord-018907-c84t1bo5	137	33	add	add	VB
cord-018907-c84t1bo5	137	34	vancomycin	vancomycin	NN
cord-018907-c84t1bo5	137	35	especially	especially	RB
cord-018907-c84t1bo5	137	36	if	if	IN
cord-018907-c84t1bo5	137	37	there	there	EX
cord-018907-c84t1bo5	137	38	is	be	VBZ
cord-018907-c84t1bo5	137	39	a	a	DT
cord-018907-c84t1bo5	137	40	risk	risk	NN
cord-018907-c84t1bo5	137	41	of	of	IN
cord-018907-c84t1bo5	137	42	MRSA	MRSA	NNP
cord-018907-c84t1bo5	137	43	or	or	CC
cord-018907-c84t1bo5	137	44	pneumococcal	pneumococcal	JJ
cord-018907-c84t1bo5	137	45	resistance	resistance	NN
cord-018907-c84t1bo5	137	46	penicillin	penicillin	NN
cord-018907-c84t1bo5	137	47	)	)	-RRB-
cord-018907-c84t1bo5	137	48	.	.	.
cord-018907-c84t1bo5	138	1	If	if	IN
cord-018907-c84t1bo5	138	2	Gram	gram	NN
cord-018907-c84t1bo5	138	3	-	-	HYPH
cord-018907-c84t1bo5	138	4	negative	negative	JJ
cord-018907-c84t1bo5	138	5	organism	organism	NN
cord-018907-c84t1bo5	138	6	is	be	VBZ
cord-018907-c84t1bo5	138	7	isolated	isolate	VBN
cord-018907-c84t1bo5	138	8	consider	consider	VBP
cord-018907-c84t1bo5	138	9	resistant	resistant	JJ
cord-018907-c84t1bo5	138	10	Gram	gram	NN
cord-018907-c84t1bo5	138	11	-	-	HYPH
cord-018907-c84t1bo5	138	12	negative	negative	JJ
cord-018907-c84t1bo5	138	13	and	and	CC
cord-018907-c84t1bo5	138	14	can	can	MD
cord-018907-c84t1bo5	138	15	change	change	VB
cord-018907-c84t1bo5	138	16	the	the	DT
cord-018907-c84t1bo5	138	17	regimen	regimen	NN
cord-018907-c84t1bo5	138	18	or	or	CC
cord-018907-c84t1bo5	138	19	broaden	broaden	VB
cord-018907-c84t1bo5	138	20	the	the	DT
cord-018907-c84t1bo5	138	21	coverage	coverage	NN
cord-018907-c84t1bo5	138	22	(	(	-LRB-
cord-018907-c84t1bo5	138	23	carbapenems	carbapenem	NNS
cord-018907-c84t1bo5	138	24	if	if	IN
cord-018907-c84t1bo5	138	25	the	the	DT
cord-018907-c84t1bo5	138	26	data	datum	NNS
cord-018907-c84t1bo5	138	27	in	in	IN
cord-018907-c84t1bo5	138	28	the	the	DT
cord-018907-c84t1bo5	138	29	center	center	NN
cord-018907-c84t1bo5	138	30	showed	show	VBD
cord-018907-c84t1bo5	138	31	that	that	IN
cord-018907-c84t1bo5	138	32	the	the	DT
cord-018907-c84t1bo5	138	33	carbapenems	carbapenem	NNS
cord-018907-c84t1bo5	138	34	has	have	VBZ
cord-018907-c84t1bo5	138	35	better	well	JJR
cord-018907-c84t1bo5	138	36	sensitivity	sensitivity	NN
cord-018907-c84t1bo5	138	37	than	than	IN
cord-018907-c84t1bo5	138	38	cephalosporin	cephalosporin	NN
cord-018907-c84t1bo5	138	39	or	or	CC
cord-018907-c84t1bo5	138	40	beta	beta	NN
cord-018907-c84t1bo5	138	41	-	-	HYPH
cord-018907-c84t1bo5	138	42	lactam	lactam	NNS
cord-018907-c84t1bo5	138	43	antibiotic	antibiotic	NN
cord-018907-c84t1bo5	138	44	)	)	-RRB-
cord-018907-c84t1bo5	138	45	.	.	.
cord-018907-c84t1bo5	139	1	If	if	IN
cord-018907-c84t1bo5	139	2	the	the	DT
cord-018907-c84t1bo5	139	3	patient	patient	NN
cord-018907-c84t1bo5	139	4	has	have	VBZ
cord-018907-c84t1bo5	139	5	catheter	catheter	NN
cord-018907-c84t1bo5	139	6	-	-	HYPH
cord-018907-c84t1bo5	139	7	associated	associate	VBN
cord-018907-c84t1bo5	139	8	soft	soft	JJ
cord-018907-c84t1bo5	139	9	tissue	tissue	NN
cord-018907-c84t1bo5	139	10	infection	infection	NN
cord-018907-c84t1bo5	139	11	,	,	,
cord-018907-c84t1bo5	139	12	vancomycin	vancomycin	FW
cord-018907-c84t1bo5	139	13	should	should	MD
cord-018907-c84t1bo5	139	14	be	be	VB
cord-018907-c84t1bo5	139	15	added	add	VBN
cord-018907-c84t1bo5	139	16	.	.	.
cord-018907-c84t1bo5	140	1	Patients	patient	NNS
cord-018907-c84t1bo5	140	2	with	with	IN
cord-018907-c84t1bo5	140	3	severe	severe	JJ
cord-018907-c84t1bo5	140	4	oral	oral	JJ
cord-018907-c84t1bo5	140	5	mucositis	mucositis	NN
cord-018907-c84t1bo5	140	6	or	or	CC
cord-018907-c84t1bo5	140	7	necrotizing	necrotize	VBG
cord-018907-c84t1bo5	140	8	gingivitis	gingivitis	NN
cord-018907-c84t1bo5	140	9	are	be	VBP
cord-018907-c84t1bo5	140	10	at	at	IN
cord-018907-c84t1bo5	140	11	risk	risk	NN
cord-018907-c84t1bo5	140	12	of	of	IN
cord-018907-c84t1bo5	140	13	anaerobic	anaerobic	JJ
cord-018907-c84t1bo5	140	14	bacteria	bacteria	NNS
cord-018907-c84t1bo5	140	15	as	as	RB
cord-018907-c84t1bo5	140	16	well	well	RB
cord-018907-c84t1bo5	140	17	as	as	IN
cord-018907-c84t1bo5	140	18	viruses	virus	NNS
cord-018907-c84t1bo5	140	19	;	;	:
cord-018907-c84t1bo5	140	20	add	add	VB
cord-018907-c84t1bo5	140	21	agent	agent	NN
cord-018907-c84t1bo5	140	22	that	that	WDT
cord-018907-c84t1bo5	140	23	is	be	VBZ
cord-018907-c84t1bo5	140	24	active	active	JJ
cord-018907-c84t1bo5	140	25	against	against	IN
cord-018907-c84t1bo5	140	26	beta	beta	NN
cord-018907-c84t1bo5	140	27	-	-	HYPH
cord-018907-c84t1bo5	140	28	lactamase	lactamase	RB
cord-018907-c84t1bo5	140	29	-	-	HYPH
cord-018907-c84t1bo5	140	30	producing	produce	VBG
cord-018907-c84t1bo5	140	31	anaerobic	anaerobic	JJ
cord-018907-c84t1bo5	140	32	bacteria	bacteria	NNS
cord-018907-c84t1bo5	140	33	including	include	VBG
cord-018907-c84t1bo5	140	34	clindamycin	clindamycin	NN
cord-018907-c84t1bo5	140	35	,	,	,
cord-018907-c84t1bo5	140	36	metronidazole	metronidazole	NN
cord-018907-c84t1bo5	140	37	,	,	,
cord-018907-c84t1bo5	140	38	and	and	CC
cord-018907-c84t1bo5	140	39	acyclovir	acyclovir	NNP
cord-018907-c84t1bo5	140	40	should	should	MD
cord-018907-c84t1bo5	140	41	be	be	VB
cord-018907-c84t1bo5	140	42	considered	consider	VBN
cord-018907-c84t1bo5	140	43	.	.	.
cord-018907-c84t1bo5	141	1	If	if	IN
cord-018907-c84t1bo5	141	2	the	the	DT
cord-018907-c84t1bo5	141	3	patient	patient	NN
cord-018907-c84t1bo5	141	4	has	have	VBZ
cord-018907-c84t1bo5	141	5	diffuse	diffuse	JJ
cord-018907-c84t1bo5	141	6	pneumonia	pneumonia	NN
cord-018907-c84t1bo5	141	7	,	,	,
cord-018907-c84t1bo5	141	8	continue	continue	VB
cord-018907-c84t1bo5	141	9	with	with	IN
cord-018907-c84t1bo5	141	10	the	the	DT
cord-018907-c84t1bo5	141	11	broad	broad	JJ
cord-018907-c84t1bo5	141	12	-	-	HYPH
cord-018907-c84t1bo5	141	13	spectrum	spectrum	NN
cord-018907-c84t1bo5	141	14	anti	anti	JJ
cord-018907-c84t1bo5	141	15	-	-	JJ
cord-018907-c84t1bo5	141	16	Gramnegative	gramnegative	JJ
cord-018907-c84t1bo5	141	17	coverage	coverage	NN
cord-018907-c84t1bo5	141	18	(	(	-LRB-
cord-018907-c84t1bo5	141	19	add	add	VB
cord-018907-c84t1bo5	141	20	trimethoprim	trimethoprim	NNP
cord-018907-c84t1bo5	141	21	-	-	HYPH
cord-018907-c84t1bo5	141	22	sulfamethoxazole	sulfamethoxazole	NNP
cord-018907-c84t1bo5	141	23	and	and	CC
cord-018907-c84t1bo5	141	24	macrolide	macrolide	NN
cord-018907-c84t1bo5	141	25	to	to	IN
cord-018907-c84t1bo5	141	26	the	the	DT
cord-018907-c84t1bo5	141	27	therapy	therapy	NN
cord-018907-c84t1bo5	141	28	)	)	-RRB-
cord-018907-c84t1bo5	141	29	.	.	.
cord-018907-c84t1bo5	142	1	Increasing	increase	VBG
cord-018907-c84t1bo5	142	2	neutrophil	neutrophil	NN
cord-018907-c84t1bo5	142	3	count	count	NN
cord-018907-c84t1bo5	142	4	on	on	IN
cord-018907-c84t1bo5	142	5	patients	patient	NNS
cord-018907-c84t1bo5	142	6	who	who	WP
cord-018907-c84t1bo5	142	7	developed	develop	VBD
cord-018907-c84t1bo5	142	8	new	new	JJ
cord-018907-c84t1bo5	142	9	infiltrates	infiltrate	NNS
cord-018907-c84t1bo5	142	10	while	while	IN
cord-018907-c84t1bo5	142	11	on	on	IN
cord-018907-c84t1bo5	142	12	antibiotic	antibiotic	NN
cord-018907-c84t1bo5	142	13	can	can	MD
cord-018907-c84t1bo5	142	14	be	be	VB
cord-018907-c84t1bo5	142	15	related	relate	VBN
cord-018907-c84t1bo5	142	16	to	to	IN
cord-018907-c84t1bo5	142	17	the	the	DT
cord-018907-c84t1bo5	142	18	recovery	recovery	NN
cord-018907-c84t1bo5	142	19	of	of	IN
cord-018907-c84t1bo5	142	20	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	142	21	.	.	.
cord-018907-c84t1bo5	143	1	If	if	IN
cord-018907-c84t1bo5	143	2	the	the	DT
cord-018907-c84t1bo5	143	3	patient	patient	NN
cord-018907-c84t1bo5	143	4	is	be	VBZ
cord-018907-c84t1bo5	143	5	stable	stable	JJ
cord-018907-c84t1bo5	143	6	observe	observe	NN
cord-018907-c84t1bo5	143	7	if	if	IN
cord-018907-c84t1bo5	143	8	the	the	DT
cord-018907-c84t1bo5	143	9	neutrophil	neutrophil	NN
cord-018907-c84t1bo5	143	10	count	count	NN
cord-018907-c84t1bo5	143	11	is	be	VBZ
cord-018907-c84t1bo5	143	12	not	not	RB
cord-018907-c84t1bo5	143	13	rising	rise	VBG
cord-018907-c84t1bo5	143	14	,	,	,
cord-018907-c84t1bo5	143	15	antifungal	antifungal	JJ
cord-018907-c84t1bo5	143	16	therapy	therapy	NN
cord-018907-c84t1bo5	143	17	should	should	MD
cord-018907-c84t1bo5	143	18	be	be	VB
cord-018907-c84t1bo5	143	19	considered	consider	VBN
cord-018907-c84t1bo5	143	20	as	as	IN
cord-018907-c84t1bo5	143	21	the	the	DT
cord-018907-c84t1bo5	143	22	patient	patient	NN
cord-018907-c84t1bo5	143	23	is	be	VBZ
cord-018907-c84t1bo5	143	24	at	at	IN
cord-018907-c84t1bo5	143	25	risk	risk	NN
cord-018907-c84t1bo5	143	26	for	for	IN
cord-018907-c84t1bo5	143	27	fungal	fungal	JJ
cord-018907-c84t1bo5	143	28	infection	infection	NN
cord-018907-c84t1bo5	143	29	.	.	.
cord-018907-c84t1bo5	144	1	In	in	IN
cord-018907-c84t1bo5	144	2	addition	addition	NN
cord-018907-c84t1bo5	144	3	to	to	IN
cord-018907-c84t1bo5	144	4	other	other	JJ
cord-018907-c84t1bo5	144	5	evaluation	evaluation	NN
cord-018907-c84t1bo5	144	6	Aspergillus	aspergillus	NN
cord-018907-c84t1bo5	144	7	galactomannan	galactomannan	NN
cord-018907-c84t1bo5	144	8	and	and	CC
cord-018907-c84t1bo5	144	9	B	B	NNP
cord-018907-c84t1bo5	144	10	-	-	HYPH
cord-018907-c84t1bo5	144	11	D	D	NNP
cord-018907-c84t1bo5	144	12	glucan	glucan	NN
cord-018907-c84t1bo5	144	13	(	(	-LRB-
cord-018907-c84t1bo5	144	14	fungitell	fungitell	NNP
cord-018907-c84t1bo5	144	15	)	)	-RRB-
cord-018907-c84t1bo5	144	16	should	should	MD
cord-018907-c84t1bo5	144	17	be	be	VB
cord-018907-c84t1bo5	144	18	done	do	VBN
cord-018907-c84t1bo5	144	19	with	with	IN
cord-018907-c84t1bo5	144	20	chest	chest	NN
cord-018907-c84t1bo5	144	21	CT	CT	NNP
cord-018907-c84t1bo5	144	22	scan	scan	NN
cord-018907-c84t1bo5	144	23	.	.	.
cord-018907-c84t1bo5	145	1	Depending	depend	VBG
cord-018907-c84t1bo5	145	2	on	on	IN
cord-018907-c84t1bo5	145	3	the	the	DT
cord-018907-c84t1bo5	145	4	CT	CT	NNP
cord-018907-c84t1bo5	145	5	scan	scan	JJ
cord-018907-c84t1bo5	145	6	findings	finding	NNS
cord-018907-c84t1bo5	145	7	bronchoalveolar	bronchoalveolar	NNP
cord-018907-c84t1bo5	145	8	lavage	lavage	NN
cord-018907-c84t1bo5	145	9	or	or	CC
cord-018907-c84t1bo5	145	10	lung	lung	NN
cord-018907-c84t1bo5	145	11	biopsy	biopsy	NN
cord-018907-c84t1bo5	145	12	should	should	MD
cord-018907-c84t1bo5	145	13	be	be	VB
cord-018907-c84t1bo5	145	14	considered	consider	VBN
cord-018907-c84t1bo5	145	15	.	.	.
cord-018907-c84t1bo5	146	1	Patient	patient	JJ
cord-018907-c84t1bo5	146	2	with	with	IN
cord-018907-c84t1bo5	146	3	prolonged	prolonged	JJ
cord-018907-c84t1bo5	146	4	fever	fever	NN
cord-018907-c84t1bo5	146	5	and	and	CC
cord-018907-c84t1bo5	146	6	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	146	7	needs	need	VBZ
cord-018907-c84t1bo5	146	8	to	to	TO
cord-018907-c84t1bo5	146	9	be	be	VB
cord-018907-c84t1bo5	146	10	observed	observe	VBN
cord-018907-c84t1bo5	146	11	if	if	IN
cord-018907-c84t1bo5	146	12	recovery	recovery	NN
cord-018907-c84t1bo5	146	13	of	of	IN
cord-018907-c84t1bo5	146	14	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	146	15	is	be	VBZ
cord-018907-c84t1bo5	146	16	not	not	RB
cord-018907-c84t1bo5	146	17	imminent	imminent	JJ
cord-018907-c84t1bo5	146	18	.	.	.
cord-018907-c84t1bo5	147	1	Antifungal	antifungal	JJ
cord-018907-c84t1bo5	147	2	therapy	therapy	NN
cord-018907-c84t1bo5	147	3	can	can	MD
cord-018907-c84t1bo5	147	4	include	include	VB
cord-018907-c84t1bo5	147	5	either	either	CC
cord-018907-c84t1bo5	147	6	regular	regular	JJ
cord-018907-c84t1bo5	147	7	amphotericin	amphotericin	NNS
cord-018907-c84t1bo5	147	8	B	b	NN
cord-018907-c84t1bo5	147	9	,	,	,
cord-018907-c84t1bo5	147	10	or	or	CC
cord-018907-c84t1bo5	147	11	lipid	lipid	NN
cord-018907-c84t1bo5	147	12	formulation	formulation	NN
cord-018907-c84t1bo5	147	13	of	of	IN
cord-018907-c84t1bo5	147	14	amphotericin	amphotericin	NNS
cord-018907-c84t1bo5	147	15	B	B	NNP
cord-018907-c84t1bo5	147	16	including	include	VBG
cord-018907-c84t1bo5	147	17	liposomal	liposomal	IN
cord-018907-c84t1bo5	147	18	amphotericin	amphotericin	NNS
cord-018907-c84t1bo5	147	19	B	b	NN
cord-018907-c84t1bo5	147	20	(	(	-LRB-
cord-018907-c84t1bo5	147	21	amBisome	ambisome	NN
cord-018907-c84t1bo5	147	22	)	)	-RRB-
cord-018907-c84t1bo5	147	23	or	or	CC
cord-018907-c84t1bo5	147	24	amphotericin	amphotericin	NNS
cord-018907-c84t1bo5	147	25	B	b	NN
cord-018907-c84t1bo5	147	26	lipid	lipid	NN
cord-018907-c84t1bo5	147	27	complex	complex	NN
cord-018907-c84t1bo5	147	28	(	(	-LRB-
cord-018907-c84t1bo5	147	29	ABLC	ABLC	NNP
cord-018907-c84t1bo5	147	30	)	)	-RRB-
cord-018907-c84t1bo5	147	31	,	,	,
cord-018907-c84t1bo5	147	32	caspofungin	caspofungin	NNP
cord-018907-c84t1bo5	147	33	or	or	CC
cord-018907-c84t1bo5	147	34	voriconazole	voriconazole	NN
cord-018907-c84t1bo5	147	35	depending	depend	VBG
cord-018907-c84t1bo5	147	36	of	of	IN
cord-018907-c84t1bo5	147	37	the	the	DT
cord-018907-c84t1bo5	147	38	availability	availability	NN
cord-018907-c84t1bo5	147	39	of	of	IN
cord-018907-c84t1bo5	147	40	medications	medication	NNS
cord-018907-c84t1bo5	147	41	and	and	CC
cord-018907-c84t1bo5	147	42	epidemiology	epidemiology	NN
cord-018907-c84t1bo5	147	43	of	of	IN
cord-018907-c84t1bo5	147	44	the	the	DT
cord-018907-c84t1bo5	147	45	institution	institution	NN
cord-018907-c84t1bo5	147	46	.	.	.
cord-018907-c84t1bo5	148	1	Infections	infection	NNS
cord-018907-c84t1bo5	148	2	in	in	IN
cord-018907-c84t1bo5	148	3	the	the	DT
cord-018907-c84t1bo5	148	4	immunocompromised	immunocompromised	JJ
cord-018907-c84t1bo5	148	5	Low	low	JJ
cord-018907-c84t1bo5	148	6	risk	risk	NN
cord-018907-c84t1bo5	148	7	episodes	episode	NNS
cord-018907-c84t1bo5	148	8	of	of	IN
cord-018907-c84t1bo5	148	9	fever	fever	NN
cord-018907-c84t1bo5	148	10	and	and	CC
cord-018907-c84t1bo5	148	11	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	148	12	in	in	IN
cord-018907-c84t1bo5	148	13	pediatric	pediatric	JJ
cord-018907-c84t1bo5	148	14	oncology	oncology	NN
cord-018907-c84t1bo5	148	15	:	:	:
cord-018907-c84t1bo5	148	16	is	be	VBZ
cord-018907-c84t1bo5	148	17	outpatient	outpatient	JJ
cord-018907-c84t1bo5	148	18	oral	oral	JJ
cord-018907-c84t1bo5	148	19	antibiotic	antibiotic	JJ
cord-018907-c84t1bo5	148	20	therapy	therapy	NN
cord-018907-c84t1bo5	148	21	the	the	DT
cord-018907-c84t1bo5	148	22	new	new	JJ
cord-018907-c84t1bo5	148	23	gold	gold	NN
cord-018907-c84t1bo5	148	24	standard	standard	JJ
cord-018907-c84t1bo5	148	25	care	care	NN
cord-018907-c84t1bo5	148	26	?	?	.
cord-018907-c84t1bo5	149	1	Predicting	predict	VBG
cord-018907-c84t1bo5	149	2	events	event	NNS
cord-018907-c84t1bo5	149	3	in	in	IN
cord-018907-c84t1bo5	149	4	children	child	NNS
cord-018907-c84t1bo5	149	5	with	with	IN
cord-018907-c84t1bo5	149	6	fever	fever	NN
cord-018907-c84t1bo5	149	7	and	and	CC
cord-018907-c84t1bo5	150	1	chemotherapy	chemotherapy	NN
cord-018907-c84t1bo5	150	2	-	-	HYPH
cord-018907-c84t1bo5	150	3	induced	induce	VBN
cord-018907-c84t1bo5	150	4	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	150	5	:	:	:
cord-018907-c84t1bo5	150	6	the	the	DT
cord-018907-c84t1bo5	150	7	prospective	prospective	JJ
cord-018907-c84t1bo5	150	8	multicenter	multicenter	JJ
cord-018907-c84t1bo5	150	9	SPOG	SPOG	NNP
cord-018907-c84t1bo5	150	10	2003	2003	CD
cord-018907-c84t1bo5	150	11	FN	FN	NNP
cord-018907-c84t1bo5	150	12	study	study	NN
cord-018907-c84t1bo5	150	13	Cefepime	Cefepime	NNP
cord-018907-c84t1bo5	150	14	and	and	CC
cord-018907-c84t1bo5	150	15	death	death	NN
cord-018907-c84t1bo5	150	16	:	:	:
cord-018907-c84t1bo5	150	17	reality	reality	NN
cord-018907-c84t1bo5	150	18	to	to	TO
cord-018907-c84t1bo5	150	19	rescue	rescue	VB
cord-018907-c84t1bo5	150	20	Clinical	clinical	JJ
cord-018907-c84t1bo5	150	21	practice	practice	NN
cord-018907-c84t1bo5	150	22	guideline	guideline	NN
cord-018907-c84t1bo5	150	23	for	for	IN
cord-018907-c84t1bo5	150	24	the	the	DT
cord-018907-c84t1bo5	150	25	use	use	NN
cord-018907-c84t1bo5	150	26	of	of	IN
cord-018907-c84t1bo5	150	27	antimicrobial	antimicrobial	JJ
cord-018907-c84t1bo5	150	28	agents	agent	NNS
cord-018907-c84t1bo5	150	29	in	in	IN
cord-018907-c84t1bo5	150	30	neutropenic	neutropenic	JJ
cord-018907-c84t1bo5	150	31	patients	patient	NNS
cord-018907-c84t1bo5	150	32	with	with	IN
cord-018907-c84t1bo5	150	33	cancer	cancer	NN
cord-018907-c84t1bo5	150	34	:	:	:
cord-018907-c84t1bo5	151	1	2010	2010	CD
cord-018907-c84t1bo5	151	2	update	update	NN
cord-018907-c84t1bo5	151	3	by	by	IN
cord-018907-c84t1bo5	151	4	the	the	DT
cord-018907-c84t1bo5	151	5	infectious	infectious	JJ
cord-018907-c84t1bo5	151	6	society	society	NN
cord-018907-c84t1bo5	151	7	of	of	IN
cord-018907-c84t1bo5	151	8	America	America	NNP
cord-018907-c84t1bo5	151	9	Etiology	Etiology	NNP
cord-018907-c84t1bo5	151	10	and	and	CC
cord-018907-c84t1bo5	151	11	clinical	clinical	JJ
cord-018907-c84t1bo5	151	12	course	course	NN
cord-018907-c84t1bo5	151	13	of	of	IN
cord-018907-c84t1bo5	151	14	febrile	febrile	JJ
cord-018907-c84t1bo5	151	15	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	151	16	in	in	IN
cord-018907-c84t1bo5	151	17	children	child	NNS
cord-018907-c84t1bo5	151	18	with	with	IN
cord-018907-c84t1bo5	151	19	cancer	cancer	NN
cord-018907-c84t1bo5	151	20	Risk	Risk	NNP
cord-018907-c84t1bo5	151	21	prediction	prediction	NN
cord-018907-c84t1bo5	151	22	in	in	IN
cord-018907-c84t1bo5	151	23	pediatric	pediatric	JJ
cord-018907-c84t1bo5	151	24	cancer	cancer	NN
cord-018907-c84t1bo5	151	25	patients	patient	NNS
cord-018907-c84t1bo5	151	26	with	with	IN
cord-018907-c84t1bo5	151	27	fever	fever	NN
cord-018907-c84t1bo5	151	28	and	and	CC
cord-018907-c84t1bo5	151	29	neutopenia	neutopenia	NNP
cord-018907-c84t1bo5	151	30	Advances	advance	VBZ
cord-018907-c84t1bo5	151	31	in	in	IN
cord-018907-c84t1bo5	151	32	the	the	DT
cord-018907-c84t1bo5	151	33	management	management	NN
cord-018907-c84t1bo5	151	34	of	of	IN
cord-018907-c84t1bo5	151	35	primary	primary	JJ
cord-018907-c84t1bo5	151	36	immunodeficiency	immunodeficiency	NN
cord-018907-c84t1bo5	151	37	Immunocompromised	immunocompromise	VBN
cord-018907-c84t1bo5	151	38	children	child	NNS
cord-018907-c84t1bo5	151	39	:	:	:
cord-018907-c84t1bo5	151	40	conditions	condition	NNS
cord-018907-c84t1bo5	151	41	and	and	CC
cord-018907-c84t1bo5	151	42	infectious	infectious	JJ
cord-018907-c84t1bo5	151	43	agents	agent	NNS
cord-018907-c84t1bo5	151	44	Emprical	Emprical	NNP
cord-018907-c84t1bo5	151	45	oral	oral	JJ
cord-018907-c84t1bo5	151	46	antibiotic	antibiotic	JJ
cord-018907-c84t1bo5	151	47	therapy	therapy	NN
cord-018907-c84t1bo5	151	48	for	for	IN
cord-018907-c84t1bo5	151	49	low	low	JJ
cord-018907-c84t1bo5	151	50	risk	risk	NN
cord-018907-c84t1bo5	151	51	febrile	febrile	JJ
cord-018907-c84t1bo5	151	52	cancer	cancer	NN
cord-018907-c84t1bo5	151	53	patients	patient	NNS
cord-018907-c84t1bo5	151	54	with	with	IN
cord-018907-c84t1bo5	151	55	neutropenia	neutropenia	NNP
cord-018907-c84t1bo5	151	56	Meta	Meta	NNP
cord-018907-c84t1bo5	151	57	-	-	HYPH
cord-018907-c84t1bo5	151	58	Analysis	Analysis	NNP
cord-018907-c84t1bo5	151	59	of	of	IN
cord-018907-c84t1bo5	151	60	a	a	DT
cord-018907-c84t1bo5	151	61	possible	possible	JJ
cord-018907-c84t1bo5	151	62	signal	signal	NN
cord-018907-c84t1bo5	151	63	of	of	IN
cord-018907-c84t1bo5	151	64	increased	increase	VBN
cord-018907-c84t1bo5	151	65	mortality	mortality	NN
cord-018907-c84t1bo5	151	66	associated	associate	VBN
cord-018907-c84t1bo5	151	67	with	with	IN
cord-018907-c84t1bo5	151	68	cefepime	cefepime	NNP
cord-018907-c84t1bo5	151	69	use	use	VBP
cord-018907-c84t1bo5	151	70	Febrile	febrile	JJ
cord-018907-c84t1bo5	151	71	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	151	72	:	:	:
cord-018907-c84t1bo5	151	73	a	a	DT
cord-018907-c84t1bo5	151	74	critical	critical	JJ
cord-018907-c84t1bo5	151	75	review	review	NN
cord-018907-c84t1bo5	151	76	of	of	IN
cord-018907-c84t1bo5	151	77	the	the	DT
cord-018907-c84t1bo5	151	78	initial	initial	JJ
cord-018907-c84t1bo5	151	79	MANAGEMENT	management	NN
cord-018907-c84t1bo5	151	80	Fever	Fever	NNP
cord-018907-c84t1bo5	151	81	and	and	CC
cord-018907-c84t1bo5	151	82	neutropenia	neutropenia	NN
cord-018907-c84t1bo5	151	83	in	in	IN
cord-018907-c84t1bo5	151	84	pediatric	pediatric	JJ
cord-018907-c84t1bo5	151	85	patients	patient	NNS
cord-018907-c84t1bo5	151	86	with	with	IN
cord-018907-c84t1bo5	151	87	cancer	cancer	NN
cord-018907-c84t1bo5	151	88	)	)	-RRB-
cord-018907-c84t1bo5	152	1	b	b	LS
cord-018907-c84t1bo5	152	2	lactam	lactam	NNP
cord-018907-c84t1bo5	152	3	monotherapy	monotherapy	NN
cord-018907-c84t1bo5	152	4	versus	versus	IN
cord-018907-c84t1bo5	152	5	b	b	LS
cord-018907-c84t1bo5	152	6	lactam	lactam	NN
cord-018907-c84t1bo5	152	7	-	-	HYPH
cord-018907-c84t1bo5	152	8	aminoglycoside	aminoglycoside	NN
cord-018907-c84t1bo5	152	9	combination	combination	NN
cord-018907-c84t1bo5	152	10	therapy	therapy	NN
cord-018907-c84t1bo5	152	11	for	for	IN
cord-018907-c84t1bo5	152	12	sepsis	sepsis	NN
cord-018907-c84t1bo5	152	13	in	in	IN
cord-018907-c84t1bo5	152	14	immunocompetent	immunocompetent	JJ
cord-018907-c84t1bo5	152	15	patients	patient	NNS
cord-018907-c84t1bo5	152	16	:	:	:
cord-018907-c84t1bo5	152	17	systemic	systemic	JJ
cord-018907-c84t1bo5	152	18	review	review	NN
cord-018907-c84t1bo5	152	19	and	and	CC
cord-018907-c84t1bo5	152	20	meta	meta	NNP
cord-018907-c84t1bo5	152	21	-	-	HYPH
cord-018907-c84t1bo5	152	22	analysis	analysis	NN
cord-018907-c84t1bo5	152	23	of	of	IN
cord-018907-c84t1bo5	152	24	randomized	randomized	JJ
cord-018907-c84t1bo5	152	25	trials	trial	NNS
cord-018907-c84t1bo5	152	26	Fever	Fever	NNP
cord-018907-c84t1bo5	152	27	in	in	IN
cord-018907-c84t1bo5	152	28	immunocompromised	immunocompromised	JJ
cord-018907-c84t1bo5	152	29	patients	patient	NNS
cord-018907-c84t1bo5	152	30	Bloodstream	bloodstream	JJ
cord-018907-c84t1bo5	152	31	infections	infection	NNS
cord-018907-c84t1bo5	152	32	in	in	IN
cord-018907-c84t1bo5	152	33	hematology	hematology	NN
cord-018907-c84t1bo5	152	34	:	:	:
cord-018907-c84t1bo5	152	35	risks	risk	NNS
cord-018907-c84t1bo5	152	36	and	and	CC
cord-018907-c84t1bo5	152	37	new	new	JJ
cord-018907-c84t1bo5	152	38	challenges	challenge	NNS
cord-018907-c84t1bo5	152	39	for	for	IN
cord-018907-c84t1bo5	152	40	prevention	prevention	NN
cord-018907-c84t1bo5	152	41	Pediatric	pediatric	JJ
cord-018907-c84t1bo5	152	42	cancer	cancer	NN
cord-018907-c84t1bo5	152	43	patients	patient	NNS
cord-018907-c84t1bo5	152	44	in	in	IN
cord-018907-c84t1bo5	152	45	clinical	clinical	JJ
cord-018907-c84t1bo5	152	46	trials	trial	NNS
cord-018907-c84t1bo5	152	47	of	of	IN
cord-018907-c84t1bo5	152	48	sepsis	sepsis	NN
cord-018907-c84t1bo5	152	49	:	:	:
cord-018907-c84t1bo5	152	50	factors	factor	NNS
cord-018907-c84t1bo5	152	51	that	that	WDT
cord-018907-c84t1bo5	152	52	predispose	predispose	VBP
cord-018907-c84t1bo5	152	53	to	to	TO
cord-018907-c84t1bo5	152	54	sepsis	sepsis	VB
cord-018907-c84t1bo5	152	55	and	and	CC
cord-018907-c84t1bo5	152	56	stratify	stratify	VB
cord-018907-c84t1bo5	152	57	outcome	outcome	NN